CA2075818A1 - Triarylmethyl radicals and the use of inert carbon free radicals in mri - Google Patents

Triarylmethyl radicals and the use of inert carbon free radicals in mri

Info

Publication number
CA2075818A1
CA2075818A1 CA002075818A CA2075818A CA2075818A1 CA 2075818 A1 CA2075818 A1 CA 2075818A1 CA 002075818 A CA002075818 A CA 002075818A CA 2075818 A CA2075818 A CA 2075818A CA 2075818 A1 CA2075818 A1 CA 2075818A1
Authority
CA
Canada
Prior art keywords
formula
group
mmol
compound
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002075818A
Other languages
French (fr)
Inventor
Mikkel Joergensen
Frode Rise
Sven Andersson
Torsten Almen
Arne Aabye
Lars-Goeran Wistrand
Haken Wikstroem
Klaes Golman
Rolf Servin
Peter Michelsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amersham Health R&D AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909003105A external-priority patent/GB9003105D0/en
Priority claimed from GB909012300A external-priority patent/GB9012300D0/en
Application filed by Individual filed Critical Individual
Publication of CA2075818A1 publication Critical patent/CA2075818A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/20Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Abstract

The invention relates to the use of carbon stable free radicals as image enhancements agents in Overhauser MRI.

Description

WO 91/12024 PCI/E:P91/00285 TRIARYLME:[HYL RADIC~LS AND TE~E USE OF INERT CARBON 2 0 7 ~ 818 FREE RADICALS IN MRI.

The present invention relates to the use of stable free radicals, in particular inert carbon radicals, as image enhancing ayents in magnetic resonance imaging (MRI) as well as to contrast media containing such radicals and to the use of such radicals and their non-radical precursors in the manufacture of MRI contrast media.
MRI is a diagnostic technique that has become particularly attractive to physicians as it is non-invasive and does not involve exposing the patient under study to potentially harmful radiation, such as for example the X-radiation of conventional radiography.
This technique, however suffers from several serious drawbacks, including in particular the expense of manufacture and operation of the MRI apparatus, the relatively long scanning time required to produce an image of acceptable spatial resolution, and the problem of achieving contrast in the magnetic resonance (MR) images between tissue types having the same or closely similar imaging parameters, for example in order to cause a tissue abnormality to show up clearly in the mages .
The expense of manufacture and operation of an MRI
apparatus is closely associated with the strength of the magnetic field that the primary magnet in the apparatus is re~uired to generate in order to produce images of acceptable spatial resolution in an acceptable time.
MR images are generated by manipulation of the MR
signals detected from the sample, for example a human or animal body, placed in a magnetlc field and exposed to pulses of radiation of a frequency (typically radiofrequency (RF)) selected to excite MR transitions in selected non-zero spin nuclei (the "imaging nuclei",
2~2~ PCT/EP~1/0~285 t ' 207~818 which are generally water protons in body fluids) in the sample.
The amplltude of the induced MR signals is dependent upon various factors such as the strenyth oE
the magnetic field experienced by the sample, the temperature oP the sample, the density of the imaging nuclei within the sample, the isotopic nature and chemical environment of the imaginy nuclei and the local inhomogeneities in magnetic field experienced by the imaging nuclei.
Thus many techniques have been proposed for enhancing MR image quality, for example by increasing MR
signal amplitude or by increasing the difference in MR
signal amplitude between different tissue types.
The imaging parameters (nuclear density, T1 and T2) for tissues of interest may be altered and many proposals have been made for doing this by the administration of magnetically responsive materials into patients under study (see for example EP-~-71564 (Schering), EP-A-13367~ (Schering) and W0-A--~5/04330 (Jacobsen)). Where such materials, generally referred to as MRI contrast agents, are paramagnetic they produce significant reduction in the T1 of the water protons in the body zones into which they are administered or at which they congregate, and.where the materials are ferromagnetic or superparamagnetic (for example as suggested by Jacobsen) they produce a significant reduction in the T2 f the water protons. In either case the result is enhanced (positive or negat.ive) contrast in the MR images of such zones.
The contrast enhancement achievable by such agents in conventional MRI is relatively limited and it is generally not such as to allow a reduction in the image acquisition period or in the field strength of the primary magnet.
Utilisation of the spin transition coupling phenomenon known as dynamic nuclear polarisation or as WO91/1~024 P~T/EP91/0028~
,::
2~73~1 ~
the Overhauser effect to amplify the population difference between the ground and excited spin states of the imaging nuclei by the excitation of a coupled ESR
transition in a paramagnetic species present in the sample being imaged has been described by Hafslund Nycomed Innovation AB in WO-~-8~/10~19.
This new technlque for generatin~ a MR image of the sample, which is hereinafter termed electron spin resonance enhanced magnetic resonance imaging (ESREMRI), or Overhauser MRI, involves exposing the sample to a first radiation of a frequency selected to excite nuclear spin transitions in selected nuclei in the sample (radiation which is generally of radiofrequency or thereabouts and thus for convenience will be referred to hereinafter as RF radiation) and also exposing the sample to a second radiation of a frequency selected to excite electron spin transitions coupled to nuclear spin transitions for at least some of the selected nuclei ~radiation which is generally of microwave frequency or thereabouts and thus for convenience is referred to hereinafter as MW or UHF radiation), the MR images being generated from the resulting amplified MR signals (free induction decay signals) emitted by the sample.
The paramagnetic substance which possesses the ESR
transition which couples wlth the NMR transition of the image nuclei may be naturally present within the imaging sample or more usually may be administered as an ESREMRI
contrast agent.
In WO-A-88/10~19 various ESRE~RI contrast agents were proposed, for the most part these being nitroxide stable free radicals, although the use of chloranil semiquinone radical and of Fremy's salt was also proposed.
In WO-A-90/00904 Hafslund Nycomed Innovation AB
proposed the use of deuterated stable free radicals, in particular deuterated nitroxide stable free radicals, as ESREMRI contrast agen~s.

WO91/12024 PCT/EP91/0~28~

20758~8 Organic free radicals however frequently have properties which render-them unsuitable for use as ESREMRI contrast agents. Thus free radicals commonly are unstable ln physiological conditions, or have very short half-lives leading to toxicity problems. A
further drawback is the low relaxivity exhibited by many free radicals, which results in poor coupliny of the electron and nuclear spin transitions and thus a poor enhancement of the magnetic resonance signal. A need therefore exists for improved free radical ESREMRI
contrast agents. ;.
The ESREMRI contrast agents so far proposed in the literature have all been "oxygen free radicals" that is to say radicals where the unpaired electron or electrons are associated with oxygen atoms.
We have now surprisingly found that carbon free radicals, i.e. radicals where the unpaired electron or electrons are primarily associated with carbon atoms are particularly attractive for use as ESREMRI contrast agents.
For such free radicals to be effective, they should be relatively long lived and to distinguish from free radicals which have a momentary existence, those usable as ESREMRI contrast agents will be referred to herein as being "inert" free radicals, that is having a half life of at least one minute at ambient temperature.
Viewed from one aspect the present invention thus provides the use of an inert carbon free radical for the manufacture of a contrast medium for use in ESREMRI.
Viewed from a further aspect, the invention also provides a method of magnetic resonance investigation of a sample, said method comprising introducing into said sample an inert carhon free radical, exposing said sample to a first radiation of a frequency selected to excite electron spin transitions in said free radical, exposing said sample to a second radiation of a frequency selected to excite nuclear spin transitions in WO91/1202~ ~CT/EP91/0~8~
2 ~ 7 ~

selected nuclei in said sample, detecting free induction decay signals from said sample, and, optionally, generating an lmage or dynamic flo~ data from said detectPd signals.
Viewed from a still fur-ther aspect, the invention also provides a magnetic resollance imaging contrast medium ~-omprisi.ng a physiologically tolerable inert carbon ~ree radical together with at least one pharmacologically acceptable carrier or excipient.
For in vivo imaging, the inert carbon free radical should of course preferably be a physiologically tolerable radical, or one presented in a physiologically tolerable, e.g. encapsulated, form.
Inert carbon free radicals are well known and a range of these has been described for example by Ballester et al. (see JACS 93: 2215 (1971), J.Org.Chem.
47:259-64 and 4498 (1982), 48 3716 (1983), 53 1267-73 (1980), 54 ~811-15 (1989), Accounts of Chemical ~esearch 18:380 (1985) and references therein); Fox et al. (see JACS 109, 7088-94); Gomberg, JACS 22, 757 (1900);
Neunhoffer Chem. Ber., 91, 1801 (1958); Maki, Chem.
Phys, 35, 761 (1963); Dunnebacke, Chem.Ber. 122 533 (1989); Jundeikis JACS 84 1132 (1961); Sinclair, JACS 90 5074 (1968); Bent, JACS 84 3250 (1932); Falle, Canad. J.
Chem. 44 1387 (1966); Ziegler, ~nnalen 458 248 (1927);
Allan, JCS (1936) 440; Acta (Chem. Scand. 16 1817 (1962); Theilacker, Annalen 594 214 (1955); Muller, Angew. Chem. 5 6 tl966); Schlenck, Annalen 372 1 (1910);
Teilacker, Angew. Chem. 69 322 (1957); Sabacky, JACS 89 2054 (1967); Muller, Tetrakedron Lett 3877, (1967);
Marvel JACS 66 415 (1944); and Trapp, J. Chem. Phys 45 3472 (1966).
Preferred inert carbon free radicals ~or use according to the invention exhibit high stability to oxygen, to p~, for example in the range pH 5-9, and in aqueous solution, particularly stability up to a concentration of 300 mM. Furtner desirable WO91/120~4 PC~/EP91/00285 2Q75~8 characteristics include reduced tendency to dimerization, long half-life, preferably greater than l minute, particularly preferably greater than l hour and especially pre~erably l year, long relaxation times, both T1e and T2e preferably beiny greater than l ~sec, high relaxivity, ~or example greater than 0.3 mM1sec and a small number of esr transition lines.
Particularly preferred inert carbon free radicals include the substituted methyl radicals, in particular triarylmethyl radicals where each of the three aromatic substituent groups may be the same or different and where two or three such groups may optionally be linked together. Particularly preferably the radical comprises optionally substituted six-membered carbocyclic or heterocyclic aromatic rings optionally carrying one or nore fused carbocyclic or heterocyclic rings.
The possibility exists to optimize different characteristics, e.g. solubility, stability, line broadening, of the overall radical by appropriate combina-tions of different aryl substituents on the methyl carbon. Combinations, where two such aryl substituents, preferably identical, are selected to optimize stability and line broadening, and one aryl substituent is selected to optimize solubility are considered particularly interesting.
In order to optimize the above-mentioned desirable properties, a number of criteria need to be borne in mind in selecting or constructing triarylmethyl radicals for use according to the invention.
Thus, the aromatic rings of the triarylmethyl radical advantageously are substituted and the nuclear identities of nuclei in all substituents and their position ~ithin the molecule should be selected so as to minimise their effect tline splitting or broadening) on the esr transition.
In such cases, a six-membered aromatic ring is preferably substituted at the ortho and para positions.

WO91/12024 PCT/EP91/0028~

7 207~8 This is desirable in order to minimise dimerisation and oxygen attack on the molecule. The meta position is optionally substituted, preferably with a bulky substituent, again to minimise attack by oxygen and at least one of the substituents should conveniently comprise a water solubilizing moiety. Such substituen-ts preferably h~ve no magnetic moment, or have a very low e~fective spin density. Alternatively, in order to minimise their effect on the esr transition, the substituents should be bonded in such a manner that they are capable of free rotation.
Particularly preferred inert carbon free radicals include the triarylmethyl radicals of formula I

.C(Ar1)3 (I) (where each group Arl, which may be the same or different, is preferably a substituted thienyl, phenyl, 4-pyridinyl, 3~pyridinyl, 2-pyridinyl, 5-pyrimidyl or 4-pyrimidyl group). Other preferred triarylmethyl radicals include those of formula la ( Ar12 ) 3C . ( Ia) where each Ar~2, which may be the same or different, comprises an optionally substituted 5-7 membered carbocyclic or heterocyclic aromatic ring optionally carying one or more fused carbocyclic or heterocyclic rings, one or more such Ar12 groups preferably being a group Ar1 as defined herein.
Particularly preferably each group Ar1 represents a 6 membe.red carbon-attached carbocyclic or heterocyclic aromatic ring containing up to ~ non-adjacent ring nitrogens optionally substituted at the or any ortho carbon by a group R1 to R4, at the or any meta carbon by a group R2 or R3 and at any para carbon by a group R1,R2,R3 or R4, with the proviso that no more than two W091/12024 PCT/EP91/0028~
d - 'i 2~75~18 ring carbons are unsubstituted, preferably only one ring carbon at most keing unsubstituted;
each of R1 to R4, which may be the same or different, independently represents a group of formula -M, -XM, -XAr2 or -Ar2; M represents a water solubiliziny group, each group X, wh.ich may be the same or different, represents an oxyyen or sulphur atom or a N~l or CH2 yroup;
~r2 represents a 5 to 10 membered aromatic ring optionally su~stituted by a solubilizing group M;
or groups Rl and/or R4 on different Arl groups may together represent bridging oxygen or sulphur atoms or NRs or CRs2 groups, where Rs represents a hydrogen atom or an optionally hydroxylated, optionally aminated, optionally alkoxylated, optionally carboxylated alkyl, oxo-alkyl, alkenyl or alkaryl group;
or groups R2 and R3 may also represent hydroien atoms or alkyl groups;
or adjacent groups R1, RZ, R3 or R4, preferably groups at the ortho and meta portions, together with the two intervening carbon atoms may represent groups of formula ~u ~Y~z ~ Z~

Rb where R6 represents a hydrogen atom, a hydroxyl group, an optionally alkoxylated, optionally hydroxylated acyloxy or alkyl group or a solubilising group M; Z represents an oxygen or sulphur atom or a group NRs, CR72, or SiR72;
each R7, which may be the same or different, represents a hydrogen atom, an alkyl, hydroxyalkyl, alkoxycarbonyl or carbamoyl group or two groups R7 together with the atom - 9 - 2~
to which they are bound represent a carbonyl group or a 5 to 8 membered cycloalkylidene, mono- or di-oxacycloalkylidene, mono- or di-azacycloalkylidene or mono or di-thiacycloalkylidene group optionally with the ring attachment carbon replaced by a silicon atom (preferably however in any spiro structure the ring linking atom will be bonded to no more than three heteroatoms) and R7 where it is other than hydrogen, is optionally substituted by a group R6;
or a salt thereof.
In the radicals of formula I, the groups Arl are preferably groups of formula R1 R2 Rl Rl R2 ~r ~ ~R2 ~(r Rl R2 ~--R2 ~R2 R/~ R ~ ' R//~ R ~

where each Y lndependently represents CH, or more preferably CM, C-XM, C-Ar2, C-XAr2 or a nitrogen atom.
Certain of the radicals of formula I are new and they, their salts and their non-radical precursors (i.e.
compounds of formula (Ar12)3CX4 or (Arl) 3CX4 where X4 is a leaving group, e.g. hydrogen, hydroxyl, halogen, carboxyl, CO2OCO.C(Ar12)3 or NNC(Ar~2) 3) form further aspects of the present invention.
In the inert carbon radicals of formula I, the solubilizing groups M may be any of the solubilizing W~91/12024 PCT/EP~ 0285 2~7~18 groups conventionally used in diagnostic and pharmaceutical products. Particularly preferred solubilizing groups M include optionally hydroxylated, optionally alkoxylated alkyl or oxo-alkyl groups and groups of formulae Rs, COORs, OCORs, CHO, CN, CH25(O)Rs, CONRs2, NRsCORs, NRs2, S02NRs2, ORs, po32 , SORs, S02Rs, SO3Ml, COOMl (where M1 is one equivalent of a physiologically tolerable cation, for example an alkali or alkaline earth metal cation, an ammonium ion or an organic amine cation, for example a meglumine ion), -(O(CH2)n)mORs (where n is an integer having a value of from 1 to 3 and m is an integer having a value of from 1 to 5), -CX(CHRs)nX or CH2R8 (where R8 is a hydrophilic Rs group) or SR10 where R10 is a group Rs or an alkyl group optionally substituted by one or more, especially two or three groups COORs, OCORs, CHO, CN, CONR52, NRsCORs, NRs2, SO2NRs2, ORs, po32~, SORs, SO2Rs, SO3M1, COOM1, or (O (CHz) n~ mORS .
Especially preferred as solubilizing groups M are groups of formula C(H)3n(CH2OH)n, R9, CoR9, SR9, SoR9, So2R9~ CoN(R4)2, NR92, NHR9 and CoNHR9 ~where R9 may xepresent a group WO 91~21~24 P(~ 91~1)0285 ;, ~- . .
2 ~

-C-CH20H ,-C-OH -CH2CH20H, -CH20H

CH2~1 CH2H

I

-CH2CHOHCH20H, -C-OH, -O-CH2CH20H, -CH20CH2CH20H, I

COOH

CHOH -C-OH

CHOH CHOH

CH2oH ~ CH2oH ~

C~120H CH3 CH3 \
-CH -COH or -C-OH
I . / /
CH2oH, CH2OH ~ CH3 (although any R9 group attached to a sulphur, nitrogen or oxygen atom is preferably not hydroxylated at the ~ carbon)], and groups of formula SRl2 where R12 is a group CH2CooRl3, CH( CoOR13 ) 2 I CH2coNHR9, CH2CoNR92, CRs(cooRl3)2, CH(CN)Co2R~3, (CH2)nS03'Ml, (CH2)nCORl~
CH(CoR9)cH2coR9 and CH(R5)CoR9 where n, M1 and Rs are as earlier defined and R13 is a hydrogen atom, an alkyl yroup or a group M1 or R9.
Further especially preferred solubilising groups M
or XM include groups of formula X' C((CH2)n CooRl3)2Rl4~
XlC(~CH2)nCooRl3)3 and XlC((cH2)nCooRl3)Rl42~ where R13 is as defined above, n is an integer from 1 to 3, X' is an WO91/12024 PCT/EP91/002~

2 Q 7 ~ 12 - "~
oxygen or sulphur atom, and R14 is a hydroxyalkyl group such as a group R9 as earlier defined.
Other examples of preferred R1 groups include for example the following structures -S~ (C~l2cH2o) n' R where n' is 0,` l or 2 and R19 i5 hydrogen or C1.4 alkyl -S-(CH2)n,-Co-R23 where R23 is C14 alkyl (e.g.
methyl, ethyl or t-butyl), NR221 or OR21 and R21 is C1 4 alkyl -COR22where R22 is hydrogen, hydroxyl, R23, or COOR

-CH20 [ CH2CH20 ] n~ CH3 and -CHX-CRs2CRs2-Xwhere X is oxygen or sulphur.
Where M represents a group containing a moiety NR52, this may also represent an optionally substituted nitrogen-attached 5 to 7 membered heterocyclic ring optionally CO11taining at least one further ring heteroatom, e.g. N or O, for example a group of formula Rs Rs rl~ rh -N ) N O
\~/ o r ~/

In the inert carbon radicals of formula (I), any alkyl or alkenyl moie~y conveniently will contain up to 6, especially up to 4, carbon atoms and any aryl moiety will preferably contain 5 to 7 ring atoms in the or any WO91/12024 PC~/EP91/0028~

- 13 - 2Q7~18 aromatic ring and especially preferably will comprise an aromatic ring with 0, l or 2 further aromatic rings fused directly or i.ndirectly thereto.
Preferrecl structures for the aryl substituents on the carbon rad.ical centre include those in which at least one of such substituents carries at least one, ancl preferably two, fused rinys of formula where X and Z are as defined before, especially rings of formulae ~x><R7 ~oX

where X is oxygen or sulphur and R7 is hydrogen or optionally hydroxylated methyl.
Particularly preferred structures for the aryl groups Arl in the inert carbon free radicals of formula I
include the following:

X X Z/~ M z/~ M M~\z ~Y ~ Y or ~Y

R~<R7 M M M--~Z
wherein X is oxygen or sulphur, Y is N, CCOORs, CSRs, CM
or C-XM and M, Rs and Z are as earlier defined.
Particularly preferred structures include those in SUBSTITI. ITF .~.4~FT

~7 ~ ~ lg - 14 -which CR72 represents CH2, C(cH2OH)2 or C(CH3)2, X
represents an oxygen o~^ s-llphur atom and those of formula Rl --~M2 ~-~) M2 ~O
X o~,o ~M O~<S ~M2 X HO_>S
` OH
, where R1 .is a group M or XM as hereinbefore defined and M2 represents a solubilising group M or a group SCH3, S(O)CH3, S(O2)CH3, SCH2CH2N(CH3)2, SCH2COOH, SCH2COOCH3, H2COOCH2CH3 and 5c(H)3~n(cH2oH)n where n is an integer of from 1 to 3.
Especially preferred groups Arl include optionally substituted benzo [1,2-d:4,5-d']bis[1,3]dioxole, benzo[l,2-d:4,5-d']bis[1,3]dithiole, and benzo[1,2-d:4,5-d']bis[1,3~oxathiole groups.
Preferred inert carbon free radicals for use accordlng to the invention include the following:

c ><o~ok c o~ SR10 Especially preferred inert cation free radicals include SUE3$TITUTE Sl IEET

WO~I/12~24 PCT/EP~1/002~
~, - 15 - 2~73~1~, ,, ~3 ko~oX
CHO

and water soluble derivatives thereof such as ko~oX

O ~ C ~ C ~ 43 R 4~

(where each of R42, R43 and R44 are non-ionic solubilising groups e.g. hydroxyalkyl or alkoxyalkyl groups);

~ 3 Xo~oX
-S ~

and water soluble derivatives thereof such as WO91/12024 PCT/EP91/OO~B5 f" . .
2 ~ 7 ~ 16 -C ' X~

C R 4~ R 43 ~ 44 (where R42, R43 and R44 are as defined above).
Inert free radicals which have relatively few transitions, e.g. less than 15, preferably less than 10, in their ESR spectra and radicals having narrow linewidth ESR transitions, e.g. up to 500 mG, preferably less than 150 mG, especially less than 60 mG and particularly less than 25mG, are especially preferred for use as ESREMRI contrast agents. (The linewidths referred to are conveniently the intrinsic linewidths (full width at half maximum in the absorption spectrum) at ambient conditions).
Whilst low numbers of ESR transition lines are generally preferred to obtain more effective coupling of the ESR and NMR transitions, we have found that surprisingly good coupling, and therefore enhancement of the MR signal, may also be achieved with radicals showing a large number of ESR transitions.
Where the radicals have a multiplicity of ESR
transitions, the hyperfine splitting constant is preferably very small. In this connection radicals having as few as possible non-zero spin n~clei, positioned as far away as possible from the paramagnetic centre are thus especially preferred.
Certain of the triarylmethyl free radicals of formula I are themselves novel and in a further aspect the present invention also provides novel inert carbon WO 91/1~24 P~t~:P9ltO0285 - 17 ~ 3~8 free radicals of formula I or salts thereof.
Most known triarylmethyl radicals have short relaxation times and half lives and are generally unstable, being oxygen-sensitive and particularly susceptible to dimerization, and thus would not generally be considered for use as contrast agents.
2~oreover known triaryl methyl radicals are water-insoluble and are therefore generally not suited for administration to the body. The choice of triaryl methyl radicals as ESREMRI contrast agents is therefore not an obvious one.
The novel triarylmethyl radicals of the invention include radicals which surprisingly are stable at physiological pH, have long half lives (at least one minute, and preferably at least one hour), long relaxation times, and exhibit surprisinyly good relaxivity. Water-soluble triaryl methyl radicals are a particularly important aspect of the invention.
The triarylmethyl radicals may be coupled to further molecules for example to lipophilic moieties such as long chain fatty acids or to macromolecules, such as polymers, proteins, polysaccharides (e.g.
dextrans), polypeptides and polyethyleneimines~ The macromolecule may be a tissue-specific biomolecule such as an antibody or a backbone polymer such as polylysine capable of carrying a number of independent radical groups which may itself be attached to a further macromolecule. Coupling to lipophilic molecules or substitution of the radical with lipophilic groups is particularly useful since it may enhance the relaxivity of the radicals in certain systems such as blood. Such lipophilic and macromolecular ~erivatives of the radicals of formula I and salts thereof form a further aspect of the present invention.
The linkage of a compound of formula I to the further molecule may be effected by any of the conventional methods such as the carbodiimide method, W091tl2024 PCT/EP~l/00~85 2 0 7 ~

the mixed anhydride procedure o~ Krejcarek et al. (see Biochemical and Biophysical Research Communications 77:
581 (1977)), the cyclic anllydride method of Hnatowich et al. (see Science 220: 613 (1983) and elsewhere), the backbone conjugation techniques of Meares et al. (see Anal. Biochem. 1~2: 68 (19B4) and elsewhere) and Schering (see EP-A--331616 for example) and by the use of linker molecules as described ~or example by Nycomed in W0-~-89/06979.
In view o~ their surprisingly beneficial properties, the novel triarylmethyl radicals of the invention may also be used as ESR spin labels in ESR
imaging or in magnetometry.
The inert carbon free radicals may be prepared from their non-radical precursor compounds by conventional radical generation methods. Suitable non-radical precursor compounds include the corresponding triaryl methanes, triaryl methyl halides and triaryl methanols, and derivatives, e.g. ethers, of the triaryl methanols.
Thus in a further aspect the invention provides a process for the preparation of the novel triarylmethyl radicals of the invention which comprises subjecting a radical precursor therefor to a radical generation step and optionally subsequently modifying the substitution on the aryl moieties, e.g. by oxidation or reduction.
By such modification for example sulphide substituents, (e.g. -SCH3 or -SCH2COOEt) may be oxidiæed to the corresponding sulphones so avoiding problems of acidic hydrogens prior to radical formulation. Similarly lipophilic substituents (such as -SCH2COOEt) may be reduced to corresponding hydrophilic substituents (e-g. -scH2cH2oH)~
Thus by way of illustration the radical-precursor can be represented by formula XXXV

(Ar12)3CLv (L~) (XXXV) WO91/12~2~ ~T/EPgl/0~8~
- ., ...................................................... . ~ .
2~7~13 where Lv is a group displaceable to produce a radical Formula XXXV embrace formulae such as Ar12)3C~
(Ar12)3C~al (III) (~rl2)3C~I (IV) (Ar12)3CCOO~I (XXXI) (Ar12)3C.CO.O.O.CO.C(Ar~2)3 (XXXII) (Ar12)3C.NN C(Ar12)3 (XXXIII) Where Hal represents halogen, e.g. Br or Cl).

Thus for example carbon free radicals may conveniently be prepared from corresponding triaryl methyl halides by reduction with a metal catalyst, such as copper, zinc or silver, or by electrolytic reaction on an electrode or by photochemical reaction in the presence of a chlorine radical scavenger, e.g. an olefin. Alternatively, carbon free radicals may be prepared from the corresponding triaryl methanes by reaction with a base, e.g. in the presence of sodium hydride followed by a reaction with an oxidant, e.g.
iodine in the presence of oxygen or a quinone such as chloranil, following for example the method described in US-~-3347941. Another method to prepare triarylmethyl radicals is to react triarylmethanes with other, 12ss stable radicals such as tert-butoxyl radicals. The latter radicals are generated in situ via thermolysis or photolysis of an appropriate precursor, such as a peroxide or an azo compound. A further example of a me~hod by which radical preparation may be effected is reaction of the corresponding triaryl methanols in the presence of an acid to form a carbonium ion followed by reduction to the free radical in the presence of a suitable reducing agent, such as metal ions e.g. Cr2+, Fe2+, or by electrochemical red~lction. The carbon free radicals may also be generated by a comproportionation reaction between cations and anions of a corresponding W~91/12024 P~T~P~1/0028~
;~
2 0 7 ~

radical precursor. In such a reaction an electron is exchanged between the anion and the cation, and two radicals are generated. Triarylmethyl radicals may thus be prepared by mixing together a triarylmethyl radical precursor cation wi.th a corresponding anion.
Triarylmethyl radicals may also be prepared by thermolysis or photolysis or a corresponding dimeric triarylmethyl structure, for example an azobistriarylmethyl or a bis (triarylmethylcarboxylic acid) peroxide. An alternative method of preparation of triarylmethyl radicals is the electrochemical decarboxylation of a triarylmethylcarboxylate.
While radicals with long half lives in aqueous solution, for example at least one hour, preferably ten days, more preferably fifty days and especially preferably at least one year are clearly particularly desirable for use in in vlvo imaging, shorter lived inert free radicals may still be utilised in imaging ~e.g. of inanimate samples) and these may particularly conveniently be prepared immediately pre-administration.
The non-radical precursors may themselves be prepared by methods conventional in the art. Thus a process for the preparation of a triaryl methyl radical precursor may comprise one or more of the following steps:-a) (to prepare a triarylmethanol of Formula II
HO-C(ArlZ)3 (II) wherein Ar12 is as hereinbefore defined) reacting a compound of formula XXIII
H-Arl2 (XXIII) with alkyl lithium (e.g. BuLi) and a compound of formula CO(OR")2 (where R" is an alkyl group, e.g. a WO91/12024 P~T/~P91/0028~

- 21 - 2~7~
Cl9 alkyl especially ethyl);

b) (to prepare a triarylmethanol of Formula II

HO-C(Ar12)3 (II) wherein Arl2 is as herein~eore defined) reacting an organometallic compound comprising a metal linked Ar12 moiety (e.g. Ar12Li or Ar12 MgHal) with a compound of formula XXV, XXVI or XXVII

R"OCOOR" (X~V) Ar12COOR" (XXVI) (Ar1Z)2CO (XXVII) where R" is as hereinbefore defined, especially methyl);

c) (to prepare a triarylmethanol of Formula II

HO-C(Arl2)3 (II) wherein Ar12 is as hereinbefore defined) hydrolysing a compound of formula III

Hal-C(Ar12)3 (II) (where Hal and Ar12 are as hereinbefore defined);

d) (to prepare a triarylmethanol of Formula II

HO-C(Ar12)3 (III) wherein Ar1Z is as hereinbefore defined) reacting a compound of formula XXVII with a ~O91/12024 PCT/EP91/00285 2 ~ 7 ~
- ! - 22 -. .
compound of formula ~al-Ar12;

e) (to prepare a triarylmethyl halide of Formula III

~O-C(~rl2)3 (III) wherein Ar12 is as hereinbefore defined) halogenating a triarylmethane of formula IV

HC(Ar12)3 (IV) (e.g. under illumination or by reaction with N-bromosuccinimide or thionyl chloride or by reaction with a tetrahalomethane, e.g. CC14, in the presence of AlCl3) or halogenating a triarylmethanol of formula II;

f) (to prepare a triarylmethane of formula IV) reacting a compound of formula XXIII with a trialkoxymethane of formula XXVIII
(R"O)3CH (XXVIII) (where R" is as hereinbefore defined, especially methyl), e.g. in the presence of AlC13;

g) (to prepare a triarylmethane of formula IV) hydrogenating or otherwise reducing a triarylmethyl halide of formula III or a triarylmethanol of formula II (e.g. using sodium borohydride or trimethylsilylchloride and potassium iodide;

h) (to prepare a triarylmethane of formula IV) reacting a compound of formula XXIII with a compound of formula XXIX

WO91/12024 PCT/~P91/002B~
r`
~ 23 ~ 2~7 (Ar~Z) n CHHaln2 (XXIX) (wherein n1 is o, l or 2 and n2 is l, 2 or 3 and n ~n2 is 3), e.g. in the presence of AlCl3;

i) (to prepare a triarylmethane of formula IV) reacting a compound of formula XXX

(Ar12) 2CHLv (XXX) (where Lv is a leaving group, e.g. OTs) with an organometallic compound comprising a metal linked Ar12 moiety (e.g. Ar12CuLi);
j) (to prepare a triarylacetic acid of formula XXXI

(Ar12) 3CCOOH (XXXI ) (where Ar12 is as hereinbefore defined) reacting a triarylmethyl halide of formula III with carbon monoxide (e.g. in the presence of Co2(CO)8) on a triarylmethyl organometallic compound with carbon dioxide;
k) (to prepare a compound of formula XXXII

(Ar12) 3CCOOOCOC (Ar12) 3 (XXXII ) (where Ar12 is as hereinbefore defined) reacting a triarylacetic acid with thionyl chloride and a peroxide, e.g. H2O2;
l) (to prepare a compound of formula XXXIII

(Ar12) 3CN=NC (Ar12) 3 (XXXIII ) (where Ar12 is as hereinbefore defined) W092/]2024 PC~/EP91/0028~
2 0 7 5 ~
- 2~ -oxidizing a triarylmethylamine halide of formula XXXIV
(Ar12)3CNHHal (XXXIV) e.g. with silveroxide;

m) reactiny a triarylmethyl radical precursor to modify the substitution on one or more of the aryl moieties.

For process step (b), the starting ketone of formula XXVII may be ~repared by oxidation, e.g. with CrO3, of the corresponding alcohol (Arl2)2CHOH (itself pre~arable by reaction of the monoaldehyde Ar12CHO with an Ar12 containing organometallic, e.g. Arl2 Li or Ar12MgHal), or by reaction of such an organometallic with the corresponding carboxylic acid Arl2COOH, or by reaction of the acid chloride Ar12COCl with Ar12H, e.g. in the presence of AlCl3.
For process step ~d), the starting material of formula XXXIV may be prepared by reaction of a corresponding triarylmethyl carbanion with NH2Cl and subsequently with bromate.
The reduction of step tg) may be effected using borane or LiAlH~ and AlCl3.
Triaryl methyl halides may be prepared following the procedures described by Dunnebacke et al. in Chem.
Ber. 122:533-535 tl989).
In synthesising substituted triaryl methyl radicals, the substituents may be introduced onto individual Ar12 groups before they are trimerized to form the triaryl radical precursor compounds, or they may be introduced directly onto the triaryl precursor compound or the actual radical itself. It is also possible to effect the substitution and trimerization steps simultaneously in a "one-pot" reaction.
The Ar12 groups may be prepared by following reaction schemes such as those suggèsted below WO91/12024 PCT/EP91/0028~
, .
- 25 - . .
'(l~ o 2~5~18 H2/Pd ~ ~

., O

( a ) ( R7 ) 2C0 7 ' ~~ R7 p 2 o 5 R 7 ~<0 -~,/,1-- OX R 7 (wherein R7' is a hydrogen atom or a group R7 as hereinbefore defined, optionally protected by a protecting group).

~ No/~H~(I) HO ~ OH

( a ) R 7 X \/~ XR 7 (wherein R7' is as defined above) WO 91/12024 PCr/~:Pgl/~)0285 ~ . .i 2~7~ 26- ~
(3) Cl Cl R20s SR20 ~q/NaSR20 _ \~/ R20- alkyl, eg iPr Cl~\Cl R20S~\SR20 S/~'S~

HS/~S R ;Xs = sxR7 or lR7 )2CO, HBFL,Et20 ) HO

~`5~ ~5~ 5~
NaSCN, Br2 . ~ X ~ ~ O><R7 H ' HS SH R71 S S R7 SUBSTITIJTE~ SHEET

WO91/12~24 PCT/EP91/00285 .
- 27 - 2 ~ 7 !5)OCH3OCH3 /Br2 ~ ~/ \~OH
HOAc B ~ nBu HS~J~\OH
Br Hl I ~I R7 IXs ~ôXRR71l To introduce substituents onto the Arl2 groups such as solubilising groups M for example, reaction schemes such as the following may be used li) CH CH
Rl~/~\ R~ ~]I'~

CC l3 COOH

iia) COH COH
RL ~ Rl I R 6 I~Rl I

R31~R jeg nBuLi) R3 32 cH32ol~s) COH COOH
1. SOC12 RLI~Rl 2. RSOH R3 CoOR5 SUBsTlTuTE ~SHFFT
4 PCr~EP91/002B5 -~
2 ~ 7 ~

(;;b) COH COH

liii~
COH COH

RL~ 1. Alkyl lithium I~Rll R31 R21 2. OHCNICH3) Ph R3 ~-- R2I
or DMF CHO

I i va ) COH COH

R l1~ 1 Alkyl I ithium1~ Y
R31 R21 2. R5SSR50r R5SCI R3 \~ R21 ( b~ SRS

SUE3STITUTE S~EET

wo gl/12024 Pcr/EPgl/oo28~
,,, `- 29- ~7~18 (iv b) RL~\R2 R3~`~:

COH
1. Alkyl lithium R~ ~, 2. ~Etû)2 CO R3~ \R2 3 H20, H~ SR5 ~ v ~ COH COH
R L l~Rl I ., \~, Rl I
R31/~ 3 or 6 eq. ~ R21 R4 ~R

R3 1--~\R2 Su BSTITI ITF ~

~ ; . f.
207.~18 vii) CH CH
RL , Rl ~lNR52 Rl~,~Rl R31J~,R2l R31~`R

R20 - alkyl 1 vii i) R~,~RlI Br2, OH- R~' ~Rl R31 / ~`R21 H20 R31'~`R

IR5 or BrR5 RLI Rll 11 1 etc.
R3 / \~\R2 l i x ) RL~,~ 1. Alkyl lithium `
1 /1 2 PhCOO tBu R31~ --' \R21 R31' \~ \R2 ~< .
1 H ~ R~Rll ~ 11 2. Base, R5Br R31~ R21 etc oR5 SU13STITUTE StlEET

WO 91/1?.024 PCI /EP91/0028;
- 31- 2~73Sl~

( X ) COH COH

R3~R;1 31\/~

SCH2CooRl3 1. ~ Equiv. alkyl lithium 2. S~
3 . CICH2 CûoR13 ( x i ) Rl~ ~1~1 Alkyl lithium ~1/ 1. Alkyl lithium R3 l R2 1 2 . S~ 3 1/~\R2l 2 ( EtO )2 Cû
3 C2H5~r CûH CûH
RL~R 1 Na, NH3(1) l l 1 2. ClCH2 COOR13 R31 ' R21 R3 /\/\R21 SCH 2 CH 3 S CH2 CoOR13 S U BSTIT l JTF .~ ~I F FT

WO 91/12024 P~r/EP91/002~35 7 ~ 3 2 -lXii) CO~I CO~
RL` /~ 1 Alkyl li~lium \~Rl ~ , _ ___,_ R31~ \~\R21 R31/\~
2. lNaO3S(CH2)nS)2 SICH2 ) nSO3~Na~

~xiii~
COH COH

RLI~ 1 Alkyl lithium ~Rl R31 2. HCONH (CH3)2 f\
CHO
or DMF or C6H5NICH3)CHO

I xiv) 1 Alkyl lithium ~~

3 C~CH2CoOR13 SCH2CoOR13 SUBSTITUTE SHE~ET

- 33 2~7~

( X V ) C. C.
R~ ~ Rll Rl ~\ R
~ / H 2 NC ( C~ 2 0H 1 3 \~

R31~R2l R3 S~ S~

CoOR13 CONHC(CH20H~3 ( xvi ) COH COH
R~ ClCH2CONR92 \~

R3 ' ~\R21 R3l~\R2l ( xvi i ) COH COH

~q~ ClCHlCOOR13)2 \~
R31/'\~\R2l R31/\~\R2l S SCH ( CooR13)2 ~c l I R.C~TITl ITF C~ ~ ~ ~T

WO 91/12024 PCl/EP91/00285 2~7~ 34 ~ `

Ixviii~
COH COH
RL ~\ Rl R~ \3 Rl ~ / Clc~llcoNR92)2 _ \~ '1 R 3 I/J~\ R 2 ! R 3 I/~"J'` R2 1 S- ` SCH ( COHR92 ) 2 ( xix ) COH COH

~q Cl CH I CN ~ C ooRl3 \~

R31~R2l R3 r-SCH I CN ~ COOR 13 ( XX~
CO- COH

R3~ R2l ~COR9 R3 --'~R2;

~ COR9 TlT! IT~ ~:~I~T

WO 91/12024 PC~r/EP91/0028 ` - 35 -2~58~

X X i ~
CO~ COH

R ~ ~ ~ R 3C O C H C HCOR 9 -- R ~ \~R
R31 ~ R21 R3 S ~ R 9CO~ S

~ COR9 I x x i i ) CO ~ CO H
Rll"~/~Rll R~l /,~R
BrCHR20 COR 9 R3 '/~//\R2 I R 31/ ~R2 ( xxiii ~
CO~ COH
Rl ~Rl I R
l ~ C I C H 2 S03 ~ Na~
R31/\~ \R2l R3 S~ ~S
SO 3- Na SUBSTITUTE S ~ ET

WO91/1~24 PCT/EP91/0028~
f:
2~7~i~1g - 36 -X X i V ) CO~ COH

R~ /~\3 Rll R;l~ R2 HO` ~
. OH

. ..

wherein in each of schemes (i) to (xxiv) set out above R1' to R4' are optionally protected groups Rl to R4 and Rs is as hereinbefore defined. Particularly preferably, Rl' and R2' and R3' and R4' may represent ring-forming groups -X-CR72-X-, e.g. OC(CH3)2O-.
Similar procedures may be used for the introduction of substitutents onto heterocyclic Ar12 groups.
The following are examples of schemes for "one-pot"
synthesis of triaryl methyl radical precursors.

~a ) 1 Alkyl ~ithium COH
RLI Rl 2 Sa R~

R31/~\R2 3 Alkyl lithiumR31/~ \R21 l . ( Et ~2 COSCH 2 CoOR13
5 CICH2COOR13 r l T ~ I T ~ ~

; ~
~ 37 ~ 2~ 3 ( b ~
1 Alkyl lithium COH
RLI~ ~Rl 2.11CON (CH3 )2 R~

R3 R21 3. Alkyl lithium L. ( EtO ) 2CO CHO

Ic~
1. Alkyl lithium CûH
R ~ 2 S3 R3 1~ R

1~. IEtO)2CO S- Li~

As indicated above, a particularly interesting group of radicals for use according to the invention includes compounds of Formula .C(Arl2)3, where one, two or three Arl2 groups comprises a central 5-6 membered carbocyclic or heterocyclic aromatic ring bearing two five-membered fused rings, each said fused ring comprising two ring heteroatoms selected from oxygen and sulphur.
The "monomer" and "dimer~' compounds, having this structure are particularly useful for the preparation of the radical precursors and thus in a further aspect the invention provides tricylic compound comprising a central S-6 membered carbocyclic or heterocyclic aromatic ring bearing two five-membered fused rings, iTlTI t,-- ~u~--2 ~7 5 8 1~ - 38 -each said fused ring comprising two ring heteroatoms selected from oxygen and suphur. Particularly preferred embodiments of such compounds are the compounds of formula XL

~1 X X ~ X X Q7 (XL) (where X and R7 are as hereinbefore defined, yl is a group CH, N, CCOORs, CSRs, CM or CXM, Rs and M are as defined in claim 6 and R40 is a hydrogen atom, or a optionally substituted hydroxyl, methyl or formyl group or group --Z ' ' ' Rl X~XXRR77 (XL~

where Z''' is CHOH, C=O or CHHal. and Hal is a halogen atom), or a salt thereof.
Particularly preferred compounds of formula XL
include those wherein each X is oxygen, each R7 is optionally hydroxylated methyl and y1 is other than N.
The invention also provides, in another aspect, process for the preparation of a compound of formula XL, said process comprising condensing a compound of formula XI,I
R40~
(XLI3 l l h ~ X H

X ~y~

W091/12024 PCT/EP~1/00285 . " 2~7 5~ ~

(wherein R40 and Y'' are groups R40 or y1 as defined in claim 23 or protected such groups, and X is as defined in claim 23) with a compound of ~ormula (R7 )2 CX (where R7 is a group R7 as defined in claim 23 or a protected R7 group) under oxidizing conditions and if necessary removing any protecting groups, optionally ~fter reduction (e~ with Fe/~Cl) of a compound of formula XLII
R~ ' ~X ~ ~ X (XLII) X ~y~xll to yield the starting material of formula XLI.
For use in ESREMRI, the inert carbon free radicals are conveniently formulated into contras~ media together with conventional pharmaceutical carriers or excipients.
Contrast media manufactured or used according to this invention may contain, besides the inert free radicals (or the non-radical precursor where radical formation is to be effected immediately be~ore administration), formulation aids such as are conventional for therapeutic and diagnostic compositions in human or veterinary medicine. Thus the media may for example include solubilizing agents, emulsifiers, viscosity enhancers, buf~ers, etc. The media may be in forms suitable for parenteral (e.g. intravenous) or enteral (e.g. oral) application, for example for application directly into body cavities having external voidance ducts (such as the gastrointestinal tract, the bladder and the uterus), or for injection or infusion into the cardiovascular system. However solutions, suspensions and dispersions in physiological tolerable media will generally be preferred.
Free radicals which are relatively unstable or insoluble in the sample environment may be encapsulated, e.g. in gastric juice resistant capsules containing a medium in which they are stable. Alternatively, the WO91/12024 PCT/~Pg1/0028~

2~7~ 40 -radical may be presented as an encapsulated freeze dried powder in a soluble capsule. Such formulations might conveniently be dissolved shortly before in vivo use.
For use in _n vivo diagnostic imhging, the medium, which pre~erably will be substantially isotonic, may conveniently be administered at a concentration sufficient to yield a 1 micromolar to 10 mM
concentration of the free radical in the imaging zone;
however the precise concentration and dosaye will of course depend upon a range of f'actors such as toxicity, the organ targetting ability of the contrast agent, and the administration route. The optimum concentration for the free radical represents a balance between various factors. In general, optimum concentrations would in most cases lie in the range 0.1 to lOOmM, especially 0.2 to lOmM, more especially 0.5 to 5mM. Compositions for intravenous administration would preferably contain the free radical in concentrations of 10 to lOOOmM
especially 50 to 500'mM. For ionic materials, the concentration will particularly preferably be in the range 50 to 200mM, especially 130 to 170mM and for non-ionic materials 200 to 400mM, especially 290 to 330mM.
For imaging of the urinary tract or the renal or biliary system however, compositions may perhaps be used having concentrations of for example 10 to lOOmM for ionic or ' 20 to 200mM for non-ionic materials. Moreover for bolus injection the concentration may conveniently be 0.1 to lOOmM, preferably 5 to 25mM, especially preferably 6 to 15mM.
The accompanying drawing, Figure 1, shows a magnetic resonance image produced according to the invention. Specifically, there is shown a coronal slice through a rat following peroral administration of a contrast medium containing tris(2,2,6,6-tetramethyl sodium-8-carboxylate methylthiobenzo[l,2-d:4,5-d'~bis(1,3)dioxole)methyl ~the radical of Example 11).
The gastrointestinal tract can be seen very clearly '.

WO91i12024 PCT/EP91/00285 2075~1~

In Figure l:
l. indicates the stomach;
2. indicates the intestines;
3. in~icates the head end of the rat;
. indicates the tail end of the rat;
5. indicates the right hand side of the rat;
6. indicates the left hand side of the rat.
The image was acquired under the following conditions:
a) TR - 0.5 sec, UHF Irradiation Time = 0.38 sec. 256 excitations (256 x 256 matrix). Slice thickness l cm. Field of view 25 cm.90 flip angle (SR).
Single echo (gradient). TE = 30 ms. Single slice.
l. Average.

b) The instrumental parameters were:

Proton frequency 417 kHz (H = lO0 G) UHF frequency = 274 MHz. The UHF-resonator had a very low loaded Q < lO (200 g rat), and a volume of approximately lL (diameter lO cm). The applied UHF power was <
30 W of which only a small fraction was deposited in the animal (< l/lO). The proton coil had a diameter of 126 cm and thus a very low filling factor when loaded with a rat (5 cm). The Q factor of this coil was high (> lO00), but loaded with both UHF-resonator and animal decreased to below 500.

c) The signal/noise (S/N) ratio was approximately lO0.

The perorlly applied volume of contrast medium was approxmiately 5ml and the concentration af radical was less than 05mM.

In the unenhanced image, where no contrast medium was administratered, the S/N ra~io was -3 resulting in WO91tl2024 PCT/~P91/00285 207~818 an image where no details could be distinguished from the background noise.
The present invention will now be further illustrated by the following non-limiting Examples (percentages, parts and ratios are by weight and temperatures are in degrees Celsius unless otherwise stated).

Example 1 2 5-Dimercapto-1 4-dihydroxYbenzene Ammonia was condensed (ca 200ml) into 150 ml of dry diethylether in a 3-necked flask, with external cooling.
Then 9.0 g (0.0256 mole) of 2,5-dibenzylmercapto-p-benzoquinone was dissolved into the liquid. Sodium (5.9 g, 0.256 mole) cut into fine pieces was added portionwise with efficient stirring. After stirring for an additional 2.5 hours, abs. ethanol (20 ml) was added and the ammonia was evaporated. Water (170 ml) was added to the reaction product and it was extracted with 2 x 30 ml of ether. The aqueous phase was then acidified to p~ 1-2, with conc. hydrochloric acid, and extracted with 3 x 80 ml of ether. The ether extracts were collected, dried (Na2S04), the solvent evaporated leaving a fluffy light brown glistening residue, 4.3 g (90%).
MS (Silated Product): M/e 4~2 (42% M~) 447 (5% M

Example 2 2,2,6.6-TetramethylbenzoL1.2-d:4,5-d'lbi.s(1,3)dithiole ~5 =5~

WV91/12024 P~r/EP9l/0028~
, 2~7~818 -1,3,5,7-Tetrathia-S-indacene-2,6-dione (4.0 g, 0.016 mole, prepared according to Larsen and Bechgaard J. Org Chem 52: 3287 (1987)) was suspended in 60 ml of a lM
solution of sodium methoxide in methanol. Stlrring was maintained for 1/2 hour at ambient temp. until a clear solution w~s formed. The reaction mixture was then evaporated to dryness and the residue acidified with 5 N
hydrochloric acid to pH 1. The aqueous phase was extracted with 3 x 70 ml of methylene chloride. The organic phases were dried (Na2SO4), the solvent evaporated leaving a light tan coloured crystalline residue. This was suspended in 50 ml of dry toluene, and 3 ml of acetone and 2.5 ml of fluoroboric acid etherate (HBF4. Et2O) were added. The mixture was stirred at ambient temperature for 5 hours then refluxed over night. The reaction mixture was then poured into 100 ml of cold saturated sodium hydrogen carbonate solution. The phases were separated and the organic phase was washed with 30 ml of water. The aqueous phases were back-extracted with 40 ml of methylene chloride. The organic phases were collected, dried (Na2SO4~ and the solvent evaporated leaving a light ~ellow cryst. residue, 4.1 g (92%).
IR(film): 2960,2920 CM1, lH-NMR (CDCl3) ~ : 1.88 (CH3 12H), 7.02 (arom H, 2H) ppm MS: m/e 236 (14% M') Example 3 Tris(benzo[1,2~d:4,5-d']bis(1,3~dioxole-4 -Yl ) methanol WO91/12024 PCT/EP9~/00285 ~ 18 - 44 -COH

<~ ~ 0>

3.2 g Benzo~1,2-d: 4,5-d']bis(1,3)dioxole prepared according to F. Dallacker et al. Liebigs Ann. Chem. 725, 99-105 (1g69) (0.019 mole) was dissolved in 100 ml dry ether under Argon. After cooling in ice-acetone to -15C, 10 ml 2.5 M butyllithium in hexanes (Aldrich) was added from a syringe. The cooling bath was removed and the mixture was stirred for 2 hours. 0.8 ml diethylcarbonate (0.0068 mole) was added with a slight increase in temperature and color change to yellow-brown. The mixture was stirred at room temperature overnight and then poured over 150 ml ice-water and extracted with 3 x 75 ml CH2C12. The organic phase was washed with 100 ml water, dried over MgSO4 and evaporated to dryness to yield 2.96 g (88%) m; 125 C (unsharp).
1H-NMR (CDCl3) ~ : 5.75 (CH2, 12H); 6.25 (Arom H, 3H) ppm MS: m/e 524 (100% M~) The corresponding radical showed a linewidth of 500 mG
in its ESR spectrum and an Overhauser enhancement of 8 at 5hr UHF power.

Example 4 l~2~4~retrahy~rox~benzene~l~2-d:4~5-dl]bistl~3)dioxole 14 g 2.5-dihydroxy-1,4-benzoquinone (o.lo mole) was suspended in 100 ml 96% ethanol. 0.1 g 10% Pd on C was added under Nz and reduced at 40 Psig in a Parr apparatus (in the usual manner) until 0.10 mole H2 was absorbed.

WO91/12024 PCT/EPgl/00285 2Q7~ 8 The dark reaction mixture was filtered to remove the catalyst and evaporated to dryness to afford the product in ~uantitative yield.

_xample 5 2,2,6.6-TetramethYlbenzo[1,2-d:4,5-d']bis(1,3)dioxole >(~1 X
o O

.
18.6 g of the 1,2,4,5-tetrahydroxybenzene prepared according to Example 4 (0.13 mole) and 70 ml acetone (58.6 g, 1.0 mole) was dissolved in 1 1 tetrahydrofuran.
168 g P2O5 (1.18 mole) was added to the vigorously stirred mixture in portions as fast as possible. The mixture was heated to reflux for ~ hours. After cooling to room temperature the solids were filtered with suction and washed with 0.5 L ether. The combined filtrates were treated with 10 g K2CO3 and stirred 1 hour, filtered and evaporated to dryness yielding a yellow-brown oily solid. ~he product was triturated with petroleum ether, decanted and evaporated to yield 13.8 g of the title compound (48%) as white-yellow crystals, mp = 122C, which can be recrystalized from a small amount of petroleum ether.
H NMR (CDCl3) ~ : 1.65 (CH3, 12~); 6.75 (Arom H, 2H) ppm 3C NMR ~ : 25.49 (CH3); 92.75 (Arom _H); 117.81 (CMe2);
140.43 (Arom C) ppm MS: m/e 222 (90% M~), 207 (100%, M~-lS) .

207~ 8 - ~6 -Example 6 3-Methylthio-2 2 6 6-tetramethy~benzo[1,2-d:4l5-d'~bls(l~3)dioxole -Xo,~ ~ OX

- SCHI
l.l g of 2,2,6,6,-tetramethylbenzo(l,2-d:4,5-d']bis(1,3)dioxole prepared according to Example 5 (0.005 mole) was dissolved in 25 ml dry ether under argon and treated with 2.2 ml 2.5 M butyllithium in hexane, at room temperature. After l hour 0.52 g dimethyldisulfide (0.0055 mole) was added and the mixture stirred overnight at room temp. The reaction mixture was then poured into 50 ml ice-water. The phases were separated and the water phase extracted with 50 ml ether. The combined organic phase was washed with 50 ml 2 M NaOH, dried over MgSO4 and evaporated to yield l.l g (82~) as white crystals, mp = l03C, which can be recrystallized from a small amount of methanol.
H NMR (CDCl3) ~ : 1.67 (CH3; 12H); 2.45 ~-SCH2, 3H) 6.26 (Arom CH,lH) Example 7 Tris(8-Methylthio-2,2,6,6-tetramethylbenzo[l 2-d:4,5-d']bis(l,3)dioxole)methanol WO91/12~24 PCr/EP91/00285 2~75~1~
- ~7 -COH

~0 /~_ 0~<

SC~

; 6.2 g 3-methylthio-2,2,6,6-tetramethylbenzo L l,2-d:4,5-d']bis(1,3)-dioxole prepared according to Example 6 (0.0235 mole) was dissolved in 150 ml dry ether under argon. The solution was cooled in an ice-methanol bath, while 10 ml 2.5 M butyllithium in hexane (0.025 mole) was added and then left with stirring at room temperature for one hour. 0.95 ml diethylcarbonate (0.0078 mole) was added.
After 18 hours the reaction mixture was poured over 200 ml ice-water and the product extracted with 3 x 75 ml CH2Cl2. The organic phase was washed with 100 ml H20, dried over MgSO4 and evaporated to dryness, yielding ca 5 g yellow solid. The product was triturated with a little cold petroleum ether and filtered to yield 2.1 g of the title compound (32%) as yellow crystals, mp >
260 C.
H NMR (CDC13) ~ : l.51 (CH3, 36H); 2.40 (SCH3, 9H); 4.20 (OH~lH) ppm 3C-NMR ~ : 17.28; 25.48; 72.56; 99.87, 111.97 138.71;
1~0.97.
MS: m/e 830 ~80% M~), 7l4 ~100% M~-116) Example 8 Tris~8-methYlthio-2,2,6~6-tetrameth~lbenzo[1,2-d:4.5-d'l-bis(1,3 ! dioxolaLmethyl '' .
.

., .

W~91/12~24 PCT/~P9l/0~28~

....
207~18 C.

/ t- \ 3 Xo ~ ~l oX

250 mg Tris-~3-methylthio-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(~,3)dioxole)methanol (0.3 mmol, Example 7) was dissolved in 50 ml dry THF (Al2O3, super I, basic) under Argon. 0.5 g CrCl2 and then 0.5 ml BF3 etherate was added to the vigorously stirred mixture. After 15 minutes the reaction mixture was poured over 50 ml 4 M
NaOH. The organic phase was separated and filtered th-ough a short column of SiO2 and eluted with dry ether.
The dark violet solution was evaporated to dryness yielding 176 mg (71%) of the title compound as a black powder. A solution of this material in tetrahydrofuran was shown to contain 41% radical according to the method of Evans (J. Chem. Soc. 2003 (1959)).
MS~: m/e 814 (60% Mt-l) Example 9 Tris(8-ethoxycarbonylmethylthio-2,2,6.6-tetramethylbenzo[l,2-d:4l -d'lbis(1,3)dioxole)methanol .

WO91/12024 PC~/EP91/00285 ,,: ,, _ 49 - ~ ~7 C O H

~0 ~ 0~

S C~12COOc2~l5 2.25g (0.010 mole) of the benzobisdioxole oP Example 5 in 50 ml tetrahydrofuran (THF, HPLC-grade) was cooled to -80 in an dry ice-acetone bath. 4.4 ml (1.1 eqv) 2.5 M
n-butyl lithium was added and the mixture allowed to come to ambient temperature. ~fter about 15 minutes 0.35g of sulphur (S8) was added in one portion. After a~out 20 minutes the sulphur had reacted and the brownish solution was cooled to -80C and treated with 4.4 mL 2.5 M n-butyl lithium. The cooling bath was removed and the temperature allowed to rise again to ambient temperature. After about 20 minutes a cloudy suspension was obtained. 0.4 mL diethylcarbonate was added.
After 1 hour, 5.5 ml (0.05 mole) of chloroacetic acid ethylester was added in one portion (slight heat formation). The reaction mixture become very dark and homogeneous. TLC in CHCl3 showe~ that a "trimer" was formed along with dimeric ketones (and other products).
After another ~ hour the reaction mixture was poured into 200 mL ice-water and extracted with 3 x 75 mL
diethyl ether. The organic phase was washed with 2 x ~0 mL H20, dried over MgS04 and evaporated to dryness yielding an orange oil it was separated on silica with CHCl3-diethyl ether as eluent.
Evaporation of the solvent yielded ~.46g orange oil (very viscous) yield: 42%~ The product was verified using lH NMR 13C NMR and mass spectrometry.
1HNMR (CDC13) ~ : 1.22 (t) (CH3,9H); 1.50 (C~3,36H), 3-57 .
(CH2,6H); 4.1 (CH2,6H) ppm 3CNMR ~ : 14 . 10; 25.44; 35.49; 61.22; 96.64; 112.45, WO91/12024 PC~/EP9l/0028~
2~75~18 `~
117.77, 138.67, 141.25, 169.016 ppm M5 m/e 1407 (10%, M+1), 1031 (30% M~-15) Example 10 T is~ ethoxycarbonylmethylthio-2,2 6,6-tetra~eth~lbenzo r 1, 2-d:4 5-d'!bis~1 3~dioxole!methyl ~ 3 ><~`~><

SCH2COOC2Hs 250 mg of tris(8-ethoxycarbonylmethylthio-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d'~bis(1,3)dioxole)methanol prepared according to Example 9 was dissolved in about 100 mL THF (HPLC-grade) and placed in a 250 mL
separating funnel. A rapid stream of argon was bubbled through the solution. 200 mg CrCl2 was added followed by 0.4 mL BF3-diethylether. After 5 minutes 75 mL
diethylether was added and then the mixture was extracted with 2 x 75 ml H2O and 1 x 75 ml 2M NaOH. The dark organic phase was filtered through 5cm SiO2, eluted with diethylether and evaporated to dryness in vacuo affording a black-brown oil that slowly solidified on addition of 5 ml methanol 177 mg black crystals were obtained, and washed with petroleum ether.
Radical content: 60% (NMR - Evans method) ESR 0.2 mM in Toluene: 7 lines ACHZ: 66 Milli Gauss linewidth : 33 Milli Gauss WO91/12024 PCT/EP91/00~85 .
- 51 - 2 ~ ~ 531 8 ExamPle 11 Tris(2 2 6 6-tetramethvl sodium-8-carbox~latemethylthio-benz_~1 2-d:4.5-d'lbis(l 3)d_o~L~m~hyl ~ ~ \ 3 Xo~ ~ o><~

SCH2COO~Na~

7Omg of tris(8-ethoxycarbonylmethylthio-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole)methyl prepared according to Example 10 in 2mL methanol, 120 ~L
NaOH/H2O (0.019 g NaOH) were sonicated for 0.5 hr. A
test sample (few drops) was diluted in H2O and diethylether was added. No color appeared in the etheric phase. The hydrolysis mixture was evaporated to dryness yielding 53 mg of the titls product.

Example 12 Tris(8-methoxycarbonylmethylthio-2,2 6 6 -tetramethylbenzo[l,2-d:4 5-d'~bis(1 3)dioxole)methanol WO91/12024 PCT/EP~l/00285 ~, .
20~ 52 -COH
f ~ 3 ><0,_~ 0~

11.38g of the benzobisdioxole of Example 5 (0.051 mole) was dissolved in 250 ml HPLC grade tetrahydrofuran under argon and cooled to -45OC in dry ice~ 26.2 mL n-butyl lithium (0.055 mole) 2.1 M, was added from a syringe over about 1 minute. The temperature rose to -30C, the cooling bath was removed and the mixture was left with stirring for 30 min. It was cooled to -30 and 1.75g S8 was added in one portion. The cooling bath was removed and after 35 minutes the temperature had risen to 0C
and all the sulphur had reacted. The mixture was cooled to -40 and 26.2 ml n-butyl lithium was added in one portion. The cooling bath was removed and a slightly colored suspension was formed just above 0C. A~ter 1 hour the temperature has risen to 15C and a white suspension had formed, which was then cooled to -20C
and 2 mL diethylcarbonate was added. The mixture changed color from yellow ~hrough green to brown and the coolina bath was removed. After 1 hour the temperature had risen to -20C, was again cooled to -10C and 10 mL
chloro-acetic acid methyl ether was added (exothermic).
The cooling bath was removed and the mixture become homogeneous and very dark. After ~ hour the reaction mixture was poured into ice-water (500 ml) and 20 mL
acetic acid added. 300 mL diethyl ether was added and the phases were separated. The water phase was extracted with additional diethyl ether. The organic phase was stirred for lS minutes with lOg WO91/12024 PCT~EP9l/0028~
, . , 2~7~18 K2CO3(anhydrous), decanted and washed with two lots of 200 mL H20, dried over MgSO4 and evaporated. It was then separated on a "TLC-SiO2"-column with CHCl3/CH2Cl2/diethylether. Fraction 3 (the diethylether~
phase) contained 9.6g of the product (57~). It was crystalli~ed ~rom cyclohexane to yield 2.5g yellow crystalline powder.
H NMR (CDCl3) C : 1.485 (CH3, 36H); 3.65 (OCH3; 9H); 3.5 (CH2 6H)ppm 3C NMR: 25.25, 35.31, 52.23; 72.41; 96.43, 112.42, 117.71, 138~57; 141.22; 169.43.
MS M/e 1004 (70~ M~); 988 (50% ~-16) Example 13 Tris(8-methoxycarbonylmethylthio-2,2 L6 l6-tetramethylbenzo[l,2-d:4,5-d']bisrl,3)dioxole)methvl " ~1 ~ 3 Xo:~q o><~

l.Og of tris(~-methoxycarbonylmethylthio-2,2,6,6,-tetramethylbenzo[l,2-d:4,5-d']bis(1,3)dioxole)methanol prepared according to Example 12 was dissolved in 150 mL
THF (HPLC-grade) in a separating funnel. l.Og CrCl2 (anhydrous) was added and a rapid stream of argon was passed through the solution. 2mL BF3/diethylether was added followed by diethylether after 10 min. Inorganic salts were extracted with H20 and 2M NaOH. The organic phase was filtered through a short column of sio2 and exaporated to a brown-black oil. It was taken up in ~ ~ 7 ~ 54 -about 20 mL meth~nol and precipitated with a half volume of H20~ filt~red and dried in v~cuum to yield 0.78g of a black brown powder.

Example 1 Tris(8-me,rcapto-2,2~6~6-tetramethylbenzo[1,2-d:4~5-d:4~ -d']bis~1,3)dioxole~methanol .
,. ' C~
X o~O><

SH

4.5g of the benzobisdioxole of Example 5 were dissolved (under N2) in about lOOml THF (HPLC-grade) and cooled to ~78C in dry-ice acetone bath, 85ml 2.5m butyllithium (BuLi) (in hexane) was added. A transient color change to red was observed with the first drops of BuLi, but almost immediately the color changed to very pale yellow. The cooling-bath was removed. After 20 minutes the reaction mixture was temporarily coooled and 0.64g S8 (powder) was added in one portion. The cooling bath was removed and the color changed to light yellow as the particles of sulphur reacted just below 0C. The reaction mixture was left to stand with stirring at ambient temperature for an additional 30 minutes. After cooling to ~78C, 2.5ml BuLi 2.5m) was added. After stirring for 1 hour at room temperature a white, thin, slurry had formed. It was cooled to 78C and 0.81 ml diethylcarbonate was added slowly. The mixture was left to stir at ambient temperature and,the white suspension thickened and changed colour from yellow to brown.

WO91/12024 PCT/EP91/0~285 - 55 - 2~7~
After 1.5 hours the reaction mixture was poured into 100 ml diethylether with about 30g NaH2PO4 saturated with ~2.
The phases were separated and the E~2O phase was extracted once with 100 ml diethylether. The combined organic phase was washed once with H2O with about 15g NaH2PO4, dried over MgSO4, filtered and evaporated in vacuo to yield 5.0 g voluminous semi solid. The product was taken up in approximately 20 ml diethylether and slowly precipitated with heptane, filtered off and dried in vac. to afford 4.55g yellow powder. It was purified on TLC-silica 60M (Merck). lg material was dissolved in 20 ml diethylether applied to a flash column (400 ml sio2 in diethylether-heptane (7:3) and eluted with diethylether until the first yellow band appeared, yielding 0~20 g of a nearly colorless yellow crystalline solid.
H NMR (CDCl3) ~ : 1.49 (CH3), 3-25 (SH), 4-10 (OH) 3C NMR O : 25.48, 72.33, 93.55, 110.66, 117.51, 138.26 and 138.54.

Example 15 Tris(8~methoxYcarbonyl-2 2 6r6-tetramethylbenzo[l 2-d:4 5-d']bis(1,3)dioxole-4-ylL~ethanol . COH MnO2 C9H
,, \"o ~ o~/ NaCN \~0 ~0~/
HOAc /\~/\
CHO MeOH, 65 C COOMe !

Tris(8-formyl-2~2~6l6-tetramethylbenzo[l~2~d:4~5-dl]-bis (1,3)dioxole-4-yl)methanol (1.26 g, 1.62 mmol (prepared by reaction of tris(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(l,3)dioxol-4-yl)methanol (See EXample 44) with nBuLi in DMF)) was dissolved in dry MeOH (80 mL). To WO 91/12024 PCr/EP91/00285 2a~ S6 -this solution was added MnO2 (18.9 g, 217 mmol), NaCN
tl-26 ~ 25-7 mmol) and acetic acid (HOAc) (1.26 mL).
The reaction mixture was heated to 65 C for 40 h and was then filtered through Celite and the filtrate was evaporated to dryness. The residue w~s partitioned between CH2Cl2 (100 mL) and water (40 mI.). The organic phase was washed with another 2x30 mL o~ water, the oryanic pha e was separated, dried (Na2SO4) and the solvent was evaporated to yield a yellow to brown residue, which was further pumped to dryness. The residual foam was chromatographed on a column packed with sio2, eluting with CH2C12~Et2O (4:1). The fractions containing pure product were collected and the solvent was evaporated to yield 1.1 g (77 %) of pure tris(8-methoxycarbonyl-2,2,6,6- tetramethylbenzo [1,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol.
H NMR (CDCl3, 300 MHz) ~: 1.44 (CH3, 36H, s), 3.78 (OCH3, 9H, s), 4.24 (OH, lH, s).
3C NMR (CDCl3, 75 MHz) ~: 163.4 (C=O), 140.5 139.2 (aromatic C-O), 118.3 (alifatic O-C-O), 115.0 (quart.
C-subst. aromatic), 99.1 (quart. p-C-subst. aromatic), 72.6 (quart. alifatic C-OH), 51.9 (OCH3), 25.5 (CH3).
MS (Thermospray): M'+23 (Na) 888, 889.

Example 16 Tris(8-carboxyl-2 2 6 6-tetramethvlbenzo r 1.2-d:4,5-d'lbi s~1.3)dio~ole-4-~1)methanol COH COH-k~X~ k~X
o ~~o MeO~VH20 O~i~--O
COOMe THF/H20 COOH

WO91/12~24 PCT/EPgl/00285 2~75~1~

The ester of Example 15, tris(8-methoxycarbonyl-2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']bis(1,3)dioxole-4-yl) methanol (0.30 g, 0.34 mmol) was dissolved in MeOH (10 mL), and NaOH (0.0~1 g, 1.02 mmol) dissolved in MeOH/H20 (2.32 M NaOH solution) was added until pH reached 7. In total 0.~4 mL o the basic solution was used. The MeOH
was evaporated in vacuum due to solubility problems and THF (3.5 mL) was added. The reaction mixture cleared with this treatment. After ~2 h the reaction mixture was turbid and a precipitate had formed. This precipitate dissolved with the addition of water (10 mL). The THF was evaporated under reduced pressure and water (10 mL) was added and the aqueous phase was extracted with ether (10 mL). The organic phase was separated and the aqueous phase was acidified (pH 3.5) with 2M HCl. A yellow precipitate was formed and the aqueous phase was extracted with ether (3x20 mL) and CH2Cl2 (30 mL). The organic phases were collected, dried (Na2SO4) and the solvent was evaporated to yield the product tris(8-carboxy-2,2,6,6-tetramethyl-benzo[l,2-d:4,5-d'] bis(l,3)dioxole-4-yl)methanol as a slightly tanned residue (0.25 g, 87%). The product contained a small impurity (appreciated to about 2% at the same extinction) according to HPLC (C18, ion pair (tetrabutyl-ammonium acetate) chromatography, CH3CN:H20) with W (254 nm) detection.
H NMR (D20, 300 MHz) ~: 1.26 (CH3, 36H, s).
3C NMR (Dz0, 300 MHz) ~: 169.6 (C=O), 138.9 138.8 (aromatic C-O), 118.2 (alifatic O-C-O), 111.9 (quart.
C-subst. aromatic), 105.9 (quart. p-C-subst. aromatic), 72.1 (quart. alifatic C-OH), 24.6 (CH3).
IR (KBr, cm-l): 3450 (OH-stretching broad), 1670 (C=O
stretching s).

WO91/12024 PCT/EP9l/00285 2~75~

Example 17 Tris(2 2 6 6-tetramethyl-benzorl 2-d:4,5-d'lbis(l 3)-dioxole-~=yl)methane COH CH
k~X (C~)3slcl k~~, o ~ C~ o~ o/\
Nal Trimethylsilyl chloride (68.1 mL, 539 mmol) and sodium iodide (81.0 g, 540 mmol) were mixed in acetonitrile (500 mL), and tris(2,2,6,6-tetramethylbenzo[1,2-d:
4,5-d']-bis(1,3)dioxole-4-yl)methanol (62.4 g, 90.2 mmol, Example 44) and was added with efficient stirring at room temperature. The reaction flask was surrounded with aluminum foil to prevent light to enter. After stirring for 24 h, the reaction mixture was poured into 2 L of a Na2S2O3 solution (70g of Na2S2O3 x 5 H20 in 2L of water). A yellow precipitate was formed, filtered off and was left to dry on the filter under suction (2 h).
The product was triturated with i-PrOH twice, filtered and washed with cold diisopropyl ether (15 mL) to yield 54.1 g (88%) of the product tris(2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']bis ~1,3)dioxole-4-yl)methane.
H NMR (CDCl3, 300 MHz) ~: 1.47 (CH3, 36H, s), 5.42 (CH, lH, q, J=0.37 Hz), 6.20 (aromatic H, 3H, d, J=0.37 Hz).
3C NMR (CDCl3, 75 MHz) ~: 139.5 139.8 (aromatic C-O), 116.7 (alifatic O-C-O), 107.6 (quart. aromatic), 90.7 (aromatic C-H), 30.7 (C-H), 25.3 (CH3).
MS (EI): M~-16 (676, 100%), M~-15 (678, 40~), 338.5 (70%).

W~91/12024 PCT/~P91/00285 2~7~1 8 Example 18 Tris(8-carboxyl-2 2 6 6-tatramethYl-benzotl,2-d:4 5-d']-3)dioxole-4-yl)m thane and bis~8-carboxyl-2~ 6-tetramethyl-benzo [1,2-d:4 5-dll-bis~L.3~dioxcle-4-yl)-(2~2t-6~6---t-et-Ec~m~ ~zo~l~2-d:~l~5-dl]-bis(l~3!dioxole -4-~l)methane CH
CH k~oX
)< ~X n-BuLi COOH
O O eth~r >~ ><
CO2 (s) ~ ~ O
HOOC ~CH~
0><0 0><0 Tris(2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']bis(1,3)-dioxole-4-yl)methane (1.65 g, 0.244 mmol, Example 17) was dissolved in dry diethyl ether (150 mL~. n-BuLi (5.86 mL, 2.5 M in toluene, 1.465 mmol) was added in two portions (2/3 and 1/3), and the temperature of the mixture was raised to 40 ~C (the ether refluxed). After maintaining this temp. for 15~20 min, the mixture was poured onto CO2(s), and left overnight. Water (9O mL) was added to dissolve the solid residue. The aqueous phase was washed with ether (50 mL). The aqueous phase was then acidified with 2M HCl to pH 1-2, and the tan coloured precipitate which formed was filtered off, washed with of water (7 mL) and dried. RP-TLC (Sio2 RP18: glassplates) in MeOH:H20 (4:1) showed mainly two spots, (diacid and triacid with Rf-0.51 and 0.81, respectively). The product tris(8-carboxyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5 d']-bis(1,3) dioxole-4-yl)methane was not separated from the mixture (1.43 ~ O.lO = 1.53 g (raw matarial of acids)) but was used without further purification in esterification or ;

WO91/12024 P~T/~P9~/~02~5 ~5 ~ 60 -amidation reactions. The products of these reactions can be separated by chromatography.

_am~le 19 Tris ~3-methoxycarbonyl-2,2 6,6-tetramethYl-benzo~l 2-d:
4.5- d']-bls~1,3)dioxole-4-yl)methane and bis~8-methoxycarbonyl-2 2.6 6-tetramethyl-benzo[l 2-d:4 5-d']-bis(1 3)dioxole-4-yl)-(2 2,6l6-tetramethyl-benzo r 1 2-d:4 5-d']-bis(1 3)dioxole-4-yl)methane CH cH
~3 0 ~r~3 ~O~CoX ~O~oX
COOH C~CO3COOMe O`xO o><o CH31o><o O O

>< >< 0~<0 ~<o A mlxture of the acids tris(8-carboxy-2,2,6,6-tetramethyl- benzo[l,2-d:4,5-d']-bis(1,3)dioxole-4-yl) methane and bis(8-carboxy-2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']-bis(1,3)-dioxole-4-yl)-(2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)met hane (3.0 g, 0.36 mmol, Example 18) were dissolved in dry DMF (70 mL) and CszCO3 (9.8 g, 30 mmol) was added.
The mixture was heated to 70 C for 1.5 h and was then cooled to room temperature and CH3I (6.74 mL, 108 mmol) was added with efficient stirring at 35 C for 40 h, and the reaction mixture was filtered and the solvent (DMF) evaporated at reduced pressure. The residue was partitioned between CH2C12 (200 mL) and water (70 mL).
The organic phase was extracted with another portion of water (70 mL). The aqueous phases were extracted back with oE CH2Cl2 (70 mL). The organic phases were extracted with a solution oE saturated NaHCO3, dried (Na2SO4) and the solvent evaporated, leaving a light WO91/1~024 PCT/~P91/0028~

- 61 - 2~7~
brown crystalline residue (3.05 g), which was chromatographed on a semi preparative reversed phase column (30 cm i.d., packed with 10~m Kromasil, C8), eluting with CN:H20 (75:25).
Yield of tris(8-methoxycarbonyl-2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)methane 1.70 g (55~)-H NMR (CDCl3, 300 MHz) ~: 1.53 (s, CH3, 36H, 3.87 (s, OCH3, 9H), 5.42 (s, CH, lH).
3C NMR (CDCl3, 75 MHz) ~: 163.8 (C = O) 140.1, 140.0 (aromatic C-O), 118.4 (aliphatic O-C-O), 110.3 (quart.
arom. C), 98.5 (p-substituted quart. aromatic), 51.8 (OCH3), 31.3 (C-H), 25-5 (CH3)-MS (Thermospray- M~+23 (Na) ~73.
Yield of bis(8-methoxycarbonyl-2,2,6,6,-tetramethyl-benzo[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)-(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)methane = 0.60 g (20%).
1H NMR (CDCl3, 300 MHz) ~. 1.47 (s, CH3, 12H, 1.53 (s, CH3, 24H), 3.87 (s, OCH3, 6H) 5.42 (s, CH, lH), 6.21 (s,aromatic H, lH).
Ms (Thermospray): M~+23 (Na) 815.

Example 20 Tris(8-methoxycarbonyl-2 2;6.6-tetramethylbenzo~1,2-d:4 5-d']-bls~1 3!-dioxole-4-yl~methane and bis(8-methoxy-carbon~l-2,~ 6.6-tetramethylbenzo[1 2-d:4 5-d " -bis(l~3)-dioxole-4-yl)-(2,2,6,6-tetramethylbenzo~l 2-d:
4 5-d'l-bis~1 3)-dioxole-4-yl)methane CH
~3 C~ 3 ~)<O~oX
~O_~o~ n-BuLiCOOMe /\o~o/\ ether>< ><
(MekCO O o o MeOOC~CH~
0~><0 0><0 W091/12024 PCT/~P91/0~285 Tris(2,2,6,6-tetramethylbenzo[1,2-d:~,5-d']-bis(1,3)-dloxole-4-yl)methane (3.00 ~, 4.~0-mmol (Example 17)) was dissolved in ether (100 mL) and n-BuLi (10.~ mL, 27.0 mmol) was added. ~'he mixture was refluxed for 20 min, and a~ter cooling to room temperature dimethylcarbonate (5.60 mL, 67.0 mmol) was added. The mixture turned dark brown, and the reaction mixture was stirred over night at room temperature. Water (40 mL) was added and the phases were separated. The aqueous phase was extracted with another portion of ether (50 mL). The organic phases were pooled, dried and filtered, and the solvent evaporated leaving a semisolid brown residue. This was chromatographed on a SiO2 column (0.040-0.063 mm), eluting first with petroleum-ether/ether (1:4) and then with ethyl acetate (EtOAc). The diester bis(8-methoxycarbonyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d'~-bis(1,3) dioxole-4-yl)-(2,2,6,6-tetramethylbenzo [1,2-d:4,5-d']-bis(1,3)dioxole-~-yl)methane (1.27 g, 33.1~) and the triester tris(8-methoxycarbonyl-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']-bis(1,3)dioxole-4-yl) methane (0.37 g, 11.0 %) were isolated. For spectroscopic data see Example 19.

WO91/1202q P~T/EP91/002X5 2~7~

ExamPle 21 Tris(8-ethoxvcarbonyl=2 2 6 6-tetramethylbenzo~1 2-d:~ 5 -d'l-bis(1,3)dioxole-4-yl)meth ne CH CH
~3 ~'3 ~o~ 0~ n-BuLi \<O ~O>,/
/\c)~o/\\ THF / o~o \
ClCOOEt COOEt Trls(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis(1,3)-dioxole-4-yl)methane (1.35 g, 2.0 mmol (Example 17)) was dissolved in dry THF (400 mL) under N2, and the temp was lowered to -40 C and n-BuLi (4.86 mL, 12.2 mmol) was added and the temperature was allowed to rise gradually to ODC. The mixture was cooled to -60 C, and a solution of ethylchloroformate (4.0, 36.7 mmol) in THF
(50 mL) was added. The reaction mixture was left overnight and worked up as described under Example 20 above. The chromatography gave (0.41 g, 24%) of tris(8-ethoxycarbonyl-2,2,6,6-tetramethylbenzo [1,2-d:4,5~d']-bis(1,3)dioxole-4-yl)methane.
H NMR (CDCl3, 300 MHz) ~: 1.35 (t, CH3, 9H), 1.52 (s, CH3, 36H), 4-34 (q, cH21 6H), 5.41 (s, CH, lH).
3C NMR (CDCl3, 75 MHz) ~: 163.4 (C = 0), 140.1, 140-0 (aromatic C-O), 118.3 (aliphatic O~C-0), 110.2 (quart.
aromatic C), 9~.8 (quart. C-substituted aromatic), 60.7 ~CH2), 31.3 (C-H), 25.5 (CH3), 14-2 (CH3)-Example 22 Tris(8-methylcarbon~loxymethvl-~ 2 6,6-tetramethylbenzoL
1.2-d:~,5-d']-bis(1 3~dioxole-4-yl)methanol W~1/12024 PCT/~P91/0028 6~-COH
CO~I ~' 3 kO~Ox(AcO)20 k~X
~o pyridine O~Me Acetic anhydride (AcO)2O (30 mL) was added to pyridine (35 mL). Tris(8-hydroxymethyl-2,2,6,6-tetramethylbenzo [1,2-d:4,5-d']-bis(1,3)dioxole-4--yl)methanol (0.400 g, 0.51 mmol (Example 33) was added under stirring, which was maintained at room temperature for two days.
Pyridine and excess anhydride were evaporated (oil-pump) at 40-50C to a syrup, which was taken up in 70 mL o~
CH2Cl2. The organic phase was washed with water (30 mL), 0.5 M HCl (~0 mL), water (50 mL) and NaHCO3 (saturated, 30 mL). The organic phase was separated, dried and the solvent was evaporated, leaving a syrup, which crystallized after standing for ca l h and the product tris(~-methylcarbonyloxymethyl-~,2,6,6-tetramethyl-benzo[1,2-d:
4,5-d']-bis(1,3)dioxole-4-yl)methanol was isolated (0.460 g, 100%).
1H NMR (300 MHz, CDCl3) ~: 1.48 (s. CH3, 36H), 2.05 (s, CH3CO, 9H), 5-25 (s, CH2, 6H), 4.19 (s, OH, lH) Ms (Thermospray): M~+23 (Na) 931.

Example 23 Tris~-foxmyl-2,2,6,6-tetramethylbenzo[1,2-d:4 5-d'l-bis (1,3 ? dloxole 4-vl)methane and bis~8-formyl-2,2,6,6-tetramethylbenzo r 1,2-d:4.5-d'l-bis(1,3)dioxole-4-yl~-l2,2l 6 6-tetramethylbenzo[1,2-d:4,5-d'l-bis(1,3L~ioxole-4-yl~methane WO91/l2024 PCT/EP91/~0285 : - .
- 65 - 2~7~
CH
~r3 ~o~oX
CH

~)<O~oX ~ ~ h ~ r 0><O o~<o O~IC-~C~I~

Tris(2l2~6l6-tetramethyl-benzo[l~2-d:4t5-dl]-bis(l~3)-di oxole-4-yl)methane (2.0 g, 3.5 mmol (Example 17)) was dissolved in dry ether (loO mL) at room temperature.
Undar an inert atmosphere n-butyl lithium (6 mL) was added, and the reaction mixture was heated to reflux (15 min). At this te~perature another portion of n-butyl lithium (2 mL) was added and the heating was interrupted. After 5 min DMF (2.7 mL, 35 mmol) was carefully added and the reaction mixture was left stirring at room temperature overnight. Water (100 mL) and glacial acetic acid (1.5 mL) were added to the reaction mixture and the phases were separated. The aqueous phase was extracted with water (2x50 mL), and dried over a mixture of Na2SO4 and K2C03. After filtering through a bed of SiO2 the solvent was evaporated leaving a yellow to red crystalline residue, which was chromatographed on a column of SiO2 with CH2Cl2/ether (4:1) as eluent, yielding pure dialdehyde bis(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:
4,5-d']-bis(1,3)-dioxol-4-yl)-(2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']-bis(1,3) dioxol-4-yl)meth ane 0.610 g (20%) and trialdehyde tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis(1,3)-dioxol-4-yl)methane 1.23 g (51%).
Bis(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis(l,3)dioxole-4-yl)-(2,2,6,6-tetramethylbenzo [1,2-d:4,5-d']-bis(1,3)dioxol-4-yl)methane:

WO 91/~2024 PCl'/EI391/00285 2~75~1~ t;'' `~

lH NMR (300 MHz CDC13) ~i: 1.50 (s, C~3, 12H) 1.55 (s, CH3 24H) 5.42 (s, C-H, lH) 6.24 (s, aromatic H, lH) 10.06 (s, C~O, 2~).
3C NMR (75 MHz, CDCI3) d:l85.59, 140.19, 140.15, 139.67, 139.59, 119.~6, 117.15, 113.10, 105.36, 105.Zl, 91.40, 31.43, 25.52, 25.36.
MS (Thermospray): M~23 (Na) 770.
Tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis (1,3)-dioxole-4-yl)methane:
1H NMR (300 MHzj CDCl3) ~: 1.56 (s. CH3, 36H) 5.44 (s.
C-H, lH) 10.07 (s. CHO, 3H).
13C NMR (75 MHz, CDCl3) ~: 185.5 (C=O) 140.3 140.1 (arom C-O) 119.7 (alif. O-C-O) 111.9 (quart. arom C) 105.4 (p-sub. quart. arom C) 31.7 (C-H) 25.6 (CH3).
IR (KBr, cm-l): 1700 (s. C=O) 2980 (m, C-H str) 1040 (s.
Ar-O-C).
MS (Thermospray): M++23 (Na) 783Ø

Example 24 , Tris~8~formyl-2,2,6 6-tetramethylbenzo[1~2-d:4 5-d']-bis (1.3~-dioxole-4-yl)methyl CH NaH ~ 3 ~O / t-BuOK ~~V/
/;<~0>~ ether /\~/\
CHO DM~) CHO

Tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis (1,3)-dioxole-4--yl)methane (140 mg, 0.18 mmol, Example 23) was dissolved in a mixture of dry DMSO (15 mL) and of dry ether (50 mL). NaH (5 mg, 0.19 mmol) and t-BuOK
(catalytic amount) were added under N2-atmosphere The WO9l/12024 PCT/EPgl/0028~
, ~ 2 0 7 ~

color of the solution changed from yellow to deep green-blue. After 4h of stirring at room temperature under N2 I2 (46 mg, 0.18 mmol) was added, and aftar 2 min the reaction mixture was poured into a saturated solution of Na2S2O3 (100 mL). The oryanic phase was separated, dried (Na2SO4) and the solvent was evaporated leaviny a black crystalline residue weighing 0.120 g (88 %) MS (Thermospray): M~23 (Na) 782Ø
Radical content (NMR method) >50%.
ESR: 4 lines (internal ratio 1:3:3:1) with line widths of ca 70 mG.
Overhauser enhancements: 9mW: 13 18mW: 25 5mW: 152 5mW:
254 after dilution to 10 mM.
i Example 25 Tris(8-formyl-2 2 6 6-tetramethylbenzo r1,2-d:4 5-d ~ -bis (1 3)dioxol-4-yl)methvl )<~X SOCI2 ~<--~X
~o ~HF o~~O
CHO CHO

zn(H9) k~oX
SnC12 CHO

Tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis (1,3)dioxole-4-yl)methanol (200 mg, 0.20 mmol) was dissolved in of dry THF (15 mL) and SOCl2 (80 mg, 0.20 mmol) was added. After stirring at room temperature for 2 h the solvent was evaporated (<70 C) and the residue was pumped dry overnight. The orange product tris(8-formyl-2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']-bis(l,3)-dioxol-4-yl)methylchloride was dissolved in of WO91/12024 PCT/EP91/0028~
2~7~18 , .~

dry THF (15 mL) and BC13 (0.2~ mL, lM in CH2Cl2) was added at room temperature and the solution immediately turned black. After 0.5 h of stirring under N2-atmosphere was added; first SnCl2 (0.15 g, 0.80 mmol) and ~hen Zn(Hg), (0.15 g, 2.20 mmol) (prepared by treating 120 g zinc powder with a mixture of 12g HgCl2, 6 mL conc. ElCl and 150 mL of water for 5 min. and decanting off the liquid). Stirring was maintained for 0.5 h. The reaction mixture was applied to a column (1 cm diameter) consisting of 3 cm of sio2 at the bottom and 15 cm of Chelex 100 on top. Elution was performed with dry THF under N2-atmosphere. The eluent was evaporated to dryness, leaving a brown-black crystalline residue (0.19 g, 100%).
Radical content was ca 27~ according to HPLC (ion pair, tetrabutylammoniumacetate, sio2 C18, CH3CN/H20 (75:25)).
ESR spectrum of 4 peaks (int ratio 1:3:3:1) with 70 mG
linewidth.

Example 26 Tris(8-methoxycarbonyl-2,2,6,6~tetramethylbenæo[1.2-d:4 5-d'~-bis(1.3~dioxole-4-yl)methYl o~o SOCi2 ~oX
~oXlHF~ ko~
COOMe COOMe c~ 3 Zn~H~ ko ~C~oX
SnCI2 COOMe Tris(8-methoxycarbonyl-2t2l6~6-tetramethylbenzo[l/2-d:4 5-d']-bis(1,3)dioxol-4-yl)methanol (240 mg, Example 15) was dissolved in of dry THF (25 mL) and SOC12 (38 mg, 23 L) was added at room temperature. Stirring was ,................................................ 2~7~818 maintained for 2.5 h. The solvent of the reaction mixture was then evaporated to dryness (<70 ~C). After pump drying over night tris(8-methoxycarbonyl-2,2,6,6~
tetramethylbenzo[l,2--d:4,5-d']-bis(1,3)clioxole-4-yl) methylchloride was dissolved in of dry THF (25 mL) and, in turn SnCl2 (0.10 g, 0.53 mmol) and then Zn(EIg) (see Example 25) (0.10 y, 1.52 mmol) were added under N2. The solution turned black and was filtered through a column (1 cm diameter) of 15 cm Chelex 100 (top) and 3 cm of sio2 (bottom~, under N2 with THF as eluent. The solvent was evaporated leaving a black crystalline residue (0.20 g).
ESR spectrum showed 10 lines with linewidths = 48 mG. A
radical content of ca 5% was estimated by ESR.
At 75 mW, the Overhauser enhancement was 80.

Example 27 Tris(8-ethoxyca~rbonylmethylthio-2 2 6 6-tetramethylbenzo rl.2- d:4,5-d'l-bis(1.3)dioxole-4-Yl) methanol k~X--ko~CoX
SH
COH
-~ ko~oX
SCH2COOEt 2,2,6,6-Tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole (2.22 g, 10 mmol (Example 5)) was dissolved in dry tetrahydrofuran (dried using sodium benzophenone ketyl) and cooled to -78 C under argon. n-Butyllithium (4.25 mL, 2.5 M in hexane, 10.6 ~mol) was added. The cooling ~O91/12024 P~T/~P91/nO2~5 2o7~l8 ~ ,.

bath was removed 35 minutes later and the mixture stirred for 40 minutes, when dry sulfur (S8, 0.320 g, 1.25 mmol) was added in one portion. The sulfur had dissolved one hour and ~i~teen minutes later. The reaction mixture was then recooled to -7~ C and n-butyllithiurn (~.25 mL, 10.6 mmol) was added. The dry ice/acetone bath was exchanged with a water/ice bath.
The new cooling bath was removed after one hour and forty ~ive min~utes. Cold (-78 C) diethylcarbonate (0.363 mL, 3 mmol) in THF (lO mL) was cannulated into the reaction mixture over a period of 10 minutes. The resulting mixture was kept at (-70) - (-78) C for two hours, followed by a period of one hour and thirty minutes at approximately o oc (ice/water bath). The mixture was then stirred till noon the following day without addition of ice, at which time the temperature inside the reaction flask was ~16 C. The mixture was then stirred without external cooling for three more hours, poured into a half saturated sodium dihydrogenphosphate buffer (100 mL) and extracted with diethylether (4xlO0 mL). The organic phase was washed with the same buffer (50 mL~ and dried tMgS04). This yielded 2.93 g of product, which by lH NMR (300 MHz, CDCl3) was shown to contain approximately 50% of trist8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis (1,3)dioxol-4-yl)methanol. The was used immediately in the next step.
Tris(8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:~,5-d']-b is (1,3)dioxol-4-yl)methanol (2.93 g, 50~, 1.86 mmol) was dissolved in dry DMF ~100 mL) under argon. X2C03 (4 g) was added and the solution cooled to the freezing point. Ethylchloroacetate (5 mL, 46.7 mmol, Janssen 11~22.85) was added, and the reaction mixture was stirred at room temperature overnight. Most of the DMF
and excess e~hylchloroacetate were removed by high vacuum distillation at 30-40 oc. The residue was mixed WO91/12024 PCT/EP91/00~8~

- 71 - 2~ 1 8 `
with saturated sodium dihydrogenphosphate buffer (100 mL) and extracted with diethyl ether t4x150 mL). The etheral phase was washed with phosphate buffer (2x50 mL) and water (50 mL), dried (MgSO4) and evaporated.
Purification was achieved through two flash chromatoyraphy (E. Merck 0.040-0.063 mm SiO2) separations with n-heptane: ethyl acetate (1:1), followed by straight phase (E.Merck 20-~5 mm CH2Cl2:EtOAc 9:1) and reversed phase (Prep-pak C18, MeOH:H20, 8:2, 15%
CHzCl2 in application volume) HPLC chromatography, and finally recrystallization from diisopropyl ether. Yleld (1~57 g, 15%, 1.5 mmol).
UV (maxima/minima): 220 (p), 249(v), 259(p), 297(v), 344(p). Other spectroscopic data; see Example 9.

Example 28 Tris(8-ethoxYcarbonylmethylthio-2,2,6,6,-tetramethylbenzo([l,2-d:4,5-d']-bis(1,3) dioxole-4-Yl) methyl C:OH C*
X~oX '' X~oX
SCH2COC)Et SCH2COOEt Tris(8-ethoxycarbonylmethylthio-2,2,6,6,-tetramethylbenzo( [l~2-d:4/5-dl]-bis(lt3)dioxole-4-yl) methanol (2.00 g 1.91 mmol) (prepared as described in ~xample 27) was dissolved in dry (sodium benzophenone ketyl) degassed (Ar) THF (1.0 L) in a separatory funnel (2.0 L). ~ rapid stream of argon was bubbled through the solution. Borontrifluoroethyl WO91/1~024 PCT/EP~1/002~
. .~, etherate (2.88 mL 48% Fluka 15720) was added with a syringe. The clear solution turned immediately dark blue, indicating formation of the corresponding cation.
I'in(II)chloride (2.90 g 15.3 mmol E.Merck 818150) was added. The color changed from blue to colorless to geen in a couple of minutes, and the resultiny mixture was bubbled with argon for 10 minutes, when Zinc (2.50 g, 38.2 mmol Janssen 19.834.46) (activated by treatment with 1 M hydrochloric acid followed by water, ethanol and diethylether washings and high vacum drying) was added. The argon bubbling was continued for another 20 minutes, when more zinc (2.5 g) was added. 45 Minutes later the last amount of zinc (3.0 g) was added, followed by borontrifluoroethyl etherate (1.4~ mL). The reaction was continously monitored by HPLC. The substrate and the radical separated on an analytical RPl8 column (Nucleosil 5 mm) with acetonitrile:water (75:25) containing the ion pair tetrabutylammonium acetate (5 mM) (pH 6.7). The detector system consisted o~ a diode array W detector (Varian 9065 polychrome).
The radical was distinguished from the substra~e by the UV spectra (see below). The reaction was stopped when the radical content reached a maximum (~90~ by W , not considering different extinction coefficients). The volume of the reaction mixture was reduced to about 700 mL during the reaction period. The reaction mixture was diluted with dry (sodium benzophenone ketyl) diethylether (1.0 L) and extracted with dry, oxygen free sodium hydroxide (2xlO0 mL, 2 M, 0 C, He). The organic phase was filtered through a SiO2 column (40 cm long, I.D. 5 cm E. Merck 9385 0.0040-0.063 mm). The column was precon;1tioned with dry oxygen free diethylether before the filtration. The last portion of the radical was eluted with pure diethylether (sodium benzophenone ketyl, Ar). The radical was obtained as black/green crystals after evaporation under argon. Yield (1.87 g, 1 814 mmol, 95%).

WO91/12~24 PCT/EP91/002g~
2Q75~1~

MS (Thermospray): M++23 (Na) 1052.
UV (Absorbtion maxima/minima): 195(p), 229(sh), 302 (v), 33g(p), 348(v).
ESR (THF): 7 lines, lw 30 mG, a~I 60 mG.
overhauser (THF less than 1 mM conc., 200 G): freq.
548~9 MHz, 9 mW 78 enhancement, 1~ mW 116 enhancement.

Example 29 Tris(2,2,6,6-tetramethYl sodium-8-carboxylato-methylthiobenzo[l 2-d:4,5-d']-bis(1 3)dioxole-4-yl)methyl C~ C*
ko~oX ` X~oX
SCH2COOEt SCH2COO-Na+

Tris(8-ethaxycarbonylmethylthio-2,2,6,6,-tetramethylbenzo-[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl) methyl (1.97 g, 1.91 mmol 90 % pure) was dissolved in a degassed (helium followed by ar~on) mixture of dioxane (Lab Scan C2512 HPLC quality) and water (200 mL (3:1)).
Sodium hydroxide (4.3 mL, 2 M, 8.58 mmol, He, Ar, 0 C) was added and tha hydrolysis performed in a ultrasound bath (Sonorex RK 2555). The reaction was followed by HPLC, RP18 column (Nucleosil 5 mm) with acetonitrile:water (75:25) containing tetrabutylammonium acetate (5 mM, pH 6.7). The detector system consisted of a diode array W detector - Varian 9065 polychrome).
During the reaction the diester- and monoester radicals were observed as well as the tricarboxylic acid salts.
The reaction mixture was ~rozen when the HPLC analysis WO91/12024 PCT/EP9l/0028
7 ~ ~ owed pure tricarboxylic acid sodium salt (mixture of radical and carbinol) and subjected to freeze drying.
Yield (2.07 g, 100% 1.90 mmol) of a black/brown, fluffy material, containing excess NaOH.
Radical content: 50% (NMR - Evans method).
ESR (H20 0.3 mM, 200 G): 7 lines, Lw 27 mG, aH 60 mG, 200G, Yreq. 548.9 MHz.
Overhauser:(~I20 0.3mM, 200 G): Freq. 54~.9 MHz, 9 mW 63 enhancement, 18 mW 81 enhancement.

Example 30
8-Mercapto-2,2,6,6-tetramethylbenæo[l.2-d:4l5-d']-bis (1,3)dioxole ko~oX -~ k~oX
SH

.

2,2,6,6-Tetramethylbenzo[1,2-d:4,5-d']bistl,3)dioxole (30.0 g, 135 mmol (Example 5)) was dissolved in dry (sodium benzophenoneketyl) diethylether (250 mL), and heated to reflux. n Butyllithium (50 mL, 2.68 M in toluene, 134 mmol) was added and the reflux continued one hour. The flask was cooled to -78 C and sulfur (4.297 g, 134 mmol) added. The cooling bath was exchanged with an ice/water cooling bath and the reaction mixture was stirred for one hour before alkaline water was added (150 mL, 1 M, degassed with argon) followed by vigorous stirring in ten minutes.
The phases were separated and the water phase was washed WO9I/I2024 PCT/EP9I/0028~
20 ~

with diethylether (100 mL, degassed with argon). The water phase was acidified with HCl (5 M). The precipitated crystals were taken up in diethylether (degassed argon), dried (MgS04) and evaporated to dryness. The pure crystals are stable for weeks under argon in t.he freezer. Yield: 24.86 y (72.5 ~).
H NMR (CDCl3, 300 M~Iz) ~: 1.65, 3.28, 6.13.
3C NMR (CDCl3, 75 MHz) ~: 139.87, 138.33, 118.31, 94.99, 90.23, 25.54.

Example 31 Tris(8-mercapto-2 2 6 6-tetramethylbenzo[1 2-d:4 5-d']-bis(l 3)dioxole-4-yl)methanol COH
X~COX ~ X~oX

SH
~, .
.
8-Mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis(1, 3)dioxole (24.9 g, 97.9 mmol (Example 30)) was dissolved in dry diethylether (200 mL) in a three necked round-bottomed flask, equipped with a sintered glass filter (no. ~) at one of the outlets. The reaction mixture was cooled to (-78) C and n-butyllithium (36.5 mL, 97.9 mmol, in toluene) was added. The dry ice/acetone bath was exchanged with a water/ice bath.
The new cooling bath was removed after one hour. The solvent, and most of the soluble impurities were removed from the lithium salt by filtration through the sintered glass filter. The whole filtration took about ten :`

WO91/12024 PCT/~P91/Q02~S

minutes. The salt was washed to the bottom of the flas~
with dry diethylether (30 mL). Tetrahydrofuran (2S0 mL, sodium benzophenone ketyl dried) was added and the solution was cooled to (-78 C). n-Butyl lithium (36.5 mL, 97.9 m~ol, in toluene) was added. After a period oE
ten minutes, the temperature was gradually raised to 0 C with a water/ice bath. The mixture was stirred with this cooling for one hour and twenty minutes, followed by a period of thirty minutes at room temperature.
~fter recooling to (-78) C, diethylcarbonate (3.63 mL, 30 mmol) in tetrahydrofuran (20 mL) was added to the reaction mixture over a period of one minute. The temperature was raised gradually with the help of a water/ice bath. The reaction was followed by taking samples (quench of small samples in sodium dihydrogenphosphate buffer under argon, evaporating organic phase) and running lH NMR. The trimerisation was complete after four hours. The mixture was quenched with sodium dihydrogenphosphate buffer (saturated, 130 mI.), stirred twenty minutes and the phases were separated. The water phase was extracted with diethylether (50 mL, argon) and the organic phases were combined, washed (sodium dihydrogen phosphate buffer, 30 mL), dried (MgSO4, 30 min) and evaporated to dryness.
Diethylether (dry, argon) was added to the brown oil to induce the crystallization. Upon the dissolution of the oil the title compound crystallized as porous yellow crystals. The product was isolated by filtration.
Yield: 10~0 g (12.7 mmol, 39 %).
H NMR (CDCl3, 300 MHz) ~: 1.49, 3.25, 4.10.
3C NMR (CDCl3, 75 MHz) ~: 138.54, 138.26, 117.51, 110.16, 93.55, 72.33, 25.53.
MS (Thermospray): M~+23 (Na) 811.
Crystallization of the mother liquor gave (lH NMR) 0.8 g of dimeric (ketone) product. (See Example 51).

W~1/12024 PCr/~P91/00285 2~ 7~81 ~

Example 32 Tris(8-etho~arbonylmethylthio-2,2,6,6-tetramethyl-benzo~l,2-d:4,5-d'l-bis(1,3)dioxole-4~yl~methanol ko~oX ~ X~oX
SH SCH2COOEt The title compound was made with pure tris(8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5--d']-bis(1,3)dioxole-4-yl)methanol (from Example 31) (2.10 g 2.67 mmol) and ethylchloroacetate (16.0 mmol), using a procedure analogous to that described in Example 27. Yield 1.93 g (98%).
H NMR (CDCl3, 300 MHz) ~: 4.12, 3.54, 1.51, 1.24.
3C NMR (CDC13, 75 MHz) ~: 169.00, 141.22, 138.64, 117.75, 112.40, 96.62, 72.48, 61.20, 35.~7, 25.42, 1~.08.

Example 33 Tris(8--hydroxy-m-ethvl-2~2~6~6-tetramethylbenzo[l~2-d:4~5 d'l-bis(1,3)-dioxol-4-Yl)methanol ., X~ox X~X

WO91/1202¢ P~r/EP~1/00285 ~ ~ 7 ~81 ~ 78 Tris(2,2,6,6-tetramethylbenzo([1,2-d:4,5-d']-bis(1,3)-dioxol-4-yl)methanol (6.35 g, 9.38 mmol) was dissolved in dry diethylether (200 mL) under argon and cooled to 0C. n-Butyllithium (22.5 mL, 56.30.10-3 mol) was added and the temperature was increased to induce reflux. The reaction mixture was refluxed f:or 25 minutes. After cooling to 0 C, dry formaldehyde (gas, formed by sublimation) (4.0 g, 133 mmol) was added and the resulting mixture was stirred over night while the temperature gradually was increased to room temperature.
After quenching with sodium dihydrogenphosphate buffer (200 mL; saturated), extraction with diethylether (5x250 mL), drying (MgSO4) and evaporation, the product was isolated by column chromatography (E. Merck 0.040-0.063 mm sio2, 6.27 cm, CH2Cl2:EtOAc 3:2 (2.0 L), CH2Cl2:EtOAc (1:1) (2.0 L), CH2Cl2:EtOAc (2:3) (2.0 L). Yield 0.239 g (0.305 mmol (3.3 %).
1H NMR (300 MHz, CDCl3) ~: 4.59 (s, CH2, 6H), 1.23 (s, CH3, 36H), OH not seen.
3C NMR (75 MHz, CDCl3) ~: 138.70, 139.38, 117.23, 105.88, 72.51, 56.66, 25.48.

Example 34 Tris(8~methoxymethyl-2,2,6,6-tetramethylbenzo~1~2-d:4,5-d'l(1,3)dioxole-4-Yl)methanol COH COH
X~oX X~oX

WOgl/12024 PCT/EPgl/00285 ;:
2~7~

Tris(8-hydroxymethyl-2,2,6,6-tetramethylhenzo[1,2-d:4,5-d'](1,3)dioxole-4-yl)methanol (0.105 g, 0.134 mmol (Example 33)) and a catalytic amount of tetrabutylammoniumhydroyen sul~ate were added to a preformed solution of dimethylsulfate (0.2 mL) and sodium hydroxide (50%, 1.0 mL) in CII2Cl2 (2 mL). The resulting solution was stirred at ambient temperature for 48 hours. The mixture was evaporated and the resulting oil chromatographed on silica (CH2Cl2:diethylether (5:1)). The major product was not completely pure according to TLC, but upon dissolution in CDCl3 the impurities did not dissolve. Evaporation of the filtered solution yielded 94 mg (0.114 mmol, 85 %) of pure title compound.
H NMR t300 MHz, CDCl3) ~: 4.40 (s, CH2, 6H), 3.30 (s, CH3, 9H3, 1.47 (s, OEI3, 36H), OH not seen.
3C NMR (75 MHz, CDCl3) ~: 139.64, 138.58, 116.97, 112.37, 102.65, 72.61, 63.49, 57.16, 25.46.

Example 35 Tris(8-methoxymethyl-2,2.6,6-tetramethYlbenzo~1,2-d:4,5-d'lbis(l 3)dioxole-4-yl)methyl .

X~oX X~oX
C:H20CH3 CH20Ctl3 i WO91/12024 PCT/E~91/0028~
2~ 75~1 ~ 80 -Tris(8-methoxymethyl-2,2,6,6-tetramethylberlzo[1,2-d:4,5-d'Jbis(1,3)dioxole-4-yl)methanol ( 94.0 mg, 0.114 mmol (Example 34)) and thionyl chloride (40 mL, 0.57 mmol) were stirred in tetrahydrofuran (2 mL) (sodium benzophenone ketyl dried) ~or 45 minutes and evaporated.
The res:idue was dissolved in fresh tetrahydrofuran (10 mL) and boron trichloride (330 m~., 1 M in CH2Cl2). The color of the solution turned light brown.
Tin(II~chloride tl27 mg, 0.986 mmol) was added 10 minutes afte~ the borcn compound, and zinc (187 mg, 2.85 mmol) was added after another 15 minutes. One hour and fifteen minutes later the reaction mixture was green.
The solution was evaporated, and subsequently filtered through a sio2 column with tetrahydrofuran as the eluent.
The residue (80 mg, 0.099 mmol, 87% (containing some radical precur) was dissolved in tetrahydrofuran and the radical characterized by ESR and Overhauser enhancements:
ESR (200 G): Linewidth 1.5 G (70 overlapping lines).
Overhauser enhancements (548.9 MHz, 200 G): 5 W 60 enhancements.

xample 36 Tris(8-hydroxyethYlthio-2 2 6 6-tetramethylbenzo[l 2-d:
4_ 5- d'J-bis(1 3)dioxole-4-yl)methanol X~ox X~ox SCI 12COOEt SCH2CH20H

W~9I/12024 PCT/~P91/~285 ,, , . - .
- 81 - 297S~18 LiAlH4 (15.2 mg, 0.40 mmol) was added to a solution of tris(8-ethoxycarbonylmethylthio-2,2,6,6-tetramethylbenzo -[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)methanol (10.5 mg 0.10 mmol (Example 27)) in diethyl ether (10 mL) under nitrogen at 20 C. The reaction was followed by HPLC
(reversed phase C18, acetonitrile:waker (3:1), 5 mM
tetrabutylammonium acetate). The mixture was queIlched with ethylacetate when no more substrate was seen by HPLC. Dilute sulfuric acid was then added until pH 6-7.
The ether phase was separated, and the water phase was extracted with diethyl ether. The combined etheric phases were dried (MgSO4) and evaporated, yielding 0.0901 g (97.8 %, 0.0978 mmol) of a yellowish oil, which gradually crystallized upon standing.
H NMR (300 MHz, Acetone d6) ~: 1.49 (s, CH3, 36H), 2.51 (bs, OH, 3H), 2.59 (t, CH2, 6H), 4.38 (s, OH lH).
C NMR (75 MHz, Acetone d6) ~: 141.96, 138.93, 117.80, 112.52, 98.06, 72.50, 60.98, 36.25, 25.18.
MS (Thermospray): ~+23 (Na) 943, ~-18 902.

Example 37 Tris(8-hydroxyethylthio-2,2,6,6-tetramethylbenzo r 1l2-d:
4 5- d']-~is(1 3)dioxole-4-yl)methyl C~ C*
~ 3 ~3 '~<~~ 0 ~ 0~
~ o~ \o~o/\
SCH2C:OOE~SC~12CH20H

.

WO9l/12024 PCT/EP91/0~
.,.. ~, 207~18- - 82 -LiAlH4 (95.8 mg, 2.52 mmol) was added to a solution of tris(8-ethoxycarbonylmethylthio-2,2,6,6-tetramethylbenzo -[1,2-~:4,5-d']-bis(1,3)dioxole-4-yl)methyl (1.30 g, 1.26 mmol, 50~ radical content (Example 28)) in diethylether (50 mL) ~Inder nitrogen at 20 ~C. The reacti.on was Pollowed by HPLC (reversed phas~ C18, acetonitrile:water (3:1), 5 mM tetrabutylammonium acetate). The mixture was quenched with ethylacetate wh~n no more substrate WAS seen according to HPLC.
Dilute sulfuric acid was then added until pH 6-7. The ether phase was separated, and the water phase extracted with diethylether (2x100 mL). The combined etheric phases were dried (Na2SO~) and evaporated, yielding 0.96 g (84%, 1.06 mmol) of a yellowish oil. The product was characterized by ESR and Overhauser measurements. HPLC
chromatography in combination with diode array detection and W spectral analysis showed a radical content of about 6-7 % after evaporation overnight.

Example 38 Tris(8-di(methvlcarbonyloxyethyllaminocarbonylmethylthio -2,2 6 6-tetramethvlbenzo r 1,2-d:4,5-d'l-bistl 3) dioxole-4-yl) methanol COH (::C)H
ko~X X~X~
SCH2COOEt SCH2CON(CH2CH20H)2 ` COH

k~oX
ScH2coN(cH2cH2oc~oc~H3)2 .

..

WO91/12024 PCTt~91/002X~
.
- 83 - 2~7~i3 Tris(8-ethoxycarbonylmethylthio-2,2,6,6,-tetramethylbenzo-([1,2-d:4,5-d']-bis(1,3)dioxole-4-yl) methanol (0.4675 y, 0.446 mmol (Example 27)) and diethanolamine (0.939 g, 8.93 mmol) were mixed and aminolysis was performed in toluene at reflux temperature under nitrogen for thirty six hours. At this time HPLC analysis (reversed phase Cl8, acetonitrile: water (3:1), 5 mM tetrabutylammonium acetate, 254 nm UV detection) showed complete consumption of the starting material. The crude reaction mixture was evaporated and checked with 13C NMR
without removing the excess diethanol amine from the intermediary tris(8-di(hydroxyethyl)-aminocarbonylmethylthio-2,2,6,6-tetramethylbenzo[1,2-d:
4,5-d'~-bis(1,3)dioxole-4-yl)methanol: [(CD30D, 75 MHz) ~: 171.34, 142.55, 139.97, 119.12, 112.99, 98.94, 60.73, 60.58, 52.97, 50.36, 36.84, 25.88, central COH at ca.
72 ppm was not seen.] and redissolved in a mixture of pyridine (7.0 mL) and acetic anhydride (5.0 mL) and stirred over night at room temperature. TLC analysis (sio2~ methanol:ethylacetate (3:7)) showed formation of a more lipophilic product. This product was purified by two consecutive chromatographic separations on sio2 (E.
Merck 0.040~0.063 mm). The first column was eluted with n-heptane:ethylacetate (1:1) and ethylacetate:ethanol (1:1). The second column was eluted with ethylacetate/n-butanol (95:5). The solvents were evaporated and the last amounts of butanol was removed by high vacuum evaporation under a period of forty eight hours. Yield 0.151 g (23%, 0.102 mmol) (about 20% more substance in the impure fractions).
H NMR (CDCl3, 300 MHz) ~: 4.23 (t, CH2, 6H), 4.15 (t, C~z, 6H), 3.74 (s, CH2, 6H), 3.70 (t, CH2, 6H), 3.54(t, CH2, 6H), 2.02 (s, CH3, 18H), 1~49 (s, CH3, 36H).
3C NMR (CDCl3, 75 MHz) ~: 170.63, 170.37, 168.40, 141.30, 138.60, 117.72, 112.38, 96.38, 72.45, 61.85, 61.83 , 47.7~, 45.52, 35.43, 25.39,20.78, 20.66, (61.85 WO91tl2~24 PCT/~P~1/0028~
2075~1~
- 8~ -and 61.83 are nonequivalent possibly due to resticted rotation arising from the amide).
MS (Thermospray): M~+23 (Na) 1~95, 1496, 1~97 and 1~98 (scale not calibrated).

Exame~ 9 Tris~8-carbox~ylmethylthio-2,2 6 6-tetramethYlbenzo-[1,2-d:4 5-d']-bis(l 3~dioxole-4-yl)methanol X~oX X~ox SCH2COOEt SCH2COOH

Tris(8-ethoxycarbonylmethylthio-2,2,6,6-tetramethylbenzo -[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)methanol (4.00 g, 3.819 mmol (Example 27)) was dissolved/suspended in a mixture of water and ethanol (200 mL, (1:1)) and cooled to approximately 5C. Sodium hydroxide (15.3 mL, 1.0 M, 15.3 mmol) was added and the reaction was followed by HPLC. The next day more sodium hydroxide (3.82 mL, 1.0 M, 3.82 mmol) and (7.64 mL, 1.0 M, 7.64 mmol) was added.
The ethanol was evaporated after complete conversion had been observed (HPLC). The alkaline aqueous phase was extracted with heptane (2xlO0 mL) and then acidified with HCl (2.0 M) to pH 5. The product was taken up in diethylether (2xloO mL). Upon further acidif~cation of the aqueous phase ~to pH 3), more precipitate was formed. This was also taken up in diethylether (2xlO0 mL). The combined ether phases were extracted once with water (100 mL) and dried (Na2S04). Evaporation yielded .
3.11 g (3.23 mmol, 85 %) of a white crystalline W091/12024 PC~/EP91/002~5 - 85 - 2 ~ 7 ~
material. When the material was dried at very high vacuum and high temperature the substance turned blue, possibly due to the formation of an internal zwitter ion. Upon exposure to moist air the white color returns.
ll NMR (300 M~lz, DMSOd6) ~: 12.55 (bs, COOH, 3}1), 3.59 (s, C}l2, 6H), 3.31 (bs, OH, 3H), 1.49 (s, CH3, 36H).
3C NMR (75 MHz, DMSOd6) ~: 170.04, 140.18, 138.17, 117.17, 111.83, 97.13, 71.47, 34.70, 24.98~
MS (Electrospray): Calc. 962.17, found 962.17.
Titration with sodium hydroxide (0.01 M) gave a purity (% of molecules with three carboxylic acids) of 99.7 %
+/- 1.9 % (SD).

Example 40 8-Hydroxy-2,2 6,6-tetramethylbenzo~1,2-d:4,5-d']-tl.3)-dioxole :

~ ko~oX ~ ko~<
OH

2,2,6,6-Tetramethylbenzo[1,2-d:4,5-d']-(1,3)dioxole (5.00 g, 22.5 mmol (Example 5)) was dissolved in diethyl ether (150 mL, sodium benzophenone ketyl) under argon.
n-Butyl lithium (10.0 mL, 25 mmol, 2.5 M in toluene) was added at room temperature followed by methyl magnesium bromide (4.25 mL, 13 mmol, 3.0 M in diethyl ether, Aldrich). the resulting mixture was stirred at room temperature for l h. Oxygen was bubbled through the 2 ~ 75 gl 8 - 86 -solution over a period of 2 hours, while cooling with a cold water bath. The reaction mixture was poured into a solution of NaOH (50 mL, lM) and e.xtracted with diethyl ether (100 ~L). The aqueous phase was acidified with conc. HCl to pH 2 while stirring. I~he product was isolated by extracting with diethyl ether (3x50 mL).
The ether was dried (Na2SO~,) and evaporated yielding 1.50 g (6.3 mmol, 2~ %) of 8-hydroxy-2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d'] bis(1,3)dioxole.
H NMR (300 MHz, DMSOd6) ~: 6.00 (s, aromatic H, lH), 1.66 (s, CH3, 12H).
MS(Thermospray): M++23 (Na,) 261 Example 41 8-Methoxy-2,2 6 6-tetramethylbenzo[1,2--d:4,5-d'1-tl 3)-dioxole o-~o~ 0 ~_0~/
o~~J~o/\ ~ /\o~J~o/\
OH OMe ., .

8-Hydroxy-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-(1,3)-dioxole (1.00 g, 4.20 mmol (Example 40)) was dissolved in CH2Cl2 (30 mL) and dimethyl sulfate (0.6 mL, 6.30 mmol), tetrahutyl-ammonium hydrogensulfate (catalytic amount) and sodium hydroxide (1.0 mL, 40 %) were added.
rrhe xesulting mixture was stirred at room temperature for 24 hours. The phases were separated and the aqueous phase was extracted with diethyl ether (2 x 50 mL). The combined organic solution was extracted with ammonia (25 WOgl/I2024 PCT/EP91/00285 ;-~ 2~7~

mL, 25%) and water (50 mL), dried (Na2SO4) and evaporated. Yield o.9g (83~) of a yellow oil.
H NMR (CDCl3, 300 MHz) ~: 6.05 (s, CH, lH), 4.02 ~s, CH3, 3H), 1.65 (s, CH3, 12H).
MS(Thermospray): ~ ~23 (Na-~) 275.
e 42 Tris(8-ethoxycarbonylmethylthio 2,2 6,6-tetramethvlbenzo r 1,2-d:4,5-d'L-bis(1 3)dioxole-4-yl~methane X~X ~X' SCH2COOEt SCH2COOEt Tris(8-ethoxycarbonylmethylthlo-2,2,6,6-tetramethylbenzo [1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)methanol (1.06 g, 1.01 mmol (Example 27)) was added to a solution of trimethyl silylchloride (0~767 mL, 6.07 mmol) and sodium iodide (0.91 g, 6.07 mmol) in acetonitrile (50 mL) and stirred for ten minutes. Saturated sodium thiosulfate (30 mL) was added, followed by diethylether (70 mL), and the mixture was stirred for 10 minutes. The phases were separated and the organic phase was washed with water (30 mL). The organic phase was diluted with more ether (100 mL), since crystals had started to form in the funnel. The solution was kept in the freezer over night after drying (MgS04) and filtration. The crystals formed were removed (impurity) and the solution evaporated to dryness. The product was purified by dissolving the substance at room temperature in diispropyl ether (E.

WO91/~2024 PCT/EPg1/00285 ., 207 ~ 81 ~ - ~8 -Merck 118867, 30 mL), followed by bubbling with helium.
The flask was stoppered and put in the refrigerator for two and a half hours. The product was collected by filtration (glass sinter no. 3), and the mother liquor was evaporated to approximately half the volume. The total yield a~ter collecting the second crop was 640 mg (0.621 mmoll 61%).
lH NMR,(300 MHz, CDCl3) ~: 1.23 (t), 1.51 (s), 3.55 (s), 4.1Y tq), 5-34 (s)-3C NMR (75 MHz, CDCl3) ~: 169.09, 140.810, 139.50,117.81, 107.65, 95.37, 61.18, 35.71, 30.70, 25.38, 14.11.
MS (Thermospray): Mt+23 (Na) 1053.

Example 43 Tris(8-dimethylaminocarbonylthio-2 2 6,6-tetramethylbenzo[1 2-d:4,5 d~l_is(1,3)dioxole-4-yl)methan COH CO~
--3 ~ 3 \~o-~o~ o-~o~
o~J~o/\ . /\o~J~o'' SH SCONMe2 ,, Tris(8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-b is (1,3)d.ioxole-~yl)methanol (1.00 g, 1.27 mmol (Example 31)) was added to an oxygen free (argon bubbling five min.) solution of K2CO3 (5.00 g) and dimethylcarbamoyl chloride (Fluka 39871, 0.367 mL, 4.0 mmol). A sample taken after forty five minutes, and controlled by 1H NMR, showed complete consumption of the substrate. Th~ solution was filtered and evaporated.

WO91/l2024 PCT/EPgl/002B~

. .
- 89 - 207~18 The crude product was g3% pure according to HPLC (C8, CH3CN:H20, (3:1), 254 nm).
The substance was dissolved in diethylether (30 mL, dry, sodium benzophenone ketyl) and ultrasonicated for five minutes, followed by rotation at 35 C for five minutes on a rotavapor at normal pressure. Cooling in the ~reezer ~or thirty minutes gave greyish crystals. Yield 0.580 g ~0.579 mmol, 45.6%).
H NMR (300 MHz, CDCl3) C: 1.54 (s), 3.3 (bd), 4.20 (bs).
3C NMR (75 MHz, CDCl3) ~: 163.02, 142.80, 138.78, 118.05, 113.52, 92.07, 72.63~ 37.01, 25.45.
MS (Thermospray): M'+23 (Na) 1024.

Example _ Tri~(2.2,6 6-tetramethylbenzo~1 2-d:4,5-d'lbis ~ 3L-dloxole-4-yl)methanol t:OH

k~CX - k~CoX

2,2,6,6-Tetramethylbenzo[1,2-d:~,5-d']bis(1,3)dioxole (17.570 g, 79.0 mmol (Example 5)) was dissolved in THF
(300 mL, sodium benzophenone ketyl) and cooled to -20 oc with an ethanol/dry ice bath while maintaining an argon atmosphere. n-Butyl lithium (37.8 mL, 2.5 M in hexane, 95.0 mmol) was added with a syringe, and the resulting mixture was allowed to reach room temperature. The mixture was recooled to -20 C and dimethyl carbonate (2037 g, 2.20 mL, 26.0 mmol) was added. The cooling bath was removed and the reaction mixture was stirred at ~ WO9l/12024 PCT/EP91/0028~
.- ! `;
2075~ 90-room temperature for 3.5 hours. The mixture was then poured onto ice/water containing HOAc (2%) and extracted with diethyl ether (2 x 300 ml). The organic phase was washed with water (2 x 100 mL) and dried (Na2SO4). The solvent was evaporated and the product triturated with petroleum ether. Yield 13.56 g (74.~ %) H ~1MR (CDCl3, 300 MHz) ~: 6.26 (s, arom. ~I, 3H), 1.48 (s, CH3, 36~l), 4.28 (s, OH, ~
3C NMR (C~C13, 75 MHz) ~ 0.10, 139.00, 116.71, 112.57, 91.64, 72.69, 25.38.
MS (Thermospray): M~+23 (Na) 715.

Example 45 Tris(8-ethyloxycarbonylthlo-2,2,6,6-tetramethylbenzo r 1,2-d:4,5-d']bis(1,3Ldioxole-4-yl)meth~21 ., COH COH
\ 0_~0 / \~0~
~0~ /\0~0/\
SH SCOOEt Tris(8-mercapto-2,2,6,6-tetramethylbenzo~1,2-d:4,5-d']bistl,3)dioxole-4-yl)methanol (1.000 g, 1.269 mmol Example 31) was added to a solution of acetonitrile (75 mL, argon bubbled) and potassium carbonate (6.0 g).
ClCO2Et (0.725 mL, 8.00 mmol) was added and the resulting mixture was vigourously stirred for 30 minutes. An NMR
sample showed complete conversion at this time. The mixture was filtered and evaporated. The pure product was obtained by chromatography on a silica column eluting with ethyl acetate:heptane 1:1. Yield 1.26 g WO91/12U24 PCT/EF~1/00285
9 1 - 2 ~ 7 ~
(98.7%).
H NMR (CDCl3, 300 MHz) ~: 4.26 (q, CH~, 6H), 4.21 (s, COH, 1H), 1.54 (s, CH3, 36H~, 1.30 (t, CH3, 9H).
3C NMR (CDC13, 75 MHz) ~: 166.18, 142.30, 138.80, 118.35 113.70, 91.26/ 72.51, 6~.09, 25.42, 1~.22.
MS (Thermospray): ~-~23 (N~) 1027.

Example 46 Tris(8-ethyloxycarbonYlthio-2 2.6 6-tetramethylbenzo[l 2-d:4.5-d'~bis(1 3)dioxole-4-Yl~methyl COH C*
~3 ~3 k~Co>( ~ )<~COX
SCOOEt SCOOEt Tris(8-ethyloxycarbonylthio-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol (0.100 g, 0.099 mmol, Example 45) was dissolved in THF (5 mL, sodium benzophenone ketyl) and SOCl2 (0.073 mL, 0.998 mmol) was added. The mixture was stirred for 3 hours and then evaporated under argon.
More THF (3x50 mL, sodium benzophenone ketyl) was added and evaporated after each addition. The residue was dissolved in THF (50 mL, sodium benzophenone ketyl) and BCl3 (955 mL, 0.998 mmol, 1 M soln. in CH2C12) and stirred for 15 minutes, when SnCl2 (0.189 g, 0.999 mmol) was added. The m xture was stirred for 10 minutes and zinc (0.653 g, 9.985 mmol, specially activated by p.a.
HCl t2 M), water, ethanol, ether, high vacuum drying 250 'C the same day)) was added. The reaction mixture was :

2~75818 i - 92 -worked up after 3 hours stirring, by diluting with dry, oxygen-free diethyl ether (300 mL), extracting with NaOH
(2x50 mL, 2 M, oxygen free) and filtering the solution through a silica column, eluting with ether. Yield 0.058 g,(0.0594 mmol 60%).
ESR (THF, 200 G): Linewidth 109 mG (one wide line containing 70 resonances).
Overhauser enhancements (THF, 548.9 MHz, 200 G): 9 mW 12 enhancement, 18 mW 25 enhancement.

Example 47 Tris(8-tertbutylcarbonylthio-2,2 6 6-tetramethylbenzo[1 2-d:4 5-d'lbis(1 3)dioxole-4-~l)methanol COH COH
~3 ~3 )<~CoX ~ k~oX
SH SCO-t Bu Tris(8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(l,3)dioxole-4-yl)methanol (1.000 g, 1.268 mmol, Example 31), pyridine (0.620 mL, 7.606 mmol) and N,N-dimethylamino-pyridine (catalytic amount) were added to degassed (argon bubbled) acetonitrile (50 mL) and cooled close to the freezing point. 2,2-Dimethylpropanoic acid chloride (0.940 mL, 7.606 mmol) was added with a syringe, and the reaction mixture was allowed to reach room temperakure over a period of 4 hours. The solvent was evaporated and the residue was dissolved in diethyl ether (200 mL). The ether was extracted with NaH2PO4 (50 mL, sat.), HCl (50 mL, 1 M), NaH2PO4 (50 mL, sat.) and WO91/12024 PC~/EP9l/00285 2 ~

NaCl (50 mL, sat.) and dried (Na2S03). Yield after filtratiorl and evaporation: 1.00 g (0.9604 mmol, 75.7 %). The compound was taken to analyical purity by dissolving in diisopropyl ether (80 mL) at room temperature with the help of ultrasound. Cooling in the refrigerator for 30 minutes gave. 0.29 g (0.2785 mmol, 22.0 ~) oE the pure compound.
H NMR (CDCl3, 300 MHz) ~: 4.21 (s, CH, 111), 1.53 (s, CH3, 36H), 1.30 (s, CH3, 36H).
3C NMR (CDCl3, 75 MHz) ~: 200.00, 142.05, 138.87, 118.01, MS (Thermospray): M~+23 (Na) 1063.

Example 48 Tris(8-tertbutylcarbonylthio-2~2~6~6-tetramethylbenzo~ll2-d:4,5-d'1bis~1,3)dioxole-4-yl)methyl x~ox x~ox SCO-t-Bu SCO-t-Bu Tris(8-tertbutylcarbonylthio-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol (0.0957 g, 0.0919 mmol, Example ~7) was dissolved in THF (25 mL, argon atmosphere., potass um benzophenone ketyl dried~, and BF3.0Et2 (0.5 mL, 48% in diethyl ether, Fluka) was added. After stirring for 5 minutes SnCl2 (0.1249 g, 0.659 mmol) was added followed by a gradual change in color to light brown. Zinc (0.5 g, 7~646 mmol) was added 1.5 hours after the SnClz. Two WO91/12024 PCT/EP~1/00285 2075~

hours later the color had changed to green. A sample taken (after letting the Zn settle) with a gas tiqht syringe showed a large Overhauser enhancement. The reaction mixture was poured onto a column consisting of three layers; top layer sio2, intermediate layer sio2 and K2CO3 1:1 and bottom layer sio2. The K2CO3 binds the ; BF3.OEt2, which has to be removed to avoid destabilizing the corresponding cation radicals. Yield: 0.079 g (0.0771i mmol, 83.9 ~).
ESR (THF, 200 G): Linewidth 109 mG, one unresolved line.
Overhauser enhancements (THF, 548.9 MHz, 200 G, conc.< 1 mM): 9 mW 96 enhancement, 18 mW 11~ enhancement.

Example 49 Tris(8-methylcarbonylthio-2 2 6,6-tetramethylbenzol1 2-d:4,5-d'1bis(1~3)dioxole-4-Yl)methanol COH COH
~3 '-1--3 \/o~o / \ 0~0~/
', /\0~~0>\ ~ ~ /<0~0/\
SH SCOMe Tris(8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(l,3)dioxole-4-yl)methanol (1.000 g, 1.268 mmol, Example 31), acetyl chloride (0.540 mL, 7.605 mmol) and K2CO3 (2.0 g, l.447 mmol) were added to CH3CN (25 mL, degassed with argon). An NMR sample showed complete reaction after 90 minutes. The solvent was evaporated and the product was purified by flash chromatography (Sio2, 230-400 mesh, i.d.35 mm, ~0cm length) followed by crystallization in diisopropyl ether (50 mL). The product was dissolved at room temperature with the help - 95 _ 2~7S~l~
of ultrasound. The product was collected after 2 hours in the freezer~ Yield: 0.61 g (0.667 mmol, 52.6~) 1H NMR (CDCl3, 300 MHz) ~: 2.42 (s, CH3, 9H), lu55 (s, CH3, 36H)-3C NMR (CDCl3, 75 MHz) ~: 190.58, 141.81, 138.86,118.32, 11~.55, 91.44, 72.50, 29.97, 25.~.
MS (Thermospray): M~+23 (Na) 937.

ExamPle 50 Tris(8-methylcarbonylthio-2 2,6 6-tetramethylbenzo~1 2-d:4 5-d'~bis(1 3)dioxole-4 -Yl ~ methyl X~oX ~ X~oX
SCOMe SCC)Me Tris(8-methylcarbonylthio-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol (0.0915 g, 0.0999 mmol, Example 49) was dissolved in THF (25 mL, argon atmosphere, potassium benzophenone ketyl dried), and BF3.OEt2 (0.5 mL, 48% in diethyl ether Fluka) was added.
A temporary red color was seen when the drops were hitting the surface of the solution. After stirring for 5 minutes, SnCl2 (0.1249 g, 0.659 mmol) was added followed by a gradual change in color to light brown.
Zinc (0.500 g, 7.646 mmol, prepared as described above) was added 1.5 hours after the SnCl2. Two hours later the color had changed to green. A sample taken (a~ter letting the Zn settle) with a gas tight syringe showed an enormous Overhauser enhancement. The reaction mixture was poured onto a column consisting of three WO91/120~4 PC~/EP91/0028~
,~
~ ~ 7 ~

layers: top layer SiOz, intermediate layer Sio2 and K2CO3 1:1 and bottom layer sio2. The K2CO3 binds the BF3.OEt2, which has to be removed to avoid destabilizing the corresponding cation radicals. Yield: 0.0720 g (0.0802 mmol, 80.3 %, unknown radical content).
ESR (TIIF, 200 G): One line;Linewidth 117 mG.
Overhauser enhancements (THF, 548.9 MHz, 200 G, <1 mM):11 mW 89 enhancement, 18 mW 110 enhancement.

E mple 51 Bis(8-mercapto 2,~,6 6-tetramethylbenzo[1,2-d:4 5-d']bis(1 3)dloxole-4-yl)ketone X~oX

The title compound was isolated as a byproduct in the reaction between diethyl carbonate and the lithium salt of 8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole, see Example 31.
H NMR (CDCl3, 300 MHz) ~: 3.46 ~s, SH, 2H), 1.63 (s, CH3, 24H)-C NMR (CDCl3, 75 MHz) ~: 183.42, 138.96, 137.90, 119.55, 106.84, 100.36, 15.24.MS (Thermospray): M~23 (Na) 557.

WOgl/12024 PCT/EP91/00285 --_ 97 _ 2~7~18 _amPle 52 Benzorl.2-d:4 5-d']bis(1 3)dioxole-2 6--irocyclohexane ~o~OH ~ P205 o<O~cO~>
HO OH o o 1,2,4,5-Tetrahydroxybenzene tS.00 g, 35.00 mmol, Example 4) was dissolved in THF (200 mL) and cyclohexanon~(13.0 mL, 140.00 mmol) was added in one portion. P2O5 was then added in small portions under efficient stirring. After a~dition was completed the temperature was increased to C for 4 hours. One large ball was formed in the flask during this time. After cooling to room temperature the ball was broken up and the reaction mixture was poured on a mixture of ice (210 g) and NaOH
(250 mL, 2 M). Ether (100 mL) was added and the phases separated. The aqueous was extracted with ether (2x50 mL). The combined organic phase was dried (Na2SO4), filtered and evaporated. The product was dissolved in MeOH (20 mL), heated, filtered, cooled and the product was collected by filtration. Yield 1.70 g (16%).
1H NMR (CDCl3, 300 MHz) ~: 6.35 (s, CH arom., 2H), 1.87 ! (t, CH2, 8H), 1.69 (t, CH2, 8H), 1.47 (m, CH2, 4H).
3C NMR (CDCl3, 75 MHz) ~: 140.37, 118.54, 92.80, 34.84, 24.57, 23.13.

2 0 7 ~ 3 1 8 9~
Exam~le s3 Tris(benzo[1 2-d:4 5-d^]bis(1 3)dioxole-2 6-dispiro-cYclohexane)methanol COH
C~o~o~ ~ ~>O

Benzo[1,2-d:4,5-d']bis(1,3)dioxole-2,6~
dispirocyclohexane (2.00 g, 6.60 mmol, Example 52) was dissolved in diethyl ether (80 ml, dried over Alz03) and cooled to -10 C in an ice acetone bath. n-Butyl lithium (3.70 mL, 2.5 M in hexane) was added with a syringe over a period of five minutes. The mixture was stirred at the same temperature for 1 hour and overnight at room temperature. Diethyl carbonate (0.28 mL, 2.4 mmol) was added at room temperature and the mixture immediately chanqed color to red-brown. After stirring for 1 hour it was poured on ice/water (100 mL). The organic phase was separated and the waterphase extracted with CH2Cl2 (100 mL). To facilitate the phase separation HCl (20 mL, 1 M) was added. The combined organic phase was dried (MgS04), filtered and evaporated. Yield 1.90 g (31~).
C NMR (CDCl3, 75 MHz): 140.1, 133.9, 117.5, 91.5, 7205, 34.6, 24.6, 22.9.

WO 91/12024 PCI/FlPg1/00285 , 207~
_amPle 5~

1,2,4,5-Tetrahy_roxybenzene 0 0~1 ~OH Na2S204 ~,OH

o HO

2,5-Dihydroxy-1,4-benzoquinone (4.00 g, 28.55 mmol) was suspended in water (50 ml, distilled) followed by Na2S2O4 (10.00 g, 57.47 mmol) and HCl (5.5 g, 55.75 nunol conc.
soln.). The mixture was stirred 30 min. at room temperature and evaporated to dryness. The residue was washed with THF (40 ml) and filtered. The THF was evaporated yielding 2000 g (14.07 mmol, 49.3 %) of the title substance.
H NMR (DMSO6, 300 MHz) ~: 7.59 (bs, OH, 4H),6.23 (s, CH, 2H).
(DMSOd6, 75 MHz) ~: 136,96, 104.65.

Example 55 1,2,4,5-Tetrahvdroxybenzene ~OH Fe/HCI ,¢~OH

o HO

2075~

2,5-Dihydroxy-1,4-benzoquinone (10.00 g, 71.43 mmol) was suspended in water (200 ml, distilled) followed by HCl (6 mL, 142.86 mmol, conc.). Iron (4.00 y, 71.43 mmol, powder) was added and the mixture was stirred 30 minutes at room temperature. The solution was filtered and the solution evaporated to dryness. The product was isolated as a grey brown powder containing some iron complexes. Yield 14.80 g. The product is used as such in the reaction with acetone and P2Os (Example 5) with no negative effects.
H NMR (DMSOd6, 300 MHz) ~: 6.9-3.0 (broad, OH, 4H), 6.21 (broad s, CH, 2H).
3C NMR (DMSOd6, 75 MHz) ~: 136,96, 104.65.

Example 56 Tris(2 2 6 6-tetramethylbenzo[1,2-d:4 5-d']bis(1 3)-dioxole-4-yl)methanol X~oX ~ X~ox 2,2,6,6-Tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole (8.80 g, 40.00 mmol, Example 5) was dissolved in THF
(100 mL) and cooled to -20 C. n-Butyllithium (25.0 mL, 40.0 mmol, 1.6 M) was added and the temperature was adjusted to ambient temperature over a period of 30 minutes and then recooled to -20 ~C. Bis(2,2,6,6-tetramethylbenzo-~1,2-d:4,5 d']bis(l,3)dioxole-4-yl)ketone (18.80 g, 39.83 mmol, Example 57) was added WO91/12024 PCT/EP91/0~2~5 - lol - 2~7S~l~
and the temperature was once more adjusted to room temperature and the mixture was stirred for 18 hours.
rrhe mixture was then poured on water/AcOH (lOU mL, 2 %
AcOH) and extracted with diethyl ether (2xl00 mL). The organic phase was washed with water (2xl00 ml) and dried (Na2SO4). The solvent was evaporated and the product was washed with petroleum ether (20 mL, 40-60 C). Yield l0.80 g (G4.l%). Spectral data see example 44.

Example 57 Bis(2 2 6.6-tetramethylbenzo r l 2-d:4 5-d'l~ls(l,3)dioxole-4-yl)ketone 70~

:'' t~o .
2,2,6,6-Tetramethylbenzo[l,2-d:4,5-d']bis(l,3)dioxole (400.0 g, 1.80 mol, Example 5) was dissolved in THF (6 h, dried, perhaps incompletely) and cooled to -20 C
with a cryostat while maintaining a nitrogen atmosphere.
n-Butyl lithium (1350 mL, l.6 M in hexane, 2.16 mol) was added with a dropping funnel, and the resulting mixture was allowed to reach room temperature. The mixture was recooled to -20 C and dimethyl carbonate (47.0 mL, 0.56 mol) was added. The cryostat was turned off and the reaction mixture was allowed to reach room temperature over night while stirring. Water (3.0 L, containing 2 %
HOAc) was added to the reaction mixture, and the resulting solution was ex~.racted with diethyl ether (2 x 3.0 l). The organic phase was washed with water (2 x WO91/12024 PCT/EP9l/002~5 ., 2Q7~18 - 102 -1.0 L) and dried (Na2S04, K2C03). The solvent was evaporated and the product triturated with petroleum ether (boiliny range 40-60 ~C). Yield after separation by recrystallisat.ion in MeOH/H20: 50.0 g (106.0 mmol, 18.9 % relative to dimethyl carbonate).
1H NMR (CDCl3, 300 MHz) ~: 6.42 (s, CH aromatic, 2H), 1.60 (s, CH3, 24~l).
13C NMR (CDCl3, 75 MHz) ~: 184.55 (C=O), 140.51, 139.43, 118.86, 109.13, 95.89, 25.56.
MS (Thermospray): M~+23 493.

Example 58 Mono-(2,2 6/ -tetramethylbenzo[1.2-d:4,5-d'~-bis(l 3)dioxol~-4-vl~-mono(phenyl)-mono(pyridin 4-~ vl!methanol ;, O k~oX

X ~ O X ~ N ~ N

2,2,6,6-Tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole (3.030 g, 13.60 mmol, Example 5) was dissolved in THF
(50 mL, sodium benzophenon ketyl) under N2. The mixture was cooled to -78 C. n-Butyllithium (5.10 mL, 13.6 mmol, 2.68 M in toluene) was added with a syringe during WO91/l2024 PCT/EPgI/00285 ;'~'`'~
- 103 - 2~7~818 5 minutes. 15 Minutes later the dry ice acetone cooling bath was excanged with a ice water bath and the reaction mixture was stirred for 1 hour. The mixture was recooled to -78 C and phenyl pyridyl ketone (2.50 g, 13.60 mmol) dissolved in THF (10 mL, Na benzophenone ketyl) was ~dded dropwise. One hour later the cooling bath wa; exchanged with a ice/water bath and the reaction was allowed to reach room temperature and stirred for 3 days. The THF was washed with NaH2O4 (2x50 mL, 1.25 M), dried (Na2SO4) and evaporated yielding 5.10 g crude product. Analytically pure compound was obtained by dissolving the crude product in a mixture of hot CH3CN and THF and crystallizing. Yield 0.826 g,(2.04 mmol 15%).
1H NMR (CDCl3, 300 MHz) d 8.52 (m, CH pyridine, 2H, AA'in AA'XX'spin system), 7.26 (m, CH pyridin, 2H, XX'in AA'XX'spin system), 6.31 (s, CH, 1H), 4.61 (s, OH, 1H), 1.47 (s, CH3, 6H), 1.40 (s, CH3, 6H).
3C NMR (CDCl3, 75 MHz) ~: 153.90, 149.16, 143.79, 140.83, 137.41, 127.85, 127.80, 1~7.53, 122.92, 118.17, 113.41, 110.08, 92.67, 79~28, 25.21, 25.10 (two resonances at 25 ppm due to nonequivalence of methyl groups).
MS (Thermospray): M~+1 406.
.
Example 59 Bis(8-methylthio-2 2 6 6-tetramethylbenzo r 1,2~d:4.5-d']bis(l~L~ioxole-4-yl~ketone ~ M ~ e WO91/12024 PCT/EP91/00~85 ~ , 2075~t~ 104 -Bis-(8-Mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis-(1,3)dioxole-4-yl)ketone (0.6000 g, 1.1236 mmol Example 51) was dissolved in a CH3CN (50 mL) and cooled to 0 C. CH3I (0.~2 ml, 6.74 mmol) and K2C03 (4.0 g) were added. The resulting mixture wa5 stirred at room ; temperature for 70 minutes. B~fore filtering aT~ay the K2C03, diethyl ether (50 ml) was added to ensure that all of the product was in solution. Filtration and evaporation yielded a quantiatative amount tO.630 g, 100 %) of the pure title compound.
lH NMR (CDCl3, 300 MHz) ~: 2.42 (s, CH3, 6H), 1.55 (s, CH3, 24H)-3C NMR (CDCl3, 75 MHz) ~: 183.30, 140.15, 138.68, 118.94, 107.68, 105.49, 26.57, 25.34, 16.12.
MS (Thermospray) M~+23 (Na) 585, M~ 39 (Ka) 601.

Example 60 Bis~8-Methylmercapto-2 2 6 6-tetramethylbenzo ~1,2-d:4,5.~d ~ bis(1,3)dioxole-4-yl)-mono(2-methylmercapto-pyrimidin-5-yl)methanol SMe r ~ ~_e 0\~

N~f;N N~N ~ MeS~\O O~\SMe SMe SMe of ~ 0 5-Bromo-2-methylthio-pyrimidine (0.250 g, 1.2195 mmo~) was dissolved in THF t50 mL, sodium benzophenone ketyl) and cooled to -105 C. n-Butyl lithium ~0.455 ml in toluenP., 1.2195 mL) was added and the temperature was increased to -75 C for 15 minutes and thereafter .

reduced to -105 ~C. Bis(8-methylthio~2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis(1,3)dioxol~-4-yl)ketone (~.63146 g, 1.1236 mmol, Example 59) was added in solid form and the temperature was gradually increased to room temperature (removal o~ cooling bath).
The mixture was stirred overnight, NaCl (15 mL, sat.) and diethyl ether (40 mL) were added and the phases separated after 5 minutes stirring. The organic phase was dried (MgS04) and evaporated yielding 0.59 crude product. Pure product was obtained by crystallization in diethyl ether followed by a second crystallization in diisopropyl ether. Yield 0.115 g (0.1669 mmol, 14.9%).
H NMR (CDCl3, 300 MHz) ~: 8.53 (s, 2H), 4.54 (lH, s), 2.55 (s, 3H), 2.41 (s, 6H), 1.49 (s, 24H).
3C NMR (CDCl3, 75 MHz) ~: 171.12, 156.42, 141.21, 137.54, 131.33, 118.26, 110.75, 101.18, 73.90, 25.38, 25.29.
MS (Thermospray) M~+23 (Na) 711.

Example 61 Trist8-meth~lcarbonylthio-2,2,6.6-tetramethylbenzo[1 2-d 4 5-d']bistl 3)dioxole-4-vl)methane COH C H -ko~oX ~ )<~oX
SCOMe SCOMe NaI (0.15972 g, 1.1256 mmol) and trimethylsilyl chloride (0.142 mL, 1.1256 mmol) were stirred in acetonitrile (50 mL). Tris(8-methylcarbonylthio-2,2,6,6-tetramethylbenzo [1,2-d:4,5-d'~bis(1,3)dioxole-4-WO91/12024 ~CT/EP91/00285 2 0 7 ~ 106 -yl)methanol (0.1286 g, 0.1407 mmol, Example 49) was added in solid form and the color of the solution became brownish. NazSzO4 (20 mL, sat.) was added after 60 minutes and the mixture was stirred 5 minutes before separation of the phases. The aqueous phase was extracted with diethyl ether t50 mL), and the combined organic phase wa5 dried (MgS04) and evaporated, yielding 0.105 g (0.1168 mmol, 83 %) o:E the title compound.
1H NMR (CDCl3, 300 MHz) ~: 5.42 ts, CH, 1H), 2.40 (s, CH3, 9H), 1.53 (s, ~H3, 36H).
3C NMR (CDC13, 75 MHz) ~: 191.16, 141.20, 139.66, 118.35, 10~.81, 90.39, ~1.01, 29.88, 25.34.
MS (Thermospray) ~+23 (Na) 921.

ExamplQ 62 Tris(8-tertbutylcarbonylthio-2,2,6,6~
tetr methylbenzo[l,2-d ~ e-4-yl)methane COH CH
)~o~X ~ k~oX
SCO-t-Bu SC:O-t-Bu NaI (0.185 g, 1.2342 mmol) and trimethylsilyl chloride (0.156 mL, 1.2336 mmol) were stirred in acetonitrile (50 mL). Tris(8-tertbutylcarbonylthio-2,2,6,6-tetramethylbenzo-[l~2-d:4~5-d~]bis(ll3)dioxole-4-yl)methanol (0.220 g, 0.2056 mmol, Example 47) was added WO~I/1202~ PCT/~P91/00285 r~
2~7 in solid form and the color of the solution became brownish. Na2S2O4 (20 mL, sat.) was added after 60 minutes and the mixture was stirr~ 5 minutes before separation of the phases. The aqueous phase was extracted with diethyl ether (50 mL~, and the combined organic phase was dried (MgS04) and evaporated, yielding 0.105 g (0.1168 mmol, 83 %) of the title compound.
Tris(8-tertbutylcarbonylthio 2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)methane (0.205 g, 0.200 mmol, 97.3 ~).
H NMR (CDCl3, 300 MHz) ~: 5.42 (s, CH, 1H), 1.51 (s, CH3, 36H), 1.29 (s, CH3, 27H).
3C NMR (CDCl3, 75 MHz) ~: 200.51, 141.45, 139.68, 117.99, 108.59, 90.78, 46.90, 31.03, 27.17, 25.34 MS (Thermospray) M~+23 (Na) 1047.

Example 63 Bis~8-formyl-2,2,6 6-tetramethylbenzo[1.2 d:4.5-d']bis(1,3)dioxole~4-vl~-mono(2,2,616-tetramethylbenzo~l,2-d:4 5-d'~bis(1 3)dioxole-4-yl)methyl .
)<O~X ' ~Xo~Cox ;. ~
X~X X~X
CHO Ct 10 Bis(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d'~bis(1,3)dioxole-4-yl)-mono(2,2,6,6-tetramethylbenzo[1,2-d 4,5-d']bis(1,3)dioxole-4-WO91/12024 PCT/EP91/0028~

r . ~ . .
~ 2~5~ 108 -yl)methane (0.100 g, 0.136 mmol) (frorn Example 23) was dissolved in a mixture of THF (40 mL, Al2O3) and DMSO (10 mL, mol. sieves.). tBuOK (0.0168 g, 0.150 mmol) was added and the resulting mixture was heated to 75 C ~or 1 hour. :The solution was dark green/black at this time.
~2 (~ 038 g, 0.150 mmol) was added and a sample was taken after 1 minute and an Overhauser enhancement experiment was done; a 19 times enhancement was measured at 5 W
irradiation (200 G, 548.9 MHz, THF). After dilution with ether (100 mL), extraction with Na2S2O3 (sat.40 mL), drying (Na2SO4) and evaporation, an Overhauser enhancement of 50 at 5 W irradiation was obtained.
ESR (200 G, 548.9 MHz, three lines, THF): Linewidth 85 mG, aH 175 mG.

Example 64 Tris~8-formyl-2 2 6,6-tetramethylbenzo[l 2-d 4 5-d'lbis-(1 3)dloxole-4-yl)methyl CH C*
X~X " X~X
CHO CHO

Tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis-(1,3)dioxole-4-yl)methane (0.104 g, 0.134 mmol, Example 23) was dissolved in a mixture of DMSO (10 mL), and diethyl ether (30 mL). NaH (0.0037 g, 0.134 mmol, 80%
in oil) and KOtBu (catalytic amount) were added and the resulting mixture was stirred under argon. Samples (about 50 mL) were taken with irregular intervals ~nd ~ 2~7~

quenched with DCl/D2O (10% DCl) under argon. After 2 hours and 15 min. the 1H NMR measurements of the evaporated diethyl ether extact from the quench showed 37 % deuteratlon (anion formation). 18 Hours after the start the deuteration level was 70 %. The calculated amount left in the flask was 78 mg at this time. I2 (0.056 y, 2 equivalents) was added and the reaction mi~ture was worked up after 2 minutes reaction time.
The mixture was diluted with diethyl ether (50 mL) and washed with Na2S2O3 (sat. 2x25 mL), dried (Na2SO4) and evaporated yielding 0.030 g (40.8%). The radical content was 60 ~ according to 1H NMR (Evans method) and 64% by HPLC (Kromasil 10 mm, C8, 250 mm long, i.d. 4.6 mm, CH3CN:H20 70:30 to 100:0 gradient 20 minutes, UV 254 nm detection).
Overhauser enhancements (200 G, 548.9 MHz, 5.9 mM in THF): 9 mW 51, 18 mW 88, 5W 251.
The HPLC chromatogram of the tris(8-~ormyl-2,2,6,6-tetramethylbenzo[l,2~d:4,5-d']bis(1,3)dioxole-4-yl)methyl radical showed a peak at 5.93 s corresponding to the radical and a peak at 6.58 s corresponding to the starting material. The HPLC separated materials also showed distinct W spectra.

Example 65 8-Mercapto-2,2,6,6-tetramethylbenzo L l, 2-d:4,5-d'lbis-~1,3~dioxole 4-yl ! carboxylic acid ethylester Oq~O Et ko~oX ~ )<O~coX
SH

WO91/12024 PCT/EP91/0028~

" .

2 ~ 7 5 ~ 18 2,2,6,6-Tetramethylbenzo[1,2-d:4,s-d~]bis(1,3)dioxole (~.00 g, 18.00 mmol, Example 5) was dissolved in diethyl ether (50 mL, sodi.um benzophenone ketyl), n-butyl lithium (7.56 mL, 18.90 mmol, 2.5 M in hexane) was added and the resulting solution was refluxed 30 minutes.
More diethyl ether (30 mL) was added and the mixture was cooled to -70.~C and S8 (0.5759 g, 17.96 mmol) was added and the temperature was increased to 0 C. THF (100 mL) was added 2 hours after increasing the temperature and the mixture was recooled to -70 C. n-Butyl lithium (8.64 mL, 18.0 mmol) was added and the temperature was increased to 0 C. One hour and forty five minutes later the slurry was filtered through a glass sinter (no. 4) at one of the three necks of the reaction flask.
The white crystals (lithium salt) were washed with diethyl ether (50 mL, sodium benzophenone ketyl) under argon, and the ether removed by filtration through the sinter. Weighing of the flask with the dry lithium salt indicated that there remained around 8 mmol lithium salt in the flask. THF (70 mL) was added to the salt, the mixture cooled to o C, and diethyl carbonate (0.654 mL, 5.4 mmol) was cannulated into the solution and the mixture was left overnight to reach room temperature.
The mixture was diluted with ether (300 mL), extracted ` with NaH2P04 buffer (2x50 mL, sat.), dried (MgSO4) and evaporated yielding the title compound, 1.60 g (4.90 mmol, 90.7 % relative to diethyl carbonate).
H NMR (CDC13, 300 MHz) ~: 4.36 (k, CH2, 2H), 1.70 (s, CH3, 12H), 1.35 (t, CH3, 3H).
MS (EI) M~ 326, 280, 224.

WO91/12024 PC~ 91/00285 ~7~

Example 66 Tris(2~methoxy_arbonylt ien-4-ylLmethane CH
~S ~ 3 COOMe CC)OMe Dry powdered AlC13 (47.12 g, 0.353 mol) was placed in a three-necked flask and a mixture of thiophene-2-carboxylic acid methyl ester (20.0 g, 0.141 mol) and chloroform (47.8 g, 32.3 ml, 0.40 mol) was added rapidly but dropwise. After heating at reflux temperature for 1.5 h, the mixture was hydrolyzed with 50 % aqueous HCl (100 ml). Extraction with CH2C12 (3x150 ml) followed by drying of the combined organic phases (MgSO4) and evaporation gave the crude product as a red solid.
Filtering through a short silica column using petroleum ether/EtOAc as the eluant, followed by evaporation gave the title compound as a light yellow solid. Yield: 17.9 g (88 %).
1H NMR (CDC13, 300 MHz) ~: 7.56 (CH, 3H, d, J=1.6 Hz), 7.12 (CH, 3H, m), 5.50 (CH, 1H, s), 3.~4 (OCH3, s, 9H).
13C NMR (CDC13, 75 MHz) ~: 162.31 (C=O), 143.79 (quart.
C-CO2Me), 134.56 (quart. C-CH), 133.59 (thienyl CH), 129.03 (thienyl CH), 52.08 ~OCH3).

WO91/12024 PCT/EP91~00285 2 ~ 7~ ~ 1 8 - 112 -Example 67 Tris(2-methoxycarbonylthien-4-ylLmethy CH C~
. `~3 '-1-3 C:OOMe COOMe ! Tris(2-methoxycarbonylthien-4-yl)methane (0.218 g, 0.5 mmol, Example 66) was dissolved in dry THF (25 ml) under an argon atmosphere. Solid KOtBu (0.055 g, 0.5 mmol) was added, the solution was stirred for 30 min. and I2 (0.127 g, 1.0 mmol) was added.
The Overhauser effect was measured directly on this solution and found to be 4 at 5 W.
, -i Example 68 Tris(8-methylsulfonyl-2,2,6,6-tetramethylbenzorl,2-d:4,5-d~1-bis(1,3~diox _e-4-yl)methyl C* C*
X~ X~ox SMe SO2Me ~ I .
Tris(8-methylthio-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']-bis(1,3)dioxole-4-yl)methyl (0.163 g, 0.20 mmol, WO91/12024 PCT/EP9l /00?85 .
~ 20J7~8~3 - 113 ~
approximately 15 % radical content, Example 8) was dissolved in CHzCl2 (10 ml) under an argon atmosphere and 3-chloroperbenzoic acid (0.207 g, 1.20 mmol) was added.
After stirring for 15 minutes, ESR spectroscopy of the reaction mixture showed a new radical.
ESR: 6 li.nes with a~: 290 mG, linewidth: 113 mG.
Overhauser enhancement: 5 at 5W.

Example 69 Bis(8-methyloxycarbonvl-2.2 6 6-tetramethylbenzo[1,2-d:4 5-d']bis(1 3)dioxole-4-yl)-mono(8-cyano-2,2 6 6-tetramethy benzo[1,2-d 4.5-d'lbis(l/3)dioxole-4-yl!methanol CN
X~oX
COH
~X
COOMe The title compound was isolated as a byproduct in thesynthesis of tris(8-methoxycarbonyl-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol (Example 15) in a yield of about 5 %.
H NMR (CDCl3, 300 MHz) ~: 3.84 (s,, 6H), 1.50 (s, CH3, 36 H).
3C NMR (CDCl3, 75 MHz) ~: 163.43, 141.70, 140.57, 139.29, 139.07, 119.92, 118.50, 116.34, 114.52, 11.58, 99.30, 78.49, 72.51, 51.89, 25.54, 25.48.
MS (EI) M~ 833~
IR (KBr, cm-l): 3000 (CH), 2240 (CN), 1760 (CO).

WO 91/l2~)24 PCr/EP91/0028~

2 ~ ~ 5 8 1 8 Example 70 Bis(2,~ 6 6-tetramethylbenzo~l 2-d:4.5~
d'~bis(1.3)dloxole-4-yl~ -mono~1,2,3-trimethoxy-5-phenyl)methanol COONle OMe ~ MeO~OMe MeO~\OMe ~J
OMe X~CoX k~X

2,2,6,6-Tetramethvlbenzo[1,2-d:4,5-d']bis(1,3)dioxole (2.22 ~, 10.0 mmol (Example 5)) was dissolved in THF (50 mL, sodium benzophenone ketyl) and cooled to -20 C. n-Butyl lithium (4.80 mL, 12.0 mmol, 2.5 M in toluene) was added and the temperature increased to ambient temperature. The mixture was recooled to -20 C and 3,4,5-trimethoxybenzoic acid methyl esther (1.13 g, 5.0 mmol) dissolvecl in THF(10 mL) was added and the resulting mixture was stirred at ambient temperature overnight. The solution was poured onto acidic water (2 % AcOH, 50 mL) and extracted with diethyl ether (2x50 mL). The organic phase was washed with water (2x50 mL), dried (Na2SO4) and evaporated yielding 3.10 g (4.7 mmol, 97 %) of the titlP compound.
H NMR (CDCl3, 300 MHz) ~: 6.75 (s, arom. H, 2H), 6.28 (s, arom. H, 2H), 3.83 (s, OCH3, 3H), 3.76 (s, OCH3, 6H), 1.44 (s, CH3, 24H).
3C NMR (CDCl3, 75 MHz) ~: 152.29, 140.33, 138.81, 138.25, 137.56, 117.07, 113.58, 105.52, 92.06, 76.77, 60.86, 56.16, 25.30, 25.19.
MS (Thermospray): M~+23 (Na) 661.

.

WO91/l?.024 PCT/EP91/00~8~

- 115 - 2~7~
Example 71 Tris(8-ethoxycarbonvlmethylthio-?~2L6 6-tetramethylbenzo[1 2-d:4~5_d'lbis(1,3~dioxol~-4=
Yl ) methYl COH C*
o ~3 ~3 ~o~oX '~ ~o~o~
SCH2CC)OEt SCH2COOEt Tris(8-ethoxycarbonylmethylthio-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol (0.050 g, 0.048 mmol (Example 27)),was dissolved in dry THF (20 mL). Under Ar (g) BF3.0Et (0.020 mL, 0.080 mmol~ was added, and an intense blue color developed (formation of carbocation)~ After l h was added a complex of Chelex-100 and SnCl2~ i.e. Chelex-100-Sn2' [0.50 g, 0.05 mequiv. of Sn2'; (Preparation of the Chelex-100-Sn~-complex: 20 g (58 mequiv. of Na') of Chelex-100 was treated with 14 g (of SnCl2.H20, 116 mequiv.) in water (100 mL). The solid material was filtered and washed with water (100 mL) and EtOH t500 mL) and ether (100 mL) and was then dried in a desiccator at 0.1 torr, yielding the dry complex (25 g).)], followed 15 min later by Zn dust (0.030 g, 0.450 mmol). The reaction mixture started to change to a brown WO9l/12024 PC~/EP91/00285 ~.
2 9 7 ~ 116 -color. The reaction mixtured was directly filtered through a 3 cm (i.d. 1 cm) glass column filled with sio2 (Merc~, 0.043-0.060 mm) eluting with diethyl ether. The eluate was dried (Na2SO4), filtered and the solvent was evaporated, yielding a black crystalline mass (0.048 g,95.~ % ) Overhauser enhancement: 89 at 9 mW in TH~ at 1.8~ mM, (concetration estimated by NMR -Evans method).
ESR spectrum: 7 lines, Linewidth 31 mG, aH = 62 mG

Example 72 1 2,4~5-Tetratrimethylsilyloxybenzene HO~OH Me3SiO ~OSiMe3 HO C)H Me3SiO~OSiMe3 1,2,4,5-Tetrahydroxybenzene (14.20 g, 100.0 mmol (Example 4)) was dispersed in pyridine (100 mL) and diethyl ether (100 mL), and Me3SiCl (70 mL, 645 mmol) was slowly added (heat evolved). After 3 hours the pyridiniumchloride was filtered off and the solvents of the filtrate (red) were evaporated, leaving a red oil, which was dissolved in ether, more solid material was filtered off, and the solvents of the filtrate (red) were evaporated. The residue was dissolved in diethyl ether and extracted with water (2x50 mL). The organic layer was separated, dried (Na2SO4), filtered and the solvent was evaporated and the residual crystalline material was washed with cold MeOH, leavin~ white crystals (needles), which were dried in vacuum (4.6 g, WO9l/12024 P'~r/EP91/0028
10%~ melting at 112 oc.
GC/MS showed M~ 430 (100%) H NMR (CDCl3, 300 MHz) ~: 6.32 (s, CH, 2H), 0.20 (s, Si(CH3~3 36H)-13C NMR (CDCl3, 75 MHz) ~: 140.17, 113.63, 000.15.

F.x~ e 73 Tris(8-nitroethenyl-2,2,6,6--tetramethylbenzo Ll.2-d:4,5-d']bis(l,3)dioxole-4-vl)methane CH CH
X~oX X~oX

Tris(8-nitromethylhydroxyme~hyl-2,2,6,6-tetramethylbenzo-[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)methane t0.670 g, 0.710 mmol (Example 83)) was dissolved in Ac20 ~30 mL) and NaOAc (2.00 g, 24.4 mmol) was added and the reaction mixture was refluxed for 0.5 h. The solution turned deep red. The solvent was evaporated and the residue was partitioned between ether (100 mL) and water (50 mL). The organic layer was separated, dried (Na2SO4), filtered and the solvent was evaporated yielding a deep red crystalline residue (0.62 g, 98%). The 1H NM~ and 13C NMR spectra were in identical to those recorded for the same product, given in Example 82.

WO91/1~024 PCr/EF~1/0028S
., 2~7~ 118 -Example 7~

3,4-Dihydroxy-2,5-thiophenyl dicarboxylic acid diethylester HO OH
EtOOC~S~,COOEt + COOEt ~ ~
EtCOO S COOFt Sodium (27.8 g, 1.21 mol) was dissolved cautiously in refluxing absolute EtOH (1300 mL) and a mixture of bis(ethoxycarbonylmethyl)sulfide (108.0 g, 0.540 mol) and diethyl oxalate (81.8 g, 0.540 mol) was added dropwise. The reaction mixture was refluxed for 1 hour, allowed to cool, filtered and acidified. The new precipitate was filtered and dried (80 C) in vacuum.
Recrystallization from EtOH:EtOAC (1~ 450 mL) gave two crops of the thiophene; ~3.2 g (67%).
3C NMR (DMSOd6, 75 MHz) ~: 161.93, 150.15, 107.92, 60.80, 14.11.

WO91/12024 PCT/EP91tO0285 , ., 2~75~1~

Example 75 3~ ethy enedioxy-2,5-thiophenedicarbo~y__c acid diethylester H~ CH2ClBr O~o EtCOO S COOEt ~
EtCOO--S~--COOEt 3,4-Dihydroxy-2,5-thiophenyl dicarboxylic acid diethylester (68.4 g, 300 mmol (Example 74)), bromochloromethane, K2Co3 (40.0 g) and Na2S204 (4 spoons) were mixed in DMSO (315 mL) and refluxed for 24 h. The reaction mixture was filtered, cooled and filtered again. The solvent was evaporated, leaving a solid j residue which was dissolved in CH2Cl2 and filtered. The filtrate was washed with water, 10% NaHCO3 and water. The ; organic layer was separated, dried (Na2SO4), filtered and the solvent was evaporated, yielding a crystalline residue, which was recrystallized from absolute EtOH

(800 mL; the filtration performed while the solvent was , . hot), yielding the desired product 3,4-methylenedioxy-2,5-thiophenedicarboxylic acid diethylester (11.8 g, 15%), melting at 124 oc.

3C NMR (DMSOd6, 75 MHz) ~: 160.13, 151.51, 113.36, 104.~0, 61.87, 14.46.

:

WO9l/120~4 PCT/EP~ 28 2 0 7 ~ xam le 76 3 4-Methylenedioxy 2~s-thiophenedicarboxylic acid mono-_hylester ~ EtOH/KOH ~

EtOOC S COOEt EtOOC S COOH

3,4-Methylenedioxy-2,5-thiophenedicarboxylic acid diethylester (3.08 g, 11.3 mmol (Example 75)) was refluxed in EtOH/KOH (88 mL EtOH and 5.57 g, 11.3 mmol ~OH) for 48 h. The reaction mixture was allowed to cool and the precipitate was filtered and the filter cake was triturated with cold 0.1 M HCl. The basic filtrate from the first filtration was also triturated with 0.1 M HCl and the crystals from these acidifications were pooled, dried and later recrystallized from water/EtOH (1:1) and yielded 2.62 g (95%) of the desired mono-carboxylic acid.
3C NMR (DMSOd6, 75 MHz) ~: 161.11, 159.83, 151.07, 150.64, 112.65, 105.43, 103.39, 61.35, 14.07.

Example 77 3/4-Methylenedioxy-2-bromo~5-ethoxycarbonyl thiophene O~O B r2 O

EtOOC S COOH EtOOC S Br WO91/12024 PCT/EP9l/00285 .
- 121 - 2~7~
(see Chem. ser. 108 (1975) p.576). 3,4-Methylene-dioxy-2,5-thiophenedicarboxylic acid monoethylester (5.00 g, 20.5 mmol (Example 76)) was dissolved in water (115 mL) and the solution was made alkaline to pH 11 with K2C03 . The solution was filtered and warmed to 50 C before Br2 (1.8 mL) was aclded duriny a period of 1 h.
Crystals precipitated, the precipitate was filtered off and the filter cake was washed with water and dried, yielding 2.3 g (34~) of the desired product, melting at 93 C.
3C NMR (DMS0d6, 75 MHz) ~: 160.11, 150.32, 147.09, 110.75, 102.96, 85.64, 6.45, 14.33.

Example 78 3,4-Methylenedioxy-2-bromo-5-carboxy thiophene EtOOC~ Br HOOC~ Br NaOH (10 %) and MeOH were mixed in the proportion 1:1 (80 mL) and added to 3,4-methylenedioxy-2-bromo-5-ethoxycarbonyl thiophene (1.91 g, 7.00 mmol (Example 77)), and the reaction mixture was heated to 60-70 C
and kept there for 2h. After cooling, the reaction mixture was filtered and the MeOH of the filtrate was evaporated and water was added. Acidification with 10 HCl precipitated the free acid 3,4-methylenedioxy 2-bromo-5-carboxy thiophene, which was filtered and dried in a desiccator (P2O5), yielding 1.41 g (82~).
MS ~EI 70 ev): M~ 324 and 322 of the TMS derivative.

W091/12024 PC~/E~JltO0285 20~5~

Example 79 3,4-Methyle.nedioxy-2-bromo-thiophene-5 carboxylic acid de O SOC12/DMF o~O

HOOC--~Br ClOC~Br '~ 3,4-Methylenedioxy-2-bromo-5-carboxy thiophene (9.64 g, 38.4 mmol tExample 78)) was dissolved in dry DMF (0.73 mL) and SOCl2 (38 mL) was added and the reaction mixture was refluxed for 5 hours. Excess SOC12 was removed by distillation under reduced pressure, yielding 9.75 g (94%) of the acid chloride, which was used in the next reaction (see Example 80)without further purification.

Example_80 Br $ COCI ~ N ~ Me~

The crude 3,4-methylenedioxy-2~bromo-thiophene-5-carboxylic acid chloride from Example 79 (0.398 mmol) was dissolved in CH2Cl2 (1.0 mL) and slowly added dropwise to a mixture of 2-amino-2-methyl-1-propanol WO91/12024 PCT/E~91/002~5 ,, ~
- 123 - 2~7~
(0.478 mmol) and 4,4-dimethylamino pyridine (0.059 g, 0.478 mmGl) in CH2Cl2 (1.0 mL) at 0 C. After 12 h at room temperature water (2 mL) was added and the organic phase was separated and washed with two more portions of water (2x2 mL). The organic phase was dried by passing it throuyh a small pipette packed with ground CaCl2 and evaporated yielding 0.1286 g (85 %).
GC/MS on the TMS derivative showed (M~-TMS-~H) at m/e 321/323 (containing Br).

Example 81 O ~ O SOCI2 o ~ O

O CH20H ~3r~$o~MMe The product of Example 80 (O.lO0 g, 0.370 mmol) was dissolved in CH2C12 and chilled to 0 C and molecular sieves (3 A, dried at 350 C in vacuum) were added before adding SOC12 (740 mmol). The reaction mixture was stirred at room temperature over night. Excess solvent and SOCl2 were removed under reduced pressure and the residue was partitioned between 10% Na2CO3 and CH2Cl2. The organic phase was separated, dried (Na2SO4), filtered and the solvent was evaporated yielding 0.050 g (44%) of the desired product.
GC/MS on the TMS derivative showed M~ at 303/305 (containing Br).

Example_82 Tris,~8-nitroethenyl-2~2,6~6-tetramethYlbenZo[l~2-d:4 ! 5-d']bis(1,3)dioxole-4-yl)methane . .

WO91/12024 PCr/EP91/0028S

..t .~
207~8 Cl J CH
~~~/ CH3N2 k~3 X
/\o~~o \ NH40Ac 0~~0 C~

Tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis-(1,3)dioxole-4-yl)methan (0.45 g, 0.59 mmol, (Example 23)), nitromethane (20 mL, 290 mmol) and ammonium acetate (0.12 g, 1.56 mmol) were mixed and heated to lOo C for 6.5 h. After cooling, water (70 mL) was added, followed by ether (100 mL). The organic phase was separated, dried (Na2SO4) and the solvents evaporated, leaving a dark-red oil, which solidified after pump drying, yielding 0.38 g (72%)of the product.
H NMR (CDCl3, 300 MHz) ~: 7.98 (d, CH-N02, 1H, JHH 11 Hz) 7.80 (d, CH, lH, JHH 11 Hz), 5.41 (s, CH, 1H), 1.54 (s, CH3, 36H)-13c NMR (CDCl3, 300 MHz) d:l37.10, 136.86, 136.01, 126.29, 116.63, 107.32, ~5.42, 68.89, 22.78.
MS (EI): ~1 891 (40 %), M' 890 (75 %), 818 (loO %).

Example 83 Trisf8~nitromethylhydroxy~ethyl-2,2l6.6-tetramethylbenzo[l,2-d:4 5-d']bis-(1,3)dioxole-4-~l)methane GH CH

\,~0 ~_0~,/ CH3NO2/dioxane ~~~X
/\0~~0/\ NaH / 0~0 CH0 CH(0H)cH2~02 WO91/1202~ PCT/EP91/0028~
2~7~

Tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis-(1,3)dioxole-4-yl)methane (0.150 g, 0.197 mmol, Example 23) and nitromethane (0.36 g, 5.9 mmol) were mixed in dry dioxane (20 mL), and NaH (0.030 g, 0.197 mmol, 80 %
in oil) was added at ~mbient temperature. After stirring overnight, the reaction was checked by TLC, and found to be completed. IR (~ilm on NaCl) of the reaction mixture confirmed this, no CHO fragment coud be detected. Water (50 mL) and a few drops of HCl (2 M) were added. The mixture was extracted with ether (3x50 mL). The organic extracts were washed with water (40 mL), dried (Na2SO4) and the solvent was evaporated, leaving a crystalline yellow residue. The product was chromatographed on a column of silica with CH2Cl2,EtOAc 45:5 as eluent. The fractions containing pure product were pooled and the solvent was evaporated, yielding 0.150 g (81 %).
H NMR (CDCl3, 300 MHz~ ~: 5.40-5.50 (m, CH-O, lH), 5.36 (s, CH, 1H), 4.79-4.86 (m, CH2NO2, 1H), 4.61-4.66 (m, CH2-NO2, 1H), 3.07 (s, OH, lH), 1.50 (s, CH3).
3C NMR (CDC13, 75 MHz) ~: 139.87, 137.08, 118.38, 118.21, 78.80, 64.94, 30.58, 25.36 and 25.30 (CH3, two resonances due to assymmetry).

Example 84 Tris(8~diethylaminocarbonyl-2 2,6,6-tetramethylbenzo~l,2-d:4l5-d']bis-(1 3)dioxole-4-l!methyl CH C~
)(~C)x t- BuO K ~<o ~~X
o ~~o n-BuLi; 12 0~~0 `, Cl:)NEt2 CONEt2 WO91/12024 PCT/EP9l/00285 ,.o7~
207 ~ 126 -Tris(8-diethylaminocarbonyl-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis-(1,3)dioxole-4-yl)methane (0.076 g, 0.080 mmol (Example 87)) was dissolved in a mixture o~ o~ dry THF (40 mL, sodium benzophenone ketyl) and dry DMSO (10 mL, molecular sieves 4A ) under N2. KOtBu (0.009 g, 0.0~0 mmol) was added and the mixture stirred at room temperature for 4 hours.
n-BuLi (0.1.mL, 2.5 M in toluene, 0.25 mmol) was added, and the colour of the reaction mixture changed to dark red, after which I2 (0.041 g, 0.16 mmol) was added. A
sample of this solution was investigated by ESR
spectroscopy, indicating a radical content of < 5 Overhauser enhancement 2-10 at 2W.

Example 85 Tris~8-methylthiobenzo[1,2-d:4,5-d ~ bis(1.3)dioxole-4-yl)methanol and tris~methylthiobenzo~1/2-d:4,5-d']bls(l,3)dioxole-4-yl~methyl COH COLi ~3 ~3 <0~0> n-BuLi <~C> MeSSMe COH C*
<~0> <o~O>
~Me SMe WO9l/12024 PCT~EP91/0023j .
- 127 - 2 ~ 7~
Tris(benzo[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol (1.00 g, 1.90 mmol (Example 3) was mixed with dry THF
(25 mL, sodium benzophenone ketyl) under Ar (g) and cooled to -78 C. n-Bu~i (3.8 mL, 2.5 M solution in hexane) was added with a syringe. The cooling bath was removed and the resulting mixture was allowed to reach room temperature. The mixture turned thick and pasty and THF (25 mL, sodium benzophenone ketyl) was added in order to facilitate stirring. After 1 day CH3SSCH3 (1 mL) was added. The mixture became homogeneous (and dark) almost instantaneously. After 2 hours, the reaction mixture was poured on ice-water (200 mL) and extracted with CH2C12 (3x100 mL). The organic phase was dried (MgSO4) and filtered and the solvent was evaporated to give a dark brown syrup, which was dissolved in CHCl3, filtered through SiO2 and evaporated to a new syrup. The brown syrup was chromatographed on SiO2 with Et2O as eluent. (The sample was applied to the column in a mixture of Et2O/C~2Cl2). Yield 1.05 g, 84 %.
MS (EI 70 ev): M~+ 662, 646, 616, 570.
Tris(8-methylthiobenzo[1,2-d:4,5-d'~bis(1,3)dioxole-4-yl)methanol was converted to the corresponding radical with BF3 . OEt3 (cation formation) and CrCl2 (reductant) as described in other Examples. The ESR spectrum showed a linewidth of 120 mG in THF at a concentration of 1 mM.
The Overhauser enhancement was 10 at 5 W.

Example 86 2,6-Dlsilicium-2,2,6,6-tetra-tert-butylbenzoLl 2-d:~l5-d'~'bisfl.~dioxole ~lo~ t- BU~ ~C~ ,t~BU

HO--~OH t BU O O t~Bu ~ WO91/120~4 PCT/EPgl/0028~

2~ 28 -1,2,4,5-Tetrahydroxybenzene (0.284 g, 2.0 mmol (Example 4)) and imidazole (0.81 g, 12.0 mmol) were dissolved in dry DMF (15 ml) and di-t-butyldichlorosilane (1.28 g, 6.0 mmol) was added dropwise with stirring. The solution was stirred for 15 h, diethyl ether (50 ml,sodium benzophenone ketyl) was added. The organic phase was washed with HC1 (2x25 ml, 5 ~), NaOH 2x25 ml, lM), water (25 ml), dried and evorporated, yielding 0.50 g of a solid yellow residue. Recrystallization from diisopropyl ether gave 0.330 g (39%) pure, slightly yellow compound.
H NMR (CDCl3, 300 MHz) ~: 6.12 (s, CH, 2H), 1.05 (s, bu, 36H)-MS (EI, 70 ev, GLC inlet) m/e: 425 (3), 424 (12), 423 (36), 422 (100), 383 (14), 382 (31) Example 87 Tris(8-diethylaminocarbonyl 2,2,6,6-tetramethylbenzo[1.2-d:4 s-d']'bis(1.3)dioxole-4-yl~methane and bisf8-diethylaminocarbonyl-2 2,6,6 -tetramethylbenzo[1 2-d:4 ! 5-dl~bis~l 3)dioxole-4-yl)-mono(2,2,6.6-tetrameth~l-benzo~1,2-d:~ 5-d']bis~l,3)dioxole-4-yl~methane CH
~ 3 ~ 3 k~X SOCI2 k$C~X
o~X~ COOH o>~o THF, HNEt2`X CONEt2 ~<

C~X ~ >< ><
A crude mixture of tris(8-carboxyl-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d'~bis(l,3)dioxole-4-:- .
, .............................. .

.: :

WO9I/~2~24 PCT/EP~I/00285 -` 2~75~18 yl)methane and bis(8-carboxyl-2,2,6,6-tetramethylbenzo-[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)mono(2,2,6,6,-te~ramethylbenzo[l,2-d:5-d']bis(1,3)dioxole-4-yl)methane(1.00 g, from Example 18) was dissolved in dry THF (10 mL) at room t~mperature, SOCl2 (0.61 mL, 8.4 mmol) was added, and stirriny was continued for 2 5 hours. The solvent and excess SOCl2 was evaporated under reduced pressure, leavin~ a brown crystalline residue, which was dried on a vacuum pump (<1 torr) for 10 h.
This residue was dissolved in dry THF (5 mL), and Et2NH
(1.50 g, 21.0 mmol) was added and stirred for 12 hours.
The reaction mixture was partitioned between ether (75 mL) and water (50 mL). The organic phase was separated, dried (Na2S04), filtered and the solvent was evaporated leavin~ a brown crystalline residue. Chromatograhpic (RP8, 10 ~, 20x250 mm, CH3CN:H2O 75:25) separation, yielded O.lOOg (0.098 mmol, 14%) of tris(8-diethylaminocarbonyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(l,3)dioxole-4-yl)methane and 0.150 g (160 mmol, 37%) of bis(8-diethylaminocarbonyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)-mono(2,2,6,6-tetramethyl-benzo[1,2-d:4,5-d']bis-(1,3)dioxole-4-yl)methane. The yields are calculated for two steps (including the reaction in Example 18).
Tris(8-diethylaminocarbonyl-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis(1,3)dioxole-4-yl)methane:
1 (300 MHz. CDCl3) ~: 1.06-1.12 (t, CH3. 3H), 1.17-1.24 (t, CH3. 3H), 1.52 (s, CH3, 36H), 3.26-3.37 (q, CH2, 2N), 3.51-3.60 (q, CH2. 2H), 5.41 (s, CH, lH).
Bis(8-diethylaminocarbonyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-4~yl)-mono(2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bos(1,3)dioxole-4-yl)methane H NMR (300 MHz. CDCl3) ~: 1.06-1.12 (t, CH3. 3H), 1.17-1.24 (t, CH3. 3H), 1.52 (s, CH3, 24H), 1.54 (s, CH3, i2H), 3.26-3.37 (q, CH2. 2H), 3.51-3.60 (qs, CH2, 2H), WO91/12024 PCT/EP~1/0028~

2~7~ 130 -5.41 (s, CH, lH), 6.21 (s, aromatic H, lH).

; Example ~

; Tr~ ornyl-2~2~ 6-tetr~ hy~ o r 1 . 2-d:4,5-d'~bls-~1 3~dioxo_e-4-yl)methyl bisulfite aclduct CA C
k~X Na2S20s k~X
o~~o H20/dioxan~ C) ~O
C~10 H~ OSO2Na Tris(8~~orTnyl-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis-(1,3)dioxole-4-yl)methyl (0.065 g, 0.976 mmol (Example 64)), with a radical content of about 10%, and Na2S2Os (0.370 g, 1.95 mmol) were mixed in a 25 mL round flask under N2(g). Water (1.5 mL, He degassed 15 min.) and dioxane (1.5 mL, He degassed 15 min.) were added. After 15 minutes sti.rring most of the solid material had dissolved. HPLC analysis showed that the starting aldehyde was consumed after 45 minutes. An Overhauser experiment confirmed the presence of radical in the reaction mixture. Overhauser enhancement was 59 at 5W
microwave power. ESR four lines, Linewidth 133 mG, aH
973 mG.
The bisulfite adduct was precipitated by the addition of dioxane and the precipitate was filtered and washed twice with dioxane. The product was dried under vacuum in room temperature overnight.

Exam~le 89 Tris(8-formyl-2 2 6 6-tetramethylbenzoCll~=sL~L,5~d'~bis-(1 3)dioxole-4-yl)methane bisulfite adduct - 131 -2~7531~

~X Na2szos)<~X
koJ~o H20ldioxane o~o CHO HO~ OS02~a This reaction was performed with tris(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d 4,5-d'~bis-(1,3)dioxole-4-yl)methane (0.050 g, 0.066 mmol (Example 23)), and Na2S2O5 ~0.285 g, 1.5 mmol) analogous to the formation of the bisulfite adduct o~ tris(8-formyl-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis-(1,3)dioxole-4-yl)methyl radical as detailed above in Example 88, yielding 0.140 g (the theoretical yield is 0.070 g) of crystals containing NaHSO3.
H NM~ (300 MHz, DzO) ~: 1.4 (d, CH3, 36H), 5.2 (s, CH, H), 5.3 (s, CH-OH, 3H).
3C NMR (75 MHz, D20) d: 24.4 (d, CH3), 28.0 (s, CH), 102 (s), 107 (s), 119 (s), 138 (s), 140 (s), 164 (s) Example 90 Tris~4-carboxy-2~ ~ _ trachloro~hen-1-yl~methyl Cl~ 1 1)hlaOH,DMSO CI~CI
CI~CI 2) 12 ~:I~CI
C;OOH C:OOH

WO91/12024 PCr/EP91/00285 2 ~7 5 ~ 132 -Tris(4-carboxy--2,3,5,6-tetrachlo~ophen-1-yl)methane (0.690 g, 0.87 mmol) [(lR (KBr, cm~) 3450 (O-H str.), 2920 (C-H str), 1720 (C=o str.), 1550, 1420 (C-C in chlorinated aryls). 1H NMR (CD30D, 300 MHz) ~: 8.00 (s, CH, 1H), 13C NM~ (CD30D, 75 MHz)) ~: 164.35, 132.40, 132.26, 133.00. 132.00, 56.88.~ was mixed with NaO~I (s) (0.090g, 3.6 mmol) in DMSO (10 mL) and stirred for 24 hours in the dark. I2 (0.110 g, 0.43 mmol) was dissolved in ether (40~mL) and this solution was added and the resulting mixture was stirred for 15 minutes The reaction mixture was poured on saturated NaHCO3 (100 mL).
The phases were separated and the aqueous phase (pH 2) was acidified to pH 1-2 (conc. HCl). The acidic aqueous phase was extracted with ether (2x100 mL). The ether phase were combined, dried (Na2SO4), filtered and the solvent was evaporated yielding a tan semi-crystalline residue of 0.250 g (36 %).
ES~ (200 G): One line, Linewidth 570 mG.
Overhauser enhancements (0.2 M in H2O, 200 G, 548.9 MHz) 2-10 at 2w microwave power.

Example 91 Tris(4-trichloromethyl-2.3 5 6-tetrachlorophen-1-yl~meth~l Cl ~CI 1) NaOH, DMSO Cl~Ci Cl ~CI 2) 12 GI~CI
CC13 C;CI ~

Tris(4-trichloromethyl-2,3,5,6-tetrachlorophen-1-yl)methane was converted to the corresponding radical as described in Example 90.

- ` 2 ~ 7 ~

ESR (200 G): One line, Linewidth 1500 mG.
Overhauser enhancements (200 G, 548~9 MHz) 2-10 at 2W
microwave power.

Example 9?

Tris~2,3,5,6-tet~rachloro-4-methylphen-1-yl)methyl CH C~
Cl - ~cl 1) NaOH, DMSO CI~CI

Cl~l 2) 12 Cl~
C~13 CH3 Tris(2,3,5,6-tetrachloro-4-methylphen-1-yl)methane was converted to the corresponding radical as described in Example 90.
ESR (200 G): One line, Linewidth 3200 mG.
Overhauser enhancements (200 G, 548.9 MHz) 2-10 at 2W
microwave power.

Examp~le 93 (Phenyl)-(pyrid-4-yl)-~thien-2-yl~ methanol N COPh ~;~

WO91/120~, PCT/~P91/~028~

207~ 134 -Thiophene (1.150 g, 13.60 mmol) was dissolved in diethyl ether (50 mL, sodium benzophenone ketyl) under argon. n-Butyl lithium (5.10 mL, 13.60 mmol) was added quickly with a syringe under evolution of heat. The resulting mixture was stirred ~or 1 hour and 15 minutes at room temperature. After cooling to -75~C, benzoylpyridine (2.50 y, 13.6 mmol) dissolved in T~IF (10 mL) was ~dded over a period of 10 minutes and the resulting mixture was stirred for 60 hours at room temperature. The resulting thick yellow suspension was diluted with THF
(100 mL) and NaH2P04 buffer (1.25 M, 100 mL) was added.
The organic layer was separated and washed with more NaH2PO4 buffer (2x30 mL, 1.25 M), dried (Na2SO4) and evaporated yielding 3.24 g of crude material.
Chromatography (flash, TLC gel 125 g, CH2Cl2:diethyl ether 4:6) yielded 1.83 g (6.85 mmol, 50%) o~ the title compound.
H NMR (DMS0 d6, 300 MHz) ~: 8.49 (m, ~1), 7.49-7.47 (q, lH), 7.35-7.24 (m, 7H), 6.97-6.95 (q, lH), 6.70-6.68 (q, lH).
3C NMR (DMSO d6, 75 MHz) ~: 155.63, 151.55, 149.29, 146.14, 127.85, 127.42, 127.00, 126.~8, 126.44, 125.96, 121.89, 77.97.
MS (EI 70 eV): M~+l 268, 190.

~xample 94 ~m-Chlorophenyl ! -~phenyl)-pyrid-4-yl)methanol Cl Cl N3COPh ~ N9 ~Br ~LI

WO9l/12024 PCT/EP91/0028~
2~7~
. - 135 -m-Chlorobromobenzene (2.60 g, 13.60 mmol) was dissolved in THF (50 mL, sodium benzophenone ketyl) under argon.
The solution was cooled to -78C and s-butyl lithium (9.7 mL, 13.60 mmol in cyclohexane/isopentane) ~as added over a period of 10 minutes. The resulting mixture w~s stirred for 1 hour at -78C. Benzoylpyridine (2.50 g, 13.6 mmol) dissolved in THF (10 mL) was added over a period of 5 minutes and the resulting mixture was stirred for 60 hours at room temperature. The resulting yellow solution was hydrolysed with NaH2PO4 buffer (1.25 M, 40 mL). The organic layer was separated and washed with more NaH2PO4 buffer (30 mL, 1.25 M), dried (Na2SO~) and evaporated. The solid was stirred with CH3CN (100 mL) for 3 hours. The solid was filtered and dried and was shown by TLC and MS to be pure.
H NMR (DMSOd3, 300 MHz) ~: 8.52-8.50 (q, CH pyridine 2H), 7.35-7.09 (m, lH).
3C NMR (DMS0d3, 75 MHz) ~: 155.20, 149.37, 148.88, 145.68, 132.76, 129.77, 127.99, 127.58, 127.37, 127.24, 127.16, 126.52, 122.52, 79.64.
MS (EI 70 eV): M++l 296 and 298, 218, 220.

ExamEle 95 Tris(8-dimethylaminocarbonylthio-2,2 6 6-tetramethylbenzo~1 2-d:4 5-d']bisrl,3)-dioxole-4-l)methane COH CH
k~oX -~~~~~~ ~<~oX
SCONMe2 SCONMe2 WO91/l2024 PCT/EP91/00~85 2~

NaI (1.135 g, 8.00 mmol) and Me3SiCl (1 mL, 8.0 mmol) were stirred in CH3CN (70 mL) at 0C. Tris(8-dimethylaminocarbonylthio-2,2,6,6-tetramethylbenzo-[1,2-d:4,5-d']bis(1,3)-dioxole-4-yl)methanol (1.00 g, 0.9979 mmol (Example 43)) dissolved in CH3CN 10 mL) was added and the resulting solution stirred for 30 minutes when lH
NMR analysis o~ a small sampl~ showed conversion to be complete. Na2S2O3 (sat., 30 mL) was added and the two phase system was stirred 30 minutes when more Na2S2O3 (sat. 30 mL) was added and the stirring was continued for 5 more minutes. The phases were separated and the organic layer was dried (MgSO4), filtered, the filter washed with diethyl ether (30 mL) and the solution was evaporated, yielding 1.16 g yellow to brown crystals.
The crystals were dissolved in CH2Cl2, the solution was washed with NaHCO3 (30 mL, sat.) and H2O (30 mL), dried (MySO4) and evaporated yielding 0.92 g of the pure title compoundO
H NNR (CDCl3, 300 MHz) ~: 5.38 (s, lH) 3.04 (s, 9H), 2.94 (s, 9H), 1.51 (s, 36H).
3C NMR (CDCl3, 75 MHz) ~: 163.22, 142.11, 139.50, 117.93, 108.75, 90.79, 36.91, 30.96, 25.30.
MS (Thermospray): M~-~18 ~003.

Example 96 Bis(8-meth~lmercapto-2 2 6,6-tetramethylbenzo~1,2-d:4.5-d']bis~1.3~ioxole-4-yl)-mono(2-methylmercaPto-pYrimidin-5-yl)methyl MQ SMe N~N N~N

C~ C~
k~X BF30E~2o~o ~~o SnCI2/Zn /\o ~l /\
SMe SMe W~9I/I2024 PCT/EP~It00~5 , - .
2 ~ 7 ~
- - 137 - ;
Bis(8-methylmercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-~-yl)-mono(2-methylmercapto-pyrimidin 5-yl)methanol (0.075 g, 0.109 mmol (Example 60)) was dissolved in T~IF (75 mL, sodium benzophenone ketyl). BF3.OEt2 (0.475 mL, 1.853 mmol, 48~ in diethyl ether) was added. The color changed from yellow to green. The solution was stirred for 15 minutes and SnC12 (0.103 g, 0.545 mmol) was added. 30 minutes later Zn (0.178 y, 2.725 mmol) was added and there followed an immediate color change to yellow/brown/greyish. More Zn (0.230 g, 3.51 mmol) was added one hour after the first addition. After leeting the Zn settle, a sample was taken with a gas tight syringe and an Overhauser enhancement experiment was performed on this solution.
The measured enhancement was 100 at 5W microwave power.

Example 97 Bist8-methoxycarbonylmethylthio-2,2I6~
tetramethylben~L1,2-d:4,5-d'lbis(l,3~dioxole~4-yl)-mono(8-ethoxYcarbonvlmethvlthio-2 2,6,6-tetramethylbenzo r 1 2-d:4.5-d'lbis(1 3)dioxole-4-vl)methanol ~;CH2COOEt X~oX
C:OH
X~oX
SCH2C:Ot: Me The title product was isolated by HPLC as a by product from ~he reaction described in Example 12.
3C NMR (CDC13, 75 MHz.) ~: 169.50, 168.99, 141.33, 141.28, 138.64, 138.62, 117.77, 117.75I 112.53, 112.33, WO91/12024 PCT/EP91/~028~

~ . .
20~S~8 - 138 -96.66, 96.46, 72.48, 52.30, 35.45, 35.40, 25.42.

Exam~le 98 Bis(8-mercapto-2 2,fi,6-tetrame-th~__enzo~1 2 d:4 5-d']bi~s~113)d:ioxole-4-yl~-mono(8-methoxycar~ l ethYl-2,2,6~6-tetra!n thylbenzo~l,2-d:4,5-d'~bis(1,3)dioxole-4-Yl)methanol SCH2COOMe ` X$~oX
C~
O
~O~OX
SH
The title product was isolated by HPLC as a by product from the reaction described in Example 12.

3C NMR (CDCl3, 75 MHz~ ~: 169.52, 141.25, 140.13, 138.79, 138.68, 117.66, 116.95, 112.73, 111.90, 96.46, 96.34, 72.53, 35.36, 25.39, 25.34.

Example 99 Tris(benzothien-2-yl)methanol Li O COI I
n-BuLi ~ EtO~OEt ~;

W~gltl~O2~ PCT/~P91/002X5 ";' 2~7~318'' ' Benzothiophene (5.42 g, 0.0382 mmol) was dissolved in diethyl ether (100 mL,). n~Butyl lithium (20.0 mL, 2M) was added at -15C under an argon atmosphere. The resulting mixture was allowed to reach room temperature and di.ethyl carbonate (1.54 mL) was aclded and when TLC
showed the reaction to be complete. The mixture was worked up by adding Na2HPO4 buffer (100 mL, sat.), separating the phases and washing the organic phase with more buffer and water. Drying (MgS04), evaporation and chromatographic separation yielded 1.40 g (25.7%) of the title compound.
3C NMR (CDC13, 75 MHz) ~: 150.12, 140.08, 139.03, 124.48, 124.08, 123.44, 122.37, 50.80.
;

Example 100 4-Allylthio-2,2 6.6-tetramethylbenzo~1,2-d:4 5-d']bis Ll,3)~dioxole o /~o1) S8 \ --~~/
\/ 11 1 ~ I /\
/\0~0 \ 2) allyibromi~e / Y--C3 S
:', The title product was synthesized from 2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis(1,3)dioxole (4.5 g, 0.02 mmol (Example 5)), n-butyl lithium (9.0 mL, 2.5 M), S8 (0.70 g) and allylbromide (2.42 g, 1.73 mL) in THF.
Yield 4.9 g (83%) of a yellow brown oil.
3C NMR (CDC13, 75 MHz) ~: 141.82, 139.90, 133.76, .25, 117.38, 98.31, 92..72, 36.66, 25.56.

WO91/12024 PCT/EPgl/0028~
2~7~81~
` - 140 -Example 101 Tris(8=di(methvlcarbonyloxYethyl~
aminocar onylmethylthio-?~ 2 6,6-tetramethylbenzo~1,2-d:~ 5-d'~bis(1 3)-dioxo e-4-yl~methy COH C~
ko~oX - - ~~ k~oX
SCH2CON(CH2cH20Ac)2 SCH2CON(CH2CH20Ac)~

Tris(8-di(methylcarbonyloxyethyl) aminocarbonylmethylthio-2,2,6,6-tetramethylbenzo-[1,2-d:4,5-d']bis(1,3)-dioxole-4-yl)methanol (0.098 g, 0.066 mmol (Example 38)) was dissolved in THF (30 mL, A12O3).
BF3.OEt2 (3.00 mL, 11.77 mmol, 48% in diethyl ether) was added. The solution was stirred for 30 minutes and SnCl2 (0.159 g, 1.122 mmol) was added. 30 minutes later Zn (0.108 g) was added and there followed an immediate color change from blue to brown. After letting the Zn settle, a sample was taken with a gas tight syringe and an Overhauser enhancement experiment was performed on this solution. The measured enhancement was 28 at 4 mW
microwave power and 69 at 0.77 W.
ESR (200 G, THF solution): One line, linewidth 187 mG.

~ WO91/12024 PCT/EPgl/00285 . .
- 2 a ~

ExamPl e 10 3 N 3 ~ n ~

ElO OEI
/ r~dlcrll lorm~l~ion vi~ ca~ion C~ ~oa`'~/ 3 ;~=N ~orm ~I o~l3 Jr via ani~n J~
The bromo oxazolidine thiophene of Example 81 is trimerized to the corresponding trityl by treatment with one equivalent of n-butyl lithium in THF at -75C for 30 minutes. 0.3 equivalents of diethyl carbonate is added at this temperature and the solution is allowed to reach room temperature over a period oE several hours. The reaction mixture is worked up by pouring the solution on cold NH4Cl or cold Na2HPO4 buffer followed by extraction with diethyl ether or H2C12. The organic phase is washed with water, dried (Na2SO4) and is evaporated to yield the crude carbinol. The pure compound is obtained by chromatography on either SiO2 or RP~ gel. The product is characterised by 1H NMR and 13C NMR as well as other spectroscopic methods. The methanol compound is either converted directly to the radical or first to the methane.

Example 1~04 BisL~-formyl-2l2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis-(1,3~dioxole-4-yl)ketone c_o ~ X ~ O~, ~oX
C~

WO91/12024 PCTtEP91~00285 -1~2~
2~7~
~,2,6,6-Tetramethylbenzo[1,2~d:4,5-d'~bis-(1,3)dioxole (8.88 g, 0.040 mol (Example 5)) was dissolved in THF
(250 mL) and cooled to -20C under a N2 atmosphere. n-Butyl lithium (19.2 mL, 2.5 M in toluene) was added and the temperature was allowed to increase to -~10C over a period of 10 minutes. The mixture was then cooled to -20C and DMF t2.92 g, 0.040 mol) was added and the temperature was allowed to re~ch room temperature in 2 hours. The mixture was again cooled to -20 a C and a second portion of n-butyl lithium (19.2 mL, 2.5 M in toluene) ~as added. The temperature was allowed to reach room temperature in 1 hour. After once again recooling to -20C, dimethyl carbonate (1.19 g, 0.0132 mol) was added and the temperature was allowed to reach room temperature overnight. Water (300 mL) and acetic acid (2 mL) were added and the solution was extracted with ether (3x150 mL). The organic extracts were combined, dried (Na2SO4 and K2CO3) and the solvent evaporated leaving a semi-crystalline dark residue. The residue was crystallized twice from EtOAc:heptane 4:1 giving the title compound as a deep red crystalline product. Yield 3.0 g (43%).
H NMR (CDC13, 300 MHz) ~: 10.11 (s, CHO, 2H), 1.68 (s, CH3, 24H)-~C NMR (CDCl3, 75 MHz) ~: 185.25, 183.05, 141.08,139.72, 121.48, 112.12, 108.09, 25.72.
IR (KBr): 1700 ~vs, C=) in CHO, 1670 (s, C=0).

Example 105 Trls(8-formyl-2.2 6.6-tetramethylbenzo[1,2-d:4 5--d']bis-(1.3)dioxole-4-yl)methanol and bis(8-formyl-2.2.6.6-tetram~ethylben7.o~l~2-d:4~5-d']bis(l~3)dioxole-4-yl ! -monor2.2 6,6-tetramethylbenzo~1,2-di:4,5-d'lbis-(1,3)dioxole-4-yl)methanol and mono(8-formyl-2,2.6l6-tetramethylbenzo[l,2-d:4,5-d'lbis(1 3)dioxole-4-yl)-bis~?,2,6 6-tetramethylbenzo[1 2-d:4,5-d'~bis(1,3) dioxole-4-ylLmethanol WO91/12024 PCT/EPgl/00285 .
-1~3~ 2~7~

Co~ Co~l ~ X ~ X ,j~,X

o ,,~ ~ o o~ o ~ C~C~ ~o o ~< o ~.<

Tris(2,2,6,6-tetramethylbenzo[1,2-d:~,5-d']bis-(1,3)dioxole-4-yl)methanol (10.0 g, 0.0145 mol (Example 44)) was suspended in dry diethyl ether (300 mL). n-butyl lithium (29 mL, 0.0725 mol, 2.5 M in hexane) was added, under nitrogen, and the solution was heated slowly to reflux temperature (ca. 20 min.). A second portion of n-butyl lithium (9.8 mL, 2.5 M in hexane) was added and the heating was disrupted. 5 minutes after removal of the oil bath, DMF (130 mL, 0.169 mol) was added carefully. The resulting mixture was stirred at room temperature over night. Water (300 mL) and AcOH
was (5 mL) was added to the solution. An orange colour appeared in the solution at this time. The mixture was extracted with diethyl ether (2x300 mL). The combined organic phase was washed with wather (3x100 mL), dried (Na2SO4, K2CO3), treated with charcoal and filtered through Sio2 (3 cm, i.d. 5 cm) and evaporated. The residual brown residue was dried under vacuum to leave a form weighing 11.1 g. This material was chromatographed on several columns of Sioz with C~I2Cl2:EtOAc 45:5 as eluent.
Yield of tris(8-formyl-2,2,6,6 tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-4 yl)methanol 1.8 g (16.9%).
lH NMR (CDCl3, 300 MHz) ~: 10.08 (s, CHO, 3H), 4.32 (s, OH, lH), 1.55 (s, CH3, 36H).
13C NMR (CDCl3, 75 ~-lz) ~: 185.41, 140.82, 139.25, WO91/12024 PCT/EP91/00~5 ~ . ~, 2~7~ 119.58, 116.58, 105.76, 72.71, 25.62.
~S (Thermospray): M~+23 (Na) 799.
Yield of bis(8-formyl-2,2,6,6-tetramethylbenzo~1,2-d:4,5-d']bis-(1,3)dioxole-4-yl)-mono(2,2,6,6-tetramethylbenzo[l,2-d:4,5-d']bis(1,3)dioxole-4-yl)-methanol 4.5 g (~2%).
3C NMR (CDC13, 75 MHz) ~: 185.51, 140.77, 140.31, 139.~1, 138.62, 119.34, 117.53, 117.19, 110.80, 105.59, 92.31, 72:70, 25.60, 25.44.
MS (Thermospray): M~23 (Na) 771.
Yield of mono(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d'~bis(1,3)dioxole-4-yl)-bis(2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3) dioxole-4-yl)methanol 2.1 g (20.1%).
3C NMR (CDC13, 75 MHz) ~: 185.69, 140.73, 140~19, 13g.57, 138.81, 119.12, 118.58, 116.95, 111.67, 105.~3, 91.98, 72.71, 25.59, 25.43.
MS (Thermospray): M~+23 (Na) 743.

Example 106 4-Formyl-2~2~6~6-tetramethylbenzo[l~2-d:4-~5-dilbis(l~3) I dioxole :`

X ~1~0--1~ X ~ X ~--~ o X
~` /~o ~ 0 1 O

: G~

2,2,6,6-Tetramethylbenzo[1,2-d:4,5-d']bis(1,3)-dioxole (20.0 g, 90 mmol (Example 5)) was dissolved in THF (300 mL) and cooled to -20C. n-Butyl lithium (38.0 mL), 2.5 M in toluene, 100 mmol) was added and the temperature was allowed to rise to O~C. The mixture was recooled to -20~C and DMF (6.9 mL, 90.0 mmol) was added.

W091/12024 PCT/EP91/0~28 , -145-2~7~
The reaction mixture was stirred over night while allowing the temperature to increase to room temperature. Water (200 mL) and AcoH (5 mL) was added.
The color changed ~rom light yellow to strong orange.
The mixture was extracted with diethyl ether (3x300 mL) and the combined oryanic phase was washed with water (2xlOOmL), dried (NazSO4) and evaporated. The product was trituated twice with petroleum ether and dried, yielding the pure title compound; 16.3 g (72%).
3C NMR (CDCl3, 75 MHz) ~: 185.51, 140.84, 140.81, 120.17, 106.38, 98.26, 25.67.

Example 107 Bis(8-formylethyleneql~colacetal-2,2,6,6-tetramethylbenzo[l,2-d:4,5-d'~bis(1,3~-dioxole~4-~l)ketone C~ Co X`1~~ X ~3 oX
C~

Bis(8-formyl-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)-dioxole-4-yl)ketone (2.0 g, 3.80 mmol (Example 104)), ethyleneglycol (50 mL) and methanesulfonic acid (0.01 mL) were mixed and stirred at room temperature over a weekend. TLC analysis (SiO2 CH2Cl2:Et20 4:1) indicated that the reaction was complete. Pyridine (0.5 mL) was added and the reaction mixture was partitioned between diethyl ether (200 mL) and water (250 mL). The aquous phase was extracted with more ether (2x200 mL). The combined organic phase was washed with water (100 mL~, dried (Na2SO4) and filtered through A1203 (2.5 cm, i.d. 2 cm). The solvent was evaporated leaving a yellow crystalline product. Yield WO 91/12024 ~CT/~P91/0~285 2~7~
2.12 g (90.9~).
H NMR (CDCl3, 300 MHz) ~: 6.06 (s, O-CH-O, 2H), 4.19-4.14 (m, CH2, 4H), 4.02-3.97 (m, CH2, 4H), 1.61 (s, CH3, 2 4 ~
3C NMR (CDC13, 75 MHz) ~: 134.06, 139.63, 138.93, 119.37, 109. 27, 108.~2, 97.9~, 65.73, 25.66.

E~m~le lQ~

Tris(2l5-dimethylthien-3-yl)methanol )~c~ e~ 3 ,, .
2, 5-Dimethyl-3-iodo-thiophene (see S. Gronowitz and R.
Beselin, Arkiv for Kemi 21: 349-355 (1963)) (0.05 mol) was dissolved in diethyl ether (150 mL, dry) and n-butyl lithium (25.0 mL, 2.06 M) was added at -78 ~C under N2 and stirred for 30 minutes. Diethyl carbonate (2.0 mL, 0.0166 mol) in diethyl ether (3 mL, dry) was added and the mixture was stirred for 30 minutes. The cooling bath was removed and the temperature was allowed to reach ~10C. At this temperature the mixture was poured onto ice/water. The organic phase was separated and washed with water (2x50 mL), dried (MgSO4~ and evaporated. The resulting oil was taken up in petroleum ether. After cooling the product was filtered and washed with a little petroleum ether. Yield 41.6%, mp.
1 1 0 ~ C .
H NMR (C6D6, 300 MHz) ~: 6.46 (H4, 3H), 2.19 (s, CH3, 9H), 2.03 (s, CH3, 9H), 1.70 (COH, lH).
MS (EI 70 eV): M+-l 361.
MS (Thermospray): M~-17 345.

. .

; WO91J12024 P~/EP91/00285 ~ 7-~ Q 7 ~
Example 109 Tris(2 5-dimethylthien-3-yl~methane C S C~3 ~1C ~I C / ~ ~` Ck~

Tris(2,5-dimethylthien-3-yl)methanol (Example 108)) was converted to tris(2,5-dimethylthien-3-yl)methane using Me3SiC1, CH3CN and NaI as described in several previous Examples, e.g. 17, 61, 62 and 95. Yield 67.8%, mp. 143-144C.
1H NMR (CDCl3, 300 MHz) ~: 6.28 (s, 3H), 5.07 (s, methane CH, lH), 2.34 (s, CH3, 9H), 2.18 (s, CH3, 9H).

Example 110 Tris(2,5-dimethylthien-3-yl)methanol CO\~

l~c / ~ ~ ~ 3 Tris(2 4,5-trimethylthien-3-yl)methanol )~ C .C~H

~C\~C~3 WO91/12024 ~T/~.Pgl/0028~
-148- g~.
2 0 7 ~ Bis(2.5-dimethylthien-3-yl)-mono~(2 3-dimethyl-4-iodo-thien-5-yl)-methanol co~ TtC~

~J~,C S C~

Bis(2,5-dimethy~thien-3-yl~-mono~2~5-di-t-butyl-thien-3-yl)~methanol It3C/[~S~u~3 ~k The title carbinols were made according to the same general procedure: To a stirred solution of the corresponding mono- or diiodinated thiophene ~0.05 mol) in diethyl ether (150 mL, dry) was added n-butyl lithium t25.0 mL, 2.06 M) at -70C under N2. The solution was stirred for 30 minutes at this temperature. The appropriate ketone (see A. Wiersma and S. Gronowitz Acta Chem Scand 24: 2593-2611 (1970) and Ya L. Goldfarb and P.A. Konstantinov, Bull. Acad. Sci. USSR, Engl transl., 108 1959) (0.05 mol), dissolved in diethyl ether (150 mL), was added and the resulting solution was stirred ~or 30 m.inutes at this temperature. The cooling bath was removed and when the reaction mixture had reached WO9l/12024 PCT/EP91/00285 ~ 149_ 207~
~10C the mixture was poured on ice and water. The workup was as described in Example 108.
Tris(2,5-dimethylthien-3-yl)methanol MS (Thermospray): M+-17 345 Trist2,4,5 trimethylthien 3-yl)methanol Yield: 3.5%
MS (Thermospray): M~-17 723 Bis~2,5-dimethylthien-3-yl)-mono-(2,3-dimethyl-~-iodo-thien-5-yl)-methanol Yield: 13.3~
MS ~Thermospray): M+-17 471 Bis(2,5-dimethylthien-3-yI)-mono(2,5-di-t-butyl-thier~-3-yl)-methanol Yield: 5.6%
MS (Thermospray): M~-17 429 Example 111 (Phenyl)-(pyrid-4-yl)-(thien-2-yl)methane ~ Q3S~ C1 ~3 CS \~ 1/0~
.
NAI (2.27 g, 16.0 mmol) and Me3Sicl (2.02, 16.0 mmol) were stirred in CH3CN (70 mL) at 0C. (Phenyl)-pyrid-4-yl-(thien-2-yl)methanol (0.534 g, 2.00 mmol (Example 93)) was added at 0C and the resulting solution was stirred over night at room temperature. Na2S203 (sat., 20 mL) was added and the two phase system was stirred 5 ` minutes. The phases were separated and the organic layer was dried tMgS04), filtered and evaporated. The resulting crystals were dissolved in CH2C12 (30 mL), the solution was washed with NaHC03 (30 mL, sat.) and H20 (30 :~ .

-150- -~
~7~ mL), dried (MgSO4) and evaporated yielding 0.41 g which was recrystallized in diisopropyl ether giving 0.22 g (43.8%) of the pure title compound.
H NMR (CDC13, 300 MHz) ~: 8.53 (m, 2H), 7.37-7.11 (m, 8H), 6.96 (q, lH), 6.71 (dt, lH) 5.6~ (broad s, 1~l).
3C NMR (CDCl3, 75 MHz) ~: 152.33, 149.91, 145.53, 1~1.98, 12~.72, 128.63, 127.23, 126.73, 126.71, 125.0~, 123.89, 51.37.

Example 112 Bis(thien-2-yl)-mono-(4-methoxyph~enyl)methyl ~ 3 ~ ~t2 o ~S ~X
L) Sn~ O~L ~- C
~ ~ Zr~

~ G~3 The carbinol of Example 115 (0.140 g, 0.463 mmol) was dissolved ln dry (Al2O3 filtered and Ar (g) saturated) THF (30 mL) and BF3.EtzO (1.12 g, 7.87 mmol) was added and stirring was maintained 30 minutes when SnCl2 (0.437 g, 2.31 mmol) was added. After stirring for another 30 minutes, Zn dust (0.756 g, 11.6 mmol) was added and the stirring was continued. 30 minutes after the Zn addition a sample was taken with a gas tight syringe, after letting the Zn settle, and Overhauser measurements showed some radical formation to have occurred.

W09l/12024 PCT/EP91/0028 2 ~
Example 113 Tris(8-diethylaminocarbonylmethylthio-2,2 6 6-tetramethyl-benzo~1.2-d:4,5-d'lbis(1,3)dioxole-4-yl)methanol C~H C~
~ ~ ~ 3 ~ /~ X ~--' -~X~xO><
SH SC~ L~P r~ ~/, Tris(8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(l,3)dioxole-4-yl)methanol (1.00 g, 1.269 mmol (Example 31)) was added to a solution consisting of CH3CN
(50 mL), K2C03 (5~0 g and BrCH2CONEt2 (0.776 g, 4.0 mmol) made from BrCH2COBr and HNEt2 in CH2Cl2) at -5C under argon. The cooling bath was removed and the temperature increased to +23C. A 1H NMR control of a small sample 20 minutes after the removal showed complete conversion to have occurred. Diethyl ether (50 mL) was added and the solution was filtered. The solvents were evaporated and the residual 1.28 g of oily material was heated in diisopropyl ether (30 mL, 40C). The material did not dissolve but changed into crystalline form in this process. Filtration and drying gave 0.96 ~ ~67.0~) of the title compound.
H NMR (CDC13, 300 MHz) ~: 4.i6 (s, COH lH), 3.36 (q, NC~2CH3, 6H), 3-32 (q, NCH2CH3, 6H), 1.50 (s, CH3, 36H), 1.18 (t, CH3, 9H, 1.08 (t, Cc3~ 9H)-3C NMR (CDCl3, 75 MHz) ~: 166.92, 141.20, 138.63, 117.57, 112.21, 97.18, 75.52, 42.44, 40.13, 35.97, 25.48, 14.30, 12.83.

W~1/12024 -15~- PCT/E~1/00?85 2 07 ~ g 1~ Example 114 Tris(8-diethylaminocarbonylmethylthio-2,2,6,6-tetramethyl-benzo[1,?-d:4,5']bis(l,3~dioxole-4-yl ! methyl '~ 3 ~ ~
Xo ~ , Xo /CO~ ~ X
S C~ 2 C~ t 2 ~` Sco ~ t Tris(8-diethylaminocarbonylmethylthio-2,2,6,6-tetramethylbenzo[1,2-d:4,5']bis(1,3)dioxole-4-yl)methanol (0.100 g, 0.0886 ~mol) was dissolved in dry (Al2O3 filtered and Ar (g) saturated) THF (30 mL) and BF3OEt2O (0.214 g, 1.51 mmol) was added and ~he color changed immediately from yellow to blue, and stirring was maintained during 30 minute. SnC12 was added (0.084 g, 0.443 mmol) and the stirring was continued for one hour. Zn dust (0.145 g, 2.22 mmol) was added and one hour later another portion of Zn dust (0.124 g, 1.89 mmol) was added. An experiment one later on a crude sample from the reaction mixture, after letting the Zn settle, showed a 108 fold Overhauser enhancement at 4 mW
microwave power.

.

WO91/120~4 PCT/EP~1/00285 -153- 2~7~813 Example 115 Bislthien-~-yl)monor4-methoxy~henyl)methanol ~O~ -~t~
c~ I

OC~, p-Bromo methoxybenzene (0.96 g, 5.2 mmol) was dissolved in THF ~50 mL) and n-butyl lithium (2.08 mL, 2.5 M in toluene) was added at -70C and stirred at this temperature for 10 minutes when the thienyl ketone tl.0 g 5.2 mmol) (see ~ACS 7~: 1733-36 (1952), JCS 1956, 698-705 and Receuil 68: 24 (1949)) dissolved in THF t5 mL) was added. The temperature was allowed to rise gradually to room temperature over night. The mixture was hydrolysed with water (50 mL). Ether (150 mL) was added and the phases were separated, the aqueous phase was extracted with more ether (100 mL) and the combined organic phase was washed with water (70 mL), dried (MgSO4) and the solvent evaporated leaving a semi-crystalline black residue. The black residue was dissolved in hot heptane/EtOAc (3:1) and chromatographed on a column of alumina with hep~ane: EtOAc 3:1 as eluent .
The product was isolated in a yield of 0.72 g (46.0%).
H NMR (CDC13, 300 MHz) ~: 7.38 (d, armoatic H m to OCH3, 2H, J 9Hz), 7.29 (q, thiophene H ~ to S, 2H, J 5.1 Hz, J
1.2 Hz), 6.95 (q, thiophene H ~ to S, 2H, J 5.1 Hz, J
3.6 Hz), 6.86 (d, aromatic H o to OCH3 2H, J 9Hz), 6.85 (s, thiophene ~ to S, 2H, J 3.6 Hz, J 1.2 Hz), 3.81 s.
OCH3, 3H), 3.04 (s, OH, lH).
13C NMR (CDC13, 75 MHz) ~: 159.04, 152.05, 138.36, 126.38, 126.37, 125.60, 113.12, 77~65, 55.18.
MS (EI 70 eV): M~ 302 (10%), ~-16 286 (100~), M~-17 285 -154- ~, 2~7~1~ ;, .... .
(90%) .

Example 116 Tris(8~ropargylthio 2.2,6,6-tetramethyl-benz_ Ll,2-d:4,5-d']bis(1 3)dioxole-4-vl~methanol Co~

X ~ X ~ O X
S Gtl ? C c~
SH

Tris(8-mercapto-2,2,6,6-tetramethylbenzo[1,2-d:4,5-d']bis(1,3)dioxole-4-yl)methanol (0.400 g, 0.50761 mmol (Example 31)) was added to a solution consisting of CH3CN
(50 mL), K2CO3 (5.o g) and BrCH2CCH (2.389 g, 2.284 mmol) at -5C under argon. The cooling bath was removed and the temperature increased to +23C. A1H NMR control of a small sample 20 minutes after the removal showed conversion to be complete. Diethyl ether (50 mL) was added and the solution was filtered. The solvents were evaporated and the residual oil weighed 0.401 g (87%).
H N~R (CDC13, 300 MHz) ~: 4.15 (s, lH, OH), 3.51 (d, 6H, CH2), 2.97 (t, 3H, CCH), 1.47 (s, CH3, 36H).
3c NMR (CDC13, 75 MHz) ~: 141.35, 138.38, 11.49, 112.38, 96.31, 79.73, 72.32, 70.80, 25.26, 21.55.
The product may be substituted at the alkyne hydrogen by lithiation followed by reaction with carbon dioxide or with R~Lv where R~ is the group (e.g. an alkyl group) to be introduced and Lv is a leaving group.

WO91/12024 PCT/EPgl/00285 20~75~18 Example 117 The following known free radicals were tested for Overhauser enhancement:

_adical PoweE Overhauser enhancement C
37mW 2 ~C~13 (See Bert et al JACS 54: 3250 (1932):
Dunnebacke et al Chem. Ber. [1989] 122 533;
Judeikis et al JACS [1961] 84, 1132;
Sinclair et al JACS [1968] 90, 5074.

C

37mW 6.5 , y 5 W 107 5 C~3 (see Dunnebacke et al (supra)) -156- ~, 2 9 7 ~ Radical Power Overhauser C~ enhancement t~J 2 (ESR Linewidth 250mG) (See Anderson et al Acta. Chem. Scand.
(1962), 16, 1817-1818;
Falle et al, Canad. J. Chem.
(1986), ~4 1387;
Ziegier et al, Annalen (1927), 458, ,, 248;
Allan et al, J.C.S. (1986), 440; and Anderson et al, Acta. Chem. Scand, ' (1962), 16, 1817).

_~3 , ', 5 W 3 (ESR linewidth 60OmG
aH 1200 mG) (see Gomberg JACS [1900], 22, 757) Example 118 C' X /~ ~. ~X

OS; (C~

2~7~ S
The title compound was prepared following the reaction scheme:
C~t X ~ ~ ~ X nBuLi ~ /

(Example 5) ~ kl~3 (CH3)3 SiCl X ~~
(CH3)3 Si N Si (CH3)3 Pyridine ether oS~,~C~3)~
nBuLi ~ X
" --- ~ ~ X ~ ~ O
THF
C~l~
(EtO)2Co BF30Et2 CrC12 The title compound showed Overhauser enhancements of 52 at 3.5W
and 2 at 22mW. The ESR spectrum showed a linewidth of 65 mG.

WO91/12024 -158- PCT/EP91/0028~
2a~ss~
FORMULATION E~AMPLES

EXAMPLE I
Intravenous enhancement aqent An Overhauser MRI enhancement solution is prepared ~s follows:

The freeze dried radical e.y. that of Example ll is dissolved in oxygen-free water containing sodium chloride to ensure iso;t`onicity. The pH of the solution is adjusted with trls buffer to pH 7.4. CaNa EDTA is added to prevent metal catalyzed oxidation. Ascorbic acid is added as an antioxidant.

An injectable solution is prepared which contains:

Radical 70 mmol Sodium chlcride q.s.
Tris buffer q.s.
CaNa EDTA O.l mmol Ascorbic acid 0.0l mmol Aqua purificata ad 500 ml EX~MPLE II
Intravenous enhancement aqent An Overhauser M~I enhancement is prepared as follows:

.
The radical (e.g. that of Example ll) is dissolved in water containing NaCl, KCl, CaCl2 and MgSO4 in physiological ratios of the cations to ensure isotonic solution. The pH of the solution is adjusted to pH 7.4 with HCl, NaOH or tris buffer.

A small amount of iron(III) chloride is added to prevent reduction of the radical.

An injectable solution is prepared which contains:

Radical 50 mmol Sodium chloride q.s.

;.
'`:

WO91/12024 PCTiEPgl/a0Z85 2~7~
KCl, CaC12, MgSO4 q.s.
Tris buffer q.s.
FeC13 O.01 mmol Aqua purificata ad 400 ml EX~MPLE III
Oral Overhauser MRI enh,ancement_aqent for,_a ominal studles A suspension for oral Overhauser MRI studies is prepared as follows:

A radical (e,g, that of Example 11) is added to a vigorously stirred solution of hydroxyethylcellulose in water (pre-stirred for 2.5 h) containing CaNa EDTA to prevent metal-catalyzed oxidation. Aspartame and a solution of anis essence, and methyl and propyl parahydroxybenzoates in ethanol are slowly added. The suspension is filled into a 700 ml bottle. The suspension contains 5 mmol radical.

Radical 5 mmol Hydroxyethylcellulose 7.9 g Methyl parahydroxybenzoate 0.7 g Propyl parahydroxybenzoate 0.14 g Ethanol 10 g Aspartame 0.2 g Anis essence 0.2 g CaNa EDTA 0.1 mmol Water ad 700 ml EXAMPLE IV
,Preparation of_capsules containinq an Overhauser MRI
enhancement aq~ t for oral use Radical ~e.g. of Example 11) 300 mg Amylum may dis q.s.

The powders are mixed and filled into capsules. (Capsule size ~O91/12024 -160- PCT/EP91/0028~

2 0 ~ 5 ~

EX~PLE V
Liposomal Overhauser MRI enhancement aqents for intravenous administration The radical (e.g. that of Example 11) is encapsulated in small unilamellar vesicles according to the method described in EP-A-160552 (Vestas).

The purified liposome dispersion is filled into 5~ ml vials and freeze dried. Each vial contains 1 mmol radical. The product is suspended in 30 ml saline before administration.

EXAMPLE VI
Low concentration intravenous enhancement medium The enhancement media of Examples I and II are diluted, 1 part by volume with 99 parts by volume of water for in~ections to produce more dilute contrast media suitable for use with sensitive SQUID based magnetometers.

Still lower concentrations, e.g. at the 10-10 -10-6 M level, can be produced by further dilution.

EXAMPLE VII
Intravenous Overhauser MRI enhancement a~ent An Overhauser enhancement solution is prepared as follows:

The radical (e.g. that of Example 11~ is dissolved in water containing NaC1, ~C1, CaCl2, MgSO4 in physiological ratio to ensure isotonic.ity solution. The pH of the solution is adjusted to pH 7.4 with HCl, NaOH or tris buffer.

A small amount of iron(III) chloride is added to prevent reduction of the radical.

An injectable solution is prepared which contains:

~'091/1~,024 PCT/~P91/0028;
-161- 2~7~
.;
Radical 50 mmol Sodium chloride q.s.
KCl, CaCl2, MgSO4 q.s.
Tris buffer q.s.
FeCl3 0.0l mmol Aqua purificata ad 170 ml EXAMPLE VIII
Intravenous Overhauser MRI enhancement aqent An Overhauser enhancement solution is prepared as follows:

The freeze dried radical (e.g. of Example ll) is dissolved in oxygen-free water. The pH of the solution is adjusted with tris buffer to pH 7.4. CaNa EDTA is added to prevent metal catalyzed oxidation. Ascorbic acid is added as an antioxidant.

An injectable solution is prepared which contains:

Radical 70 mmol Sodium Chloride q.s.
Tris buffer q.s.
CaNa EDTA O.l mmol Ascorbic acid 0.0l mmol Aqua purificata ad 50 ml ;' .~

Claims (25)

Claims
1. The use of an inert carbon free radical for the manufacture of a contrast medium for use in electron spin resonance enhanced magnetic resonance imaging.
2. Use as claimed in claim 1 of an inert triarylmethyl.
3. Use as claimed in claim 2 of a triarylmethyl wherein the aryl moieties, which may be the same or different, each comprise an optionally substituted 6-membered carbocyclic or heterocyclic ring optionally carrying one or more fused carbocyclic or heterocyclic rings.
4. Use as claimed in claim 3 of a triarylmethyl wherein one or more of the aryl moieties carries at least one fused ring of formula wherein each X, which may be the same or different, is an oxygen or sulphur atom and R7 represents hydrogen or an optionally hydroxylated methyl group.
5. Use as claimed in claim 1 of a triarylmethyl of formula I
.CAr? (I) where each group Ar1, which may be the same or different, is an optionally substituted phenyl, 4-pyridinyl, 3-pyridinyl, 2-pyridinyl, 5-pyrimidyl or 4-pyrimidyl group.
6. Use as claimed in claim 5 of a triarylmethyl of formula I
where each group Ar1 represents a 6-membered ring optionally substituted at the or any ortho carbon by a group R1, R2, R3 or R4, at the or any meta carbon by a group R2 or R3 and at any para carbon by a group R1,R2,R3 or R4, with the proviso that no more than two ring carbons are unsubstituted, each of R1, R2, R3 or R4, which may be the same or different, independently represents a group of formula -M, -XM, -XAr2 or -Ar2; M
represents a water solubilizing group, each group X, which may be the same or different, represents an oxygen or sulphur atom or a NH or CH2 group, Ar2 represents a 5 to 10 membered aromatic ring optionally substituted by a solubilizing group M, or groups R1 and/or R4 on different Ar1 groups may together represent bridging oxygen or sulphur atoms or NR5 or CR52 groups; where R5 represents a hydrogen atom or an optionally hydroxylated, optionally aminated, optionally alkoxylated, optionally carboxylated alkyl, oxo-alkyl, alkenyl or alkaryl group, or groups R2 and R3 may also represent hydrogen atoms or alkyl groups, or adjacent pairs of groups R1, R2, R3 or R4 together with the two intervening carbon atoms may represent groups of formula or where R6 represents a hydrogen atom, a hydroxyl group, an optionally alkoxylated, optionally hydroxylated acyloxy or alkyl group or a solubilising group M; Z represents an oxygen or sulphur atom or a group NR5, CR72 or SiR27, each R7, which may be the same or different, represents a hydrogen atom, an alkyl, hydroxyalkyl, carboxy, alkoxycarbonyl or carbamoyl group or two R2 groups together with the atom to which they are bound represent a carbonyl group or a 5 to 8 membered cycloalkylidene, mono- or di-oxacycloalkylidene, mono- or di-azacycloalkylidene, or mono- or di-thiacycloalkylidene group optionally with the ring attachment carbon replaced by a silicon atom and R7 where it is other than hydrogen, is optionally substituted by a group R6, or a salt thereof.
7. Use as claimed in claim 6 of a triarylmethyl of formula I, wherein one or more of the aryl moieties is of formula or where each Y independently represents CH, CM, C-XM, C-Ar2, C-XAr2 or a nitrogen atom and R1 to R4, M, X and Ar2 are as defined in claim 6.
8. Use as claimed in claim 1 of a triarylmethyl wherein at least one of the aryl moieties is of formula where R1 is as defined in claim 6.
9. A radical compound of formula Ia .CAr? (Ia) wherein each Ar12 which may be the same or different represents a 6-membered carbocyclic or nitrogen-containing heterocyclic ring, at least one group Ar12 being a group Ar1 as defined in either of claims 5 and 6.
10. A compound of formula Ia as claimed in claim 9 wherein the Ar1 group or groups are of formula or where each Y independently represents CH, CM, C-XM, C-Ar2, C-XAr2 or a nitrogen atom where R1 to R4, X, M and Ar2 are as defined in claim 6.
11. A compound of formula Ia as claimed in either of claims 9 and 10 wherein each group Ar12 is a group Ar1.
12. A compound of formula Ia as claimed in any one of claims 9 to 11 wherein each group Ar1 carries two fused groups of formula wherein X and Z are as defined in claim 6.
13. A compound of formula Ia as claimed in claim 12 wherein each group Ar1 carries two fused groups of formula wherein R7 is as defined in claim 6.
14. A compound of formula Ia as claimed in claim 13 wherein each group Ar1 is of formula wherein R1 is a group M or XM and X and M are as defined in claim 6.
15. A triarylmethyl radical-precursor for a radical compound as claimed in any one of claims 9 to 14.
16. A process for the preparation of a radical compound as claimed in any one of claims 9 to 14 comprising subjecting a radical-precursor as claimed in claim 15 to a radical generation step and optionally subsequently modifying the substitution on the aryl moieties.
17. A process for the preparation of a triarylmethyl radical-precursor as claimed in claim 15 comprising one or more of the following steps:

a) (to prepare a triarylmethanol of formula II
HO-C(Ar12)3 (II) (wherein Ar12 is as defined in claim 9)) reacting a compound of formula XXIII

H-Ar12 (XXIII) with alkyl lithium and a compound of formula CO(OR")2 (where R" is an alkyl group);

b) (to prepare a triarylmethanol of formula II) reacting an organometallic compound comprising a metal-linked Ar12 moiety with a compound of formula XXV, XXVI or XXVII

R"OCOOR" (XXV) Ar12COOR" (XXVI) (Ar12)2CO (XXVII);

c) (to prepare a triarylmethanol of formula II) hydrolysing a compound of formula III

Hal-C(Ar12)3 (III);

d) (to prepare a triarylmethanol of formula II) reacting a compound of formula XXVII with a compound of formula Hal-Ar12;

e) (to prepare a triarylmethyl halide of formula III) halogenating a triarylmethane of formula IV
H-C(Ar12)3 (IV) or a triarylmethanol of formula II;

f) (to prepare a triarylmethane of formula IV) reacting a compound of formula XXIII with a trialkoxymethane of formula XXVIII
(R"O)3CH (XXVIII);

g) (to prepare a triarylmethane of formula IV) hydrogenating or otherwise reducing a triarylmethyl halide of formula III or a triarylmethanol of formula II;

h) (to prepare a triarylmethane of formula IV) reacting a compound of formula XXIII with a compound of formula XXIX
(Ar12)n1 CHHaln2 (XXIX) (wherein n1 is 0, 1 or 2 and n2 is 1, 2 or 3 and n1 plus n2 is 3);

i) (to prepare a triarylmethane of formula IV) reacting a compound of formula XXX
(Ar12)2 CHLv (XXX) (wherein Lv is a leaving group) with an organometallic compound comprising a metal-linked Ar12 moiety;

j) (to prepare a triarylacetic acid of formula XXXI
(Ar12)3CCOOH (XXXI)) reacting a triarylmethyl halide of formula III with carbon monoxide or a triarylmethyl organometallic compound with carbon dioxide;

k) (to prepare a compound of formula XXXII
(Ar12)3CCOOOCoC(Ar12)3 (XXXII) reacting a triarylacetic acid of formula XXXI with thionyl chloride and a peroxide;

l) (to prepare a compound of formula XXXIII
(Ar12)3CN=NC(Ar12)3 (XXXIII)) oxidizing a triarylmethylamine halide of formula XXXIV
(Ar12)CNHHal (XXXIV); and ' m) reacting a triarylmethyl radical precursor to modify the substitution on one or more of the aryl moieties.
18. A process as claimed in claim 17 wherein alkyl lithium is used to activate a starting material and wherein the resulting organo-lithium salt is filtered before further reaction.
19. A magnetic resonance imaging contrast enhancing composition comprising a physiologically tolerable inert carbon free radical together with at least one pharmacologically acceptable carrier or excipient.
20. A composition as claimed in claim 18 wherein said free radical is a triarylmethyl as defined in any ane of claims 2 to 14.
21. A method of magnetic resonance investigation of a sample, said method comprising introducing into said sample an inert carbon free radical, exposing said sample to a first radiation of a frequency selected to excite electron spin transitions in said free radical, exposing said sample to a second radiation of a frequency selected to excite nuclear spin transitions in selected nuclei in said sample, detecting free induction decay signals from said sample, and, optionally, generating an image or dynamic flow data from said detected signals.
22. A tricylic aromatic compound comprising a central 5-6 membered carbocyclic or heterocyclic aromatic ring bearing two five-membered fused rings, each said fused ring comprising two ring heteroatoms selected from oxygen and suphur.
23. A compound as claimed in claim 22 of formula XL

(XL) (where X and R7 are as defined in claim 2, y1 is a group CH, N, CCOOR5, CSR5, CM or CXM, R5 and M are as defined in claim 6 and R40 is a hydrogen atom, or an optionally substituted hydroxyl, methyl or formyl group or a group where Z''' is CHOH, C=O or CHHal and Hal is a halogen atom), or a salt thereof.
24. A compound of formula XL as claimed in claim 23 wherein each X is oxygen, each R7 is optionally hydroxylated methyl and is other than N.
25. A process for the preparation of a compound of formula XL, said process comprising condensing a compound of formula XLI

(XLI) (wherein R40' and Y" are groups R40 or y1 as defined in claim 23 or protected such groups, and X is as defined in claim 23) with a compound of formula (R7')2 CX (where R7' is a group R7 as defined in claim 23 or a protected R7 group) under oxidizing conditions and if necessary removing any protecting groups, optionally after reduction (eg with Fe/HCl) of a compound of formula XLII

(XLII) to yield the starting material of formula XLI.
CA002075818A 1990-02-12 1991-02-12 Triarylmethyl radicals and the use of inert carbon free radicals in mri Abandoned CA2075818A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9003105.5 1990-02-12
GB909003105A GB9003105D0 (en) 1990-02-12 1990-02-12 Compositions
GB9012300.1 1990-06-01
GB909012300A GB9012300D0 (en) 1990-06-01 1990-06-01 Compositions

Publications (1)

Publication Number Publication Date
CA2075818A1 true CA2075818A1 (en) 1991-08-13

Family

ID=26296651

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002075818A Abandoned CA2075818A1 (en) 1990-02-12 1991-02-12 Triarylmethyl radicals and the use of inert carbon free radicals in mri

Country Status (14)

Country Link
US (2) US5599522A (en)
EP (1) EP0515458B1 (en)
JP (1) JP3175940B2 (en)
AT (1) ATE126707T1 (en)
AU (1) AU651570B2 (en)
CA (1) CA2075818A1 (en)
DE (1) DE69112384T2 (en)
DK (1) DK0515458T3 (en)
ES (1) ES2076522T3 (en)
FI (1) FI923589A (en)
GR (1) GR3017947T3 (en)
IE (1) IE69365B1 (en)
NO (1) NO923117L (en)
WO (1) WO1991012024A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024528D0 (en) * 1990-11-12 1991-01-02 Instrumentarium Corp Improvements in and relating to magnetic resonance imaging
DK0662004T3 (en) * 1991-08-09 1998-10-19 Nycomed Innovation Ab Use of stable free radicals in magnetic resonance imaging
GB9117258D0 (en) * 1991-08-09 1991-09-25 Hafslund Nycomed Innovation Use of radicals
US5728370A (en) * 1993-04-02 1998-03-17 Nycomed Imaging As Free Radicals
GB9307027D0 (en) * 1993-04-02 1993-05-26 Nycomed Innovation Ab Free radicals
GB9704669D0 (en) * 1997-03-06 1997-04-23 Nycomed Imaging As Free radicals
WO1998022148A1 (en) * 1996-11-20 1998-05-28 Washington University Mri contrast agents and ligands
US6278893B1 (en) 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
DE10029075A1 (en) * 2000-06-13 2001-12-20 Bayer Ag Two- or three-stage preparation of high-purity 3,4-alkylenedioxythiophene-2,5-dicarboxylic derivatives or acids is effected without isolation of the intermediates
NL1017122C2 (en) * 2001-01-16 2002-07-17 Doornes Transmissie Bv Transverse element for a drive belt for a continuously variable transmission.
US7126332B2 (en) * 2001-07-20 2006-10-24 Baker Hughes Incorporated Downhole high resolution NMR spectroscopy with polarization enhancement
NO20031736D0 (en) * 2003-04-15 2003-04-15 Amersham Health As compounds
CN101027310B (en) * 2004-07-30 2012-08-22 通用电气医疗集团股份有限公司 Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process
US9023320B2 (en) 2004-07-30 2015-05-05 Ge Healthcare As Method of producing a composition, composition and its use
EP1940475A4 (en) * 2005-09-28 2010-05-26 Harvard College Hyperpolarized solid materials with long spin relaxation times for use as imaging agents in magnetic resonance imaging
NO20055681D0 (en) * 2005-12-01 2005-12-01 Amersham Health As Method of dynamic nuclear polarization
ATE534407T1 (en) 2005-12-01 2011-12-15 Ge Healthcare As METHOD FOR DYNAMIC NUCLEAR POLARIZATION (DNP) USING A TRITYL RESIDUE AND A PARAMAGNETIC METAL ION
CN101325977A (en) 2005-12-08 2008-12-17 皇家飞利浦电子股份有限公司 System and method for monitoring in vivo drug release using overhauser-enhanced NMR
US20080284429A1 (en) * 2005-12-10 2008-11-20 The President And Fellows Of Harvard College Situ Hyperpolarization of Imaging Agents
ES2393750T3 (en) * 2005-12-16 2012-12-27 Ge Healthcare As Procedure for producing hyperpolarized carbosylates of organic amines
US20090252686A1 (en) * 2006-01-11 2009-10-08 President And Fellows Of Harvard College Ex Vivo Hyperpolarization of Imaging Agents
JP2009527768A (en) 2006-02-21 2009-07-30 ベルザー,アブラム Hyperpolarization methods, systems and compositions
US8703102B2 (en) 2008-04-04 2014-04-22 Millikelvin Technologies Llc Systems and methods for producing hyperpolarized materials and mixtures thereof
JP2009531422A (en) * 2006-03-29 2009-09-03 ジーイー・ヘルスケア・アクスイェ・セルスカプ Method for producing hyperpolarized carboxylate and sulfonate
WO2008026937A1 (en) 2006-08-30 2008-03-06 Ge Healthcare As Method of dynamic nuclear polarisation (dnp) and compounds and compositions for use in the method
WO2008123504A1 (en) 2007-03-30 2008-10-16 Fujifilm Corporation Ultraviolet ray absorber composition
CN101821273A (en) 2007-08-16 2010-09-01 富士胶片株式会社 Heterocyclic compound, ultraviolet ray absorbent, and composition comprising the ultraviolet ray absorbent
EP2072061A1 (en) 2007-12-19 2009-06-24 GE Healthcare Limited Composition and method for generating a metabolic profile using 13C-MR detection
JP2010059235A (en) 2008-09-01 2010-03-18 Fujifilm Corp Ultraviolet absorbent composition
US20100092390A1 (en) * 2008-10-09 2010-04-15 President And Fellows Of Harvard College Methods for Making Particles Having Long Spin-Lattice Relaxation Times
US8697034B2 (en) 2008-10-10 2014-04-15 The Board Of Regents Of The University Of Texas System Hyperpolarized 89-yttrium and methods relating thereto
WO2011029854A1 (en) 2009-09-10 2011-03-17 Ge Healthcare Limited 13c-mr detection using hyperpolarised 13c-fructose
US8593141B1 (en) 2009-11-24 2013-11-26 Hypres, Inc. Magnetic resonance system and method employing a digital squid
EP2555803B1 (en) 2010-04-08 2018-09-12 Bracco Imaging S.p.A Process for preparing hyperpolarized substrates and method for mri
US8970217B1 (en) 2010-04-14 2015-03-03 Hypres, Inc. System and method for noise reduction in magnetic resonance imaging
EP2399913B1 (en) * 2010-06-25 2013-09-18 Universität Potsdam Fluorescent dye and its application
FR2967158A1 (en) * 2010-11-08 2012-05-11 Phosphoenix Sarl NEW TRIARYLMETHYL RADICALS: THEIR PREPARATION AND APPLICATION
US9511154B2 (en) 2011-10-12 2016-12-06 Bracco Imaging S.P.A. Process for the preparation of hyperpolarized derivatives for use in MRI analysis
WO2013083535A1 (en) 2011-12-05 2013-06-13 Bracco Imaging Spa Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation mri analysis
US9925280B2 (en) 2012-04-02 2018-03-27 Bracco Imaging S.P.A. Hyperpolarized amino acids
JP6026824B2 (en) * 2012-09-04 2016-11-16 紀本電子工業株式会社 Method for producing radical anion of aromatic nitro compound
JP7427354B2 (en) 2018-01-29 2024-02-05 日清オイリオグループ株式会社 Oil and fat composition for cooking rice, rice, and method for producing rice

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3328365A1 (en) * 1983-08-03 1985-02-21 Schering AG, 1000 Berlin und 4709 Bergkamen NEW DIAGNOSTIC AGENTS
IE61448B1 (en) * 1987-06-23 1994-11-02 Hafslund Nycomed Innovation Improvements in and relating to magnetic resonance imaging
GB8819753D0 (en) * 1988-08-19 1988-09-21 Nycomed As Apparatus

Also Published As

Publication number Publication date
EP0515458B1 (en) 1995-08-23
IE69365B1 (en) 1996-09-04
FI923589A0 (en) 1992-08-11
ATE126707T1 (en) 1995-09-15
US5827501A (en) 1998-10-27
AU7235091A (en) 1991-09-03
JP3175940B2 (en) 2001-06-11
NO923117L (en) 1992-10-08
DE69112384D1 (en) 1995-09-28
IE910462A1 (en) 1991-08-14
DK0515458T3 (en) 1995-09-25
NO923117D0 (en) 1992-08-11
WO1991012024A1 (en) 1991-08-22
AU651570B2 (en) 1994-07-28
DE69112384T2 (en) 1996-03-28
ES2076522T3 (en) 1995-11-01
JPH05506428A (en) 1993-09-22
FI923589A (en) 1992-08-11
US5599522A (en) 1997-02-04
GR3017947T3 (en) 1996-02-29
EP0515458A1 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
CA2075818A1 (en) Triarylmethyl radicals and the use of inert carbon free radicals in mri
US5728370A (en) Free Radicals
US5435991A (en) Use of persistent heterocyclic free-radicals in magnetic resonance imaging
KR19980701674A (en) Bismuth compounds
US5530140A (en) Free radicals
US5554357A (en) Magnetic resonance imaging agents containing hydrazide moieties
EP0966414B1 (en) Triarylmethyl free radicals as image enhancing agents
CN114315880B (en) Near infrared two-region fluorescence and photoacoustic bimodal imaging reagent based on fluorine-boron complex
US6063360A (en) Free radicals comprising benzodithiole derivatives
WO1993002710A2 (en) Use of persistent free radicals in magnetic resonance imaging
WO2011131912A1 (en) Magneto-optical nano-objects for cancer detection
Zapolotsky et al. Synthesis, crystal structure and NMR-study new mononuclear paramagnetic Er (III) complex based on imine derivatives of thiacalix [4] arene
Bogatian et al. Pyrylium Salts with Long Alkyl Substituents, II 2, 4-Dimethyl-6-undecylpyrylium Perchlorate and Derived Pyridinium Salts
Jiang et al. AIE activity, mechanochromic property and solvent inclusion of two β-diketones with tetraphenylethylene unit
WO2020263761A1 (en) Iron(iii) and gallium(iii) metal organic polyhedra, methods of making same, and uses thereof
Merlic et al. Synthesis of Quadruply Carbon-13 Labeled Tetramethyltetrathiaful Valene
WO2012062975A1 (en) Novel triarylmethyl radicals: preparation and use thereof
SHAHBAZI et al. Synthesis and Application of New Gadolinium-Porphyrins as Potential MR Imaging Contrast Agents for Cancer Detection in Nude Mice
MXPA97005609A (en) Composite of bism
JPS6312055B2 (en)

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued